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Abstract 
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Growth Rates. Doctor’s dissertation. 
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Initiation of chromosome replication is a tightly controlled process. We have developed a 
stochastic model with all known major features of the regulation of the initiation in 
Escherichia coli, which automatically generates the correct initiation frequency and 
chromosome number, synchronous initiation of multiple origins and increasing cell size 
with increasing cell growth rate. We further suggest a principle for how an initiator may at 
the same time adequately regulate its own gene expression.    
   In Eubacteria, macrolide antibiotics bind at the entrance of the nascent peptide exit tunnel 
of the large ribosomal subunit and induce premature termination of translation by drop-off 
of peptidyl-tRNA. We have combined biochemical experiments and in vivo growth 
experiments with modelling to study peptide-mediated resistance against two different 
macrolides, erythromycin and josamycin. The mechanism behind resistance is different for 
the two drugs. In the case of erythromycin, we have verified that synthesis of a cis-acting 
peptide accelerates the rate of dissociation of erythromycin. In the case of josamycin, the 
drop-off rate of peptidyl-tRNA is considerably slowed down for a peptide sequence 
mediating resistance in relation to a control peptide sequence. We also show that peptide-
mediated resistance requires the AcrAB-TolC efflux system in the cell membrane. 
   The most widely spread resistance mechanism against macrolides are a modification of 
the 23S rRNA by an Erm methylase which considerably lowers the affinity of macrolides to 
the ribosome. Induction of erythromycin resistance by ErmC requires ribosomes both with 
and without erythromycin. Modelling suggests that there exists a maximal induction rate of 
the synthesis of ErmC and resistant ribosomes at a certain concentration of the antibiotic. 
      We also derive how bi-stable growth rates may arise for bacterial cells growing 
exponentially at a fixed external antibiotic concentration as a consequence of low 
membrane permeability of the drug and high growth rate sensitivity to the intracellular 
concentration of the drug concentration. 
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Chromosome replication in Escherichia coli 
Introduction 
The regulation of chromosome replication in the gram-negative Enterobacteriaceae 
family member, Escherichia coli, is the most thoroughly studied within Eubacteria. 
The genome consists of a single circular chromosome and initiation of replication 
starts at a unique site, oriC (Marsh & Worcel, 1977). Two replication forks move 
along the chromosome bi-directionally from oriC to the ter sites in the terminus 
region (Hill, 1996). For generation times between 60 minutes down to the shortest 
generation time of 20 minutes, it takes about 40 minutes to complete one round of 
replication (the C-period) and another 20 minutes to complete cell division 
following termination of replication (the D-period). Since it takes 60 minutes to 
complete one cell cycle, the bacterium have overlapping cell cycles at generation 
times below 60 minutes, and also overlapping rounds of replication for generation 
times below 40 minutes (Fig. 1). A cell is then born with 2, 4 or 8 origins and 
replication initiates in the mother, grandmother or grand-grandmother generation, 
respectively. When the generation time is longer than 60 minutes there also exists a 
time period between cell birth and initiation of replication (the B-period) (Cooper 
& Helmstetter, 1968). Multiple origins initiate synchronously and initiation is 
triggered once every cell generation (Skarstad, Boye & Steen, 1986; Boye, Løbner-
Olesen & Skarstad, 2000). Three proteins seem central for initiation control (see 
below). The DnaA protein binds at oriC and builds-up a nucleoprotein complex, 
which promotes strand opening and thereby initiates replication  (Messer, 2002). 
Along the chromosome DnaA binding sites are scattered, where the datA locus 
reached by the replication fork eight minutes after initiation are known to titrate the 
highest number of DnaA molecules (Kitagawa et al., 1996). DnaA exists in two 
forms, DnaA-ATP and DnaA-ADP and DnaA-ATP is active at initiation (Messer, 
2002). Both forms of DnaA can repress the dnaA gene (Speck, Weigel & Messer, 
1999). Conversion of DNA-bound DnaA-ATP to DnaA-ADP is stimulated by 
passage of the replication fork (called RIDA) (Katayama et al., 1998). Following 
initiation  oriC becomes hemi-methylated. The SeqA protein and the 
methyltransferase Dam regulate the methylation status of oriC. SeqA binds oriC 
after initiation and prevents immediate re-methylation by Dam (Lu et al., 1994; 
von Freiesleben, Rasmussen & Schaechter, 1994; Løbner-Olesen, Skovgaard & 
Marinus, 2005). Fig. 2 shows the three proteins involvement in the control of 
replication initiation. 
 
The DnaA protein and its role in replication control 
DnaA binding sites 
Along the chromosome are different types of DnaA binding sites scattered. The 
DnaA box is a 9-mer with the consensus sequence 5´-TT
T/ATNCACA which both 
forms of DnaA bind with the same affinity (KD between 0.6 and 50 nM) and 
constitutes a strong DnaA binding site (Messer, 2002). About 300 DnaA boxes of 
the stringent form are found on the E.coli genome (Roth and Messer, 1998). Less 
stringent definitions of the 9-mer also exist. In addition to DnaA boxes, DnaA-ATP   8
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Growth and division for a cell with a generation time of 60 or 20 minutes, 
respectively. It takes 40 minutes to complete one round of replication and division occurs 
20 minutes after termination of replication, why the cell with a generation time of 20 
minutes has overlapping rounds of replication. 
 
 
 
 
 
 
 
Figure 2. Proteins involved in the regulation of chromosome replication. DnaA (in the 
ATP-form) triggers initiation at oriC. Following initiation oriC becomes hemi-methylated 
and sequestered by the SeqA protein, preventing initiation. The dnaA gene, located one 
minute away from oriC is similarily sequestered by SeqA after initiation and both forms of 
DnaA can repress dnaA expression. The Dam enzyme methylates hemi-methylated GATC 
sites. The datA locus, located eight minutes away from oriC can bind a high number of 
DnaA molecules.   9 
also binds 6-mer sequences called DnaA-ATP boxes. The affinity to the less 
stringent 9-mer DnaA boxes and to DnaA-ATP boxes is lower (KD about 400 nM) 
than to the stringent strong DnaA box (Messer, 2002). In oriC, there is also weak 
9-mer sequences, I-sites, which binds DnaA-ATP (Grimwade, Ryan & Leonard, 
2000). All the weak boxes require an adjacent strong 9-mer DnaA box for DnaA 
binding (Messer, 2002; Leonard & Grimwade, 2005).  Besides the primary 
nucleotide sequence of the DnaA box is the sequence surrounding the box of 
importance for DnaA binding efficiency (Schaper & Messer, 1995). 
The site known to titrate the highest number of DnaA molecules (about 370 in 
vitro) is called datA (DnaA titration). It is located 470 kb from oriC and is reached 
by the replication fork approximately eight minutes after initiation (Kitagawa et al., 
1996). At initiation a nucleoprotein complex involving 20-30 DnaA monomers are 
formed (Messer, 2002). A fine-tuned sequential order of DnaA binding to boxes 
with varying affinity has been unravelled which suggest a switch, quickly creating 
strand opening once a high enough free concentration of the DnaA protein is 
reached (see orisome building below). Besides datA and oriC only four additional 
high-affinity binding sites, rather evenly distributed along the chromosome, have 
been found. No consensus as to the number and spacing of the DnaA boxes as well 
as the ±40 bp sequences surrounding the DnaA boxes were found which could 
explain why these sites bind DnaA with high affinity (Roth & Messer, 1998).  
 
Orisome building by DnaA 
Binding of DnaA-ATP to the AT-rich region at the left border of oriC (Fig. 3) 
promotes strand opening followed by the consequent loading of the enzymes 
required for replication fork assembly and movement (DnaB helicase, DnaG 
primase and DNA polymerase III etc.) (Messer, 2002). Therefore, the building of a 
stable orisome (nucleoprotein complex at oriC) by binding of DnaA-ATP to the 
AT-rich region should be a key event to be tightly regulated to generate the correct 
timing of initiation of replication. Regulation by the rate of DnaA-ATP 
accumulation in the cell and by fine tuned differences in binding affinities of the 
DnaA binding sites in oriC appear as a straightforward way to achieve this, and is 
supported by experiments. Results from replication-synchronised cultures indicate 
that there may exist a cell cycle dependent oscillation of DnaA-ATP, where the 
fraction of DnaA in the ATP-form temporarily increases at the time of initiation 
(Kurokawa et al., 1999). The affinity for DnaA of the different types of binding 
sites in oriC varies, and can be grouped in three classes: (i) strong sites (R1, R2, 
R4), (ii) weak sites (R5, R3, I1, I2, I3) and (iii) the single stranded DnaA-ATP box 
within the 13-mers in the AT-rich region (Leonard & Grimwade, 2005).  
In addition to DnaA, the Fis (factor of inversion stimulation) and the IHF 
(integration host factor) proteins stand out as important in the control of orisome 
assembly. DnaA is bound to the strong sites R1, R2 and R4 most of the cell cycle 
(Samitt et al., 1989) while DnaA binding to the other sites in oriC only occurs at 
the time of initiation (Ryan et al., 2004). Similarly, Fis is bound most of the cell 
cycle at its primary binding site next to the R2 box while IHF only bind at the time 
of initiation (Cassler, Grimwade & Leonard, 1995). Foot printing studies in vitro 
showed that Fis suppresses IHF and DnaA binding to the weak sites but an   
  10
 
Figure 3. Binding sites of DnaA and SeqA and the primary binding sites of IHF and Fis 
within the E.coli replication origin, oriC. The sequences are all derived from the top DNA 
strand and are in the correct orientation on that strand. The 9-mer DnaA boxes (R1, R2, R3, 
R4, R5 (or M)) binds both DnaA-ADP and DnaA-ATP while the I-sites (I1, I2, I3) and 6-
mer DnaA-ATP boxes in the AT-rich region only binds DnaA-ATP. The GATC sites, which 
binds SeqA when hemi-methylated, are shown in bold text. Adapted from Leonard & 
Grimwade (2005). 
 
increased concentration of DnaA weakened Fis binding and allowed IHF to bind 
along with DnaA to the remaining R boxes, R5 and R3, and the I-sites. At this 
point the AT-rich region is unwound and DnaA-ATP binds to the ssDNA 13-mer 
sites ensuring stable strand separation (Ryan et al., 2002; McGarry et al., 2004; 
Ryan et al., 2004). Taken together, it suggests that a raising level of DnaA-ATP 
can create a switch with the aid of Fis and IHF during orisome assembly to rapidly 
form a stable orisome once the DnaA-ATP concentration has reached a certain 
concentration.  
 
DnaA as a repressor of transcription 
The dnaA gene is transcribed from two promoters, dnaAp1 and dnaAp2, where 
dnaAp2 is the strongest (Hansen, Hansen & Atlung, 1982; Chiaramello & Zyskind, 
1990). DnaA binding sites, two 9-mer DnaA boxes and three 6-mer DnaA-ATP 
boxes are located between the promoters (Speck, Weigel & Messer, 1999). 
Inactivation of DnaA in temperature-sensitive mutants derepresses dnaA 
transcription and DnaA overproduction leads to repression of the chromosomal 
dnaA expression (Atlung, Clausen & Hansen, 1985). Speck, Weigel & Messer 
(1999) studied expression of the two promoters in vitro in the presence of either 
DnaA-ATP or DnaA-ADP for concentrations between 0 and 300 nM. 
Transcription from the promoters decreases sharply and simultaneously from 100% 
to 40 % when adding DnaA-ATP up to 100 nM and is negligible at 300 nM. 
Expression from the two promoters also decreases synchronously when increasing 
the DnaA-ADP concentration but the change is less distinct than in the presence of 
DnaA-ATP. Up to 200 nM the expression level roughly decreases two-fold when 
doubling the DnaA-ADP concentration. At 300 nM the promoters still show 
approximately 35% activity. Thus, both forms of DnaA can repress transcription, 
and promoter activity is more sensitive to changes in the DnaA-ATP concentration 
than to the DnaA-ADP concentration (Speck, Weigel & Messer, 1999).    11 
DnaA also represses the expression of other genes, e.g. the mioC, uvrB and rpoH 
genes. DnaA has also been reported to activate transcription of the glpD gene and 
the nrd operon (Messer & Weigel, 1997). However, DnaA was recently shown to 
repress the nrd operon (Gon et al., 2006). The nrd operon encodes the two 
subunits of the ribonucleotide reductase (RNR) enzyme which catalyses the 
reduction of ribonucleotides to deoxyribonucleotides. The nrd promoter contains 
two 9-mer DnaA boxes as well as sequences for DnaA-ATP boxes (Gon et al., 
2006), similar to the region between the dnaA gene promoters.  
 
Conversions between the two forms of the DnaA protein 
Newly synthesised DnaA protein is expected to form complex with ATP since the 
ATP concentration in the cell is approximately ten times higher than the ADP 
concentration (Bochner & Ames, 1982). Spontaneous hydrolysis of ATP to ADP 
and exchange of nucleotides are slow in solution. The spontaneous rate of ATP 
hydrolysis corresponds to a 50% percent reduction of DnaA-ATP in 15 minutes. 
About 50% of the DnaA-ADP complexes had changed nucleotide after 30 minutes 
in excess ATP. Similar results were observed for the nucleotide exchange of 
DnaA-ATP (Sekimizu, Bramhill & Kornberg, 1987). Besides spontaneous 
conversions between the DnaA forms, there exists a regulated inactivation of 
DnaA-ATP to DnaA-ADP connected to the movement of the replication fork. 
Acidic phospholipids in the cell membrane can dissociate a nucleotide bound to 
DnaA, which offers a rejuvenation pathway of inactive DnaA-ADP to active 
DnaA-ATP, but its significance in vivo is unclear. 
 
Regulatory inactivation of DnaA 
Regulatory inactivation of DnaA (RIDA) accelerates the hydrolysis of ATP bound 
to DnaA, generating DnaA-ADP, which is incapable of triggering initiation of 
replication. The essential components of RIDA are the β-subunit of the DNA 
polymerase III holoenzyme, encoded by the dnaN gene, and the Hda (“homologous 
to DnaA”) protein (former named IdaB) (Katayama et al., 1998; Kato & 
Katayama, 2001). The β-subunit is called the “the sliding clamp” because it forms 
a ring-shaped homodimer, which encircles and slides on DNA (Kuriyan & 
O’Donnell, 1993). Based on the in vitro observations that RIDA require dsDNA 
present in cis to the loaded β clamp, that the Hda protein forms a stable complex 
with the sliding clamp and that DnaA-ATP bound to DnaA boxes present in trans 
are less sensitive to RIDA than free DnaA-ATP, Su’etsugu et al. (2004) suggest 
that DnaA-ATP proteins bound to DnaA binding sites along the chromosome are 
released by passage of the replication fork and converted to DnaA-ADP by 
interacting with a dsDNA:β clamp:Hda complex. 
In an asynchronous, exponentially growing wild-type culture only 15-30% of the 
DnaA protein exist in the ATP form. To sustain a high DnaA-ADP fraction 
ongoing replication is required as shown by comparing a wild-type culture to a 
dnaN temperature sensitive (Ts) mutant culture grown at the restrictive 
temperature. A high percentage DnaA-ADP also requires de novo synthesis of 
DnaA as demonstrated by the same dnaN (Ts) mutant grown at the restrictive 
temperature in the presence and absence of chloramphenicol, which inhibits 
translation (Kurokawa et al., 1999).   Cells with a deleted hda gene, Δhda, have an  12
asynchronous, over-initiating phenotype (Camara, Skarstad & Crooke, 2003; 
Camara et al., 2005; Morigen, Molina & Skarstad, 2005). The DnaA/total protein 
ratio is only slightly increased while the oriC/terminus ratio is significantly 
increased (~ 2 times) in a Δhda strain compared to the wild-type (Camara et al., 
2005). Measurements of the oriC/terminus ratio in an hda (Ts) mutant gave the 
same qualitative results (Kato & Katayama, 2001). RIDA is usually assumed to be 
required for reducing the initiation potential following initiation, why the Δhda 
phenotype has been ascribed the cells expected inability to reduce the initiation 
potential (Morigen, Molina & Skarstad, 2005). However, the growth defect seen in 
a Δhda strain was overcome by overexpressing the ribonucleotide reductase (RNR) 
enzyme, which catalyses the reduction of ribonucleotides to deoxyribonucleotides 
(dNTPs). DnaA regulates the nrd genes encoding RNR, as described above. The 
apparent connection between Hda presence and RNR indicates that the distorted 
replication observed in Δhda cells at least partly is a consequence of an increased 
repression of the nrd expression by an increased concentration of DnaA-ATP in 
the cell, generating a lack of dNTPs and DNA fork stalling (Gon et al., 2006). 
Perhaps the adverse effect on growth and the regulation of replication initiation 
observed in Δhda cells, mainly follow from altered gene expression of dnaA and 
nrd, both regulated by DnaA. Recently, Riber et al. (2006) showed a correlation 
between the Hda concentration in the cell and dnaA gene expression. 
 
Acidic phospholipids 
Acidic phospholipids e.g. cardiolipin, in a fluid phase membrane, accelerates the 
dissociation of either of the nucleotides in complex with DnaA and are responsible 
for the increased rate of nucleotide exchange detected in vitro. Phospholipid 
treated DnaA-ADP can be reactivated and trigger in vitro replication in the 
presence ATP, oriC DNA and replication enzymes (Sekimizu & Kornberg, 1988). 
Since the free ATP concentration in the cell is expected to be much higher than the 
free concentration of ADP, it suggests that phospholipids constitute a rejuvenation 
pathway for DnaA-ADP to DnaA-ATP. Recent in vitro experiments using DnaA-
ATP interacting with membrane to study the exchange of DnaA bound nucleotides 
by phospholipids suggest that there exists a switch in the phospholipd/DnaA 
protein ratio at which the dissociation rate constant of phospholipid promoted 
nucleotide dissociation is changed. When the membrane occupancy is low enough, 
the rate of nucleotide dissociation is increased, which makes dissociation critically 
dependent on the crowding of total protein on the membrane (Aranovich et al., 
2006).  
Initiation of replication is dependent on the presence of acidic phospholipids in 
the cell membrane. When the concentration of acidic phospholipids drops below a 
critical level, DnaA-dependent initiation of replication at oriC is inhibited and cell 
growth arrests (Xia & Dowhan, 1995; Zheng et al., 2001). Constitutive replication 
initiated from oriK sites or mutated DnaA protein in the carboxyl region required 
for DnaA-phospholipid interactions in vitro, allows replication to proceed and 
restores cell growth (Xia & Dowhan, 1995; Zheng et al., 2001). However, while 
this suggests that DnaA binding to acidic phospholipids in the membrane is 
essential for initiating replication it does not directly implicate that acidic 
phospholipids also are responsible for developing a high initiation potential by   13 
accelerating the dissociation of ADP from DnaA at the time of initiation. Instead 
the DnaA-membrane interaction may be a control mechanism to promote proper 
chromosome segregation prior to cell division. Recently Li et al. (2005) showed 
that a mutant DnaA protein, which restores growth in phospholipid-deficient cells, 
does so independent of its capacity to bind and exchange nucleotides. 
 
The initiation mass mess 
For generation times between 60 and 20 minutes, the replication time of the 
chromosome (the C-period) and the time from termination of replication to cell 
division (the D-period) are approximately constant, 40 and 20 minutes, 
respectively (Cooper & Helmstetter, 1968). Donachie (1968) combined the 
findings by Cooper & Helmstetter with cell mass measurements of Salmonella 
typhimurium grown in different media (Schaechter, Maaløe & Kjeldgaard, 1958) 
to introduce the concept of a constant initiation mass, defined as cell 
mass/#chromosome origins, at the onset of one round of replication. Later 
estimates of the initiation mass question its constancy but instead indicate that the 
mass might vary considerably and increase with growth rate (B/r strain) 
(Churchward, Estiva & Bremer, 1981) in some strains of E.coli and stay 
approximately constant in others (K-12 strain) (Wold et al., 1994). The initiation 
mass has most certainly been of conceptual help in the process of elucidating the 
regulation of chromosome replication but probably is its constancy of less 
importance for the bacterium. Instead focus should be on the factors determining 
the initiation mass (Herrick et al., 1996). Many experiments point in the direction 
of the number of DnaA boxes and the number of DnaA molecules in the cell 
determining the initiation mass. Thus, the demand and supply of DnaA seem to set 
the initiation frequency, which determines the cell size at initiation and influences 
the initiation mass accordingly.  
 
Phenotypes resulting from manipulations of the number of DnaA boxes and the 
DnaA concentration  
Results from numerous experiments show that the amount of DnaA in relation to 
the number of DnaA binding sites on the chromosome by and large controls the 
initiation of replication. One way to manipulate the relation between DnaA and its 
binding sites in the cell is to change the concentration of the DnaA protein. When 
the DnaA concentration varies both below and above the normal concentration in 
cells completely dependent on plasmid-borne dnaA expression, the cell size is 
increased or decreased, respectively (Løbner-Olesen et al., 1989). Overproduction 
of DnaA by controlling the expression of the dnaA gene carried on a plasmid 
increases the mini-chromosome copy number (Atlung, Løbner-Olesen & Hansen, 
1987) and the chromosomal gene dosage of oriC proximal DNA but not the overall 
DNA content (Atlung, Løbner-Olesen & Hansen, 1987; Skarstad et al., 1989). The 
response of cells subjected to a gradual elevating DnaA overproduction can be 
divided into 3 states (Atlung & Hansen, 1993). A slight overproduction (up to 1.5 
times the normal DnaA concentration) generates a nearly proportional increase 
between  oriC and DNA concentration. Between 1.5 to 3-fold normal DnaA 
concentration the oriC concentration increases more than the DNA concentration. 
Beyond a 3-fold increase in DnaA concentration there is no further increase of the  14
oriC concentration. Asynchronous initiations of multiple origin cells increase both 
at a lower and higher than normal concentration of DnaA (Løbner-Olesen et al., 
1989; Skarstad et al., 1989; Atlung & Hansen, 1993) although retained synchrony 
in DnaA over-producing cells has also been reported (Løbner-Olesen et al., 1989). 
DnaA overproduction also result in slowed down replication fork movement and 
stalled or collapsed replication forks (Atlung, Løbner-Olesen & Hansen, 1987; 
Løbner-Olesen  et al., 1989; Skarstad et al., 1989; Atlung & Hansen, 1993; 
Simmons et al., 2004), which may explain the disproportional increase between 
oriC and overall DNA concentration.    
Another way to change the wild-type relation between the amount of DnaA and 
its binding sites is to change the number of binding boxes in the cell, either by 
deletion of boxes on the chromosome or by introducing extra boxes, usually 
carried on plasmids. Extra-chromosomal oriC boxes result in larger cells, increased 
asynchrony and derepression of the dnaA promoters (Christensen, Atlung and 
Hansen, 1999). A 4-fold increase in datA dosage (MiniR1-borne datA) or a 12-fold 
increase (pACYC177-borne datA) result in an increased cell size, a decreased 
DNA concentration and a lowered origin/terminus ratio compared to the wild-type. 
The differences accumulate with increasing datA copy number. Introduction of a 
DnaA-overproducing plasmid suppresses the effects of the extra datA sites 
(Morigen, Løbner-Olesen & Skarstad, 2003). With an increasing number of datA 
copies in the cell, increased initiation asynchrony and dnaA derepression also 
follow (Morigen et al., 2001; Morigen, Løbner-Olesen & Skarstad, 2003). 
Interestingly, the 4-fold increase of datA dosage also resulted in a 2-fold increase 
in replication fork movement. A further increase in datA dosage (above 10-fold) 
induces the SOS response and slows down or inhibits replication fork movement. 
The  datA locus has been suggested to be important for reducing the initiation 
potential following initiation because of its capacity of binding a high number of 
DnaA molecules. In line with this idea, deletion of datA was reported to generate 
an asynchronous phenotype (Kitagawa et al., 1998). The fraction of cells 
containing an even number of chromosomes after replication run-out is a measure 
of how synchronously multiple origins fired in the cell. Rifampin blocks de novo 
initiation of replication by inhibiting primer formation but allows ongoing rounds 
of replication to finish. By increasing the concentration of rifampin added in 
replication run-out experiments Morigen, Molina & Skarstad (2005) demonstrated 
that the previously observed initiation asynchrony largely depends on rifampin-
resistance in the ΔdatA strain, allowing for extra rounds of replication to be 
initiated in replication run-out experiments. The cause of the observed rifampin-
resistance is not clear. Besides a moderate increased initiation asynchrony, the 
ΔdatA cells have on the average an 18% lower cell mass compared to wild-type 
cells (Morigen, Molina & Skarstad, 2005). 
Hansen, Christensen & Atlung (1991) proposed that DnaA binds oriC and 
initiates replication when it has saturated all its binding sites outside oriC (the 
initiator titration model, see below). The observed changes in cell size when either 
the DnaA concentration or the concentration of DnaA boxes are changed is in line 
with this idea (Christensen, Atlung & Hansen, 1999; Morigen, Molina & Skarstad, 
2005). An increased concentration of DnaA or deletion of datA generates smaller 
than normal cells as expected if the boxes are saturated faster than normal so that 
initiation takes place earlier during the cell cycle. The increased concentration of   15 
oriC DNA in the DnaA over-producing cells is in line with an increased initiation 
frequency. A lower than normal concentration of DnaA or introduction of extra 
copies of oriC boxes or of the datA locus, result in larger cells as expected if it 
takes a longer time to saturate the DnaA binding sites and initiation therefore 
occurs later than normal during the cell cycle.  
The observed change in replication fork movement is not directly explained by 
alterations in the DnaA protein-DnaA box relation, but it may create changes in 
gene expression of DnaA regulated promoters. If the replication fork movement is 
mainly limited by the supply of dNTPs an altered nrd gene expression may explain 
the effects on fork movement. Overproduction of DnaA slows down the speed of 
replication forks in line with the idea that the free concentration of DnaA-ATP is 
elevated, which represses nrd expression more than normal in these cells. An 
elevated copy number of oriC boxes or of datA seem to cause derepression of the 
dnaA promoters and likewise the nrd promoter might become further derepressed, 
increasing the RNR synthesis and thereby dNTPs production. This may allow a 
faster than normal fork movement, which would explain why replication forks in 
cells with a 4-fold increase in datA dosage moves with twice the speed of wild-type 
replication forks. A changed speed of the replication forks should also change the 
rate DnaA boxes become duplicated and the rate of DnaA-ATP conversion to 
DnaA-ADP by RIDA, which in turn feeds back and affects the DnaA regulated 
gene expression. 
The observed increased asynchrony when the wild-type relation between the 
amount of DnaA protein and DnaA boxes is altered may be generated in at least 
three different ways. Generally, plasmids replicate throughout the division cycle to 
keep a constant plasmid concentration in the host cell. Thus, accumulation of 
DnaA boxes in proportion to the cell volume increase, if carried on plasmids, may 
interfere and disrupt the build-up of an initiation potential, leaving some origins 
fired and others unfired (Christensen, Atlung & Hansen, 1999). Asynchrony in 
cells with a DnaA synthesis below the wild-type level may be generated by a peak 
in the free concentration of DnaA-ATP less distinct at the time of initiation, while 
asynchrony in cells with a DnaA synthesis above the wild-type level may be a 
result of failed oriC sequestration following initiation. Yet another explanation 
may be the disturbed movement of replication forks. Both a high enough DnaA 
overproduction and a high enough datA dosage result in replication fork stalling 
and collapse, which would make cells appear asynchronous in replication run-out 
experiments even if initiation occurred synchronously. 
 
Mini-chromosomes 
The attention that mini-chromosomes, plasmids replicating exclusively from a 
cloned  oriC copy, have received originates from several seemingly puzzling 
properties. Mini-chromosomes are not only compatible with the chromosome but 
replication is initiated in synchrony with the chromosome and a high copy number 
of mini-chromosomes can be maintained within the cell although at high loss 
frequencies (Helmstetter & Leonard, 1987; Løbner-Olesen, 1999). Therefore, it 
seems that E.coli cells do not control mini-chromosomal number and that there 
does not exist a copy number control of the chromosomal origin (Jensen, Løbner-
Olesen & Rasmussen, 1990). However, mini-chromosomes only contain the DNA  16
sequence required for replication initiation and lacks the dnaA gene and the DnaA 
boxes along the chromosome, both of which potentially control initiation of 
replication (Dasgupta & Løbner-Olesen, 2004). Thus, the apparent lack of 
incompatibility of mini-chromosomes only demonstrates that the copy number of 
the origin is not directly regulated but it does not exclude that some other control 
element, with a copy number proportional to the origin, may be regulated. Many 
mini-chromosomes of other species of bacteria show a high incompatibility with 
the chromosomal origin. However, these bacteria also contain a high number of 
DnaA boxes in the origin, which may bind a high number of DnaA molecules 
(Dasgupta & Løbner-Olesen, 2004), suggesting that the origin acts as a control 
element. The high loss frequencies of mini-chromosomes, has been attributed to a 
lack of partition mechanism (Jensen, Løbner-Olesen & Rasmussen, 1990) but may 
also be a consequence of the chromosome determining the initiation potential. 
Once the chromosomal origin has fired among all the oriC copies in the cell, dnaA 
expression is shut-off and DnaA will bind to boxes along the chromosome, 
especially the datA locus. Thus, mini-chromosomes that did not fire prior to the 
chromosomal oriC will not fire, why mini-chromosomes copy number will vary 
from generation to generation dependent on when the chromosomal origin fired. 
 
The Dam methyltransferase 
Dam methylation of GATC sites 
The  dam gene encodes a DNA methyltransferase (DamMT), which transfers 
methyl groups from S-adenosyl-L-methionine to the adenine residues in the 
sequence 5´-GATC-3´ in double-stranded DNA so that they contain an N
6-
methyladenine (Marinus, 1996). Methylation lags behind the replication fork why 
newly synthesised DNA exists in a hemi-methylated state (Campbell & Kleckner, 
1990). Dam methylation affects post-replicative mismatch repair, nucleoid 
structure, control of DNA replication and gene regulation (Løbner-Olesen, 
Skovgaard & Marinus, 2005). Initiation of replication is prevented from a hemi-
methylated oriC (Russell & Zinder, 1987). The Dam enzyme acts as a functional 
monomer and only one strand is modified in each DNA binding event (Urig et al., 
2002). From in vitro experiments, Dam was estimated to scan 3000 GATC sites 
and to methylate 55 sites on the average per binding event in a random walk on 48 
502 base-pairs of λ-DNA containing 116 GATC sites (Urig et al., 2002). The 
highly processive reaction of Dam greatly speeds up DNA methylation, which may 
explain why a low number of Dam molecules (20-130) in the cell can sustain 
GATC methylation during replication (Boye, Marinus & Løbner-Olesen, 1992; 
Szyf et al., 1984; Urig et al., 2002). Processive methylation of DNA also results in 
DNA stretches completely methylated alternated by completely unmethylated 
stretches (Urig et al., 2002). The concentration of Dam is critical for coordination 
of initiations. The cellular level of Dam was controlled using a plasmid-borne dam 
gene with a temperature-inducible promoter and the effect on the regulation of 
replication initiation was studied (Boye & Løbner-Olesen, 1990). Initiation 
synchrony was found only within a narrow temperature range. Most GATC sites 
become methylated within 1-2 minutes, except for the sites in oriC and in the dnaA 
promoter region, which stays hemi-methylated a prolonged period of time 
(Campbell & Kleckner, 1990). Exactly how long oriC and dnaA are sequestered   17 
following initiation is not known. Campbell and Kleckner (1990) estimated the 
time period from the average value in a non-synchronised culture at two different 
growth rates. The calculated sequestration times for two individual GATC sites in 
oriC was approximately 30% for a generation time of about 28 minutes and 
approximately 40% for a generation time of about 53 minutes. This is so often 
cited in the literature as a sequestration period of one-third of a cell cycle 
independent of growth rate. However, one may argue that estimated times from 
only two different generation times might be too uncertain and too scarce data to 
generalise from. The sequestration time of the studied GATC site in dnaA 
promoter region was about 50% shorter than for the sites in oriC. In a synchronised 
culture the same GATC sites in oriC and in the dnaA promoter became methylated 
approximately after the same time, 13 minutes following initiation. (Campbell & 
Kleckner, 1990; Lu et al., 1994). Thus, there is a discrepancy between the 
sequestration periods of oriC and of the dnaA promoter in the non-synchronised 
and synchronised culture. This may be a result of a bad estimate of the 
sequestration time from average values in the non-synchronised culture or there 
really is a difference in length dependent of growth rate and manipulation when 
synchronising the culture may generate a longer sequestration period of the dnaA 
promoter. Thus, how the sequestration period varies with the generation time is not 
clear. 
 
The SeqA protein 
SeqA negatively controls initiation of chromosome replication 
The molecule responsible for the prolonged sequestration time of oriC and dnaA is 
the SeqA protein (Lu et al., 1994). In a seqA null mutant the hemi-methylated state 
was reduced from 13 to 5 minutes for GATC sites in oriC and the dnaA promoter 
in a synchronised culture (Campbell & Kleckner, 1990; Lu et al., 1994). SeqA 
inhibits initiation of replication from oriC in vitro by preventing prepriming 
complex formation (Taghbalout et al., 2000; Torheim & Skarstad, 1999; Wold et 
al., 1998) and in vivo the GATC sequence, number and spacing between the sites 
in  oriC yields full sequestration by SeqA (Bach & Skarstad, 2004; Bach & 
Skarstad, 2005). In vitro, SeqA exhibits a higher affinity for hemi-methylated oriC 
than for fully methylated oriC (Slater et al., 1995; Taghbalout et al., 2000). SeqA 
forms a homotetramer composed of two dimers. One monomer of each dimer binds 
a hemi-metylated GATC site. Thus two nearby located hemi-methylated GATC 
sites are required for a stable complex formation. Binding of SeqA to hemi-
methylated GATC sequences induces a conformational change of the DNA. Two 
SeqA tetramers bind cooperatively when the spacing between the pairs of hemi-
methylated GATC sites is up to 30 bases apart, which induces even longer distance 
interactions between DNA-bound SeqA molecules and also aggregation of free 
SeqA protein onto DNA-bound. No cross-linking between SeqA on separate DNAs 
occurs (Brendler et al., 2000; Han et al., 2003; Han et al., 2004). Electron 
microscopy studies revealed that SeqA preferentially binds to two sites that each 
contains 3 GATC sequences, situated on each side of DnaA box R1 in oriC 
(Skarstad et al., 2000; Skarstad et al., 2001). SeqA binds strongly from the AT-
rich region to the M DnaA box in oriC, especially around DnaA box R1 and M 
(Taghbalout et al., 2000). DnaA bound to a hemi-methylated fragment containing  18
DnaA box R1 and M were completely displaced by an equimolar concentration of 
SeqA. This suggests that SeqA exerts its negative control on replication initiation 
by out-competing bound DnaA molecules from the region required for strand 
opening (Taghbalout et al., 2000). What ends sequestration and triggers 
methylation is not known, but would shed light on the related questions if the 
sequestration period is invariable or variable with growth rate and if the 
mechanism ending sequestration acts in cis or in trans.  
 
SeqA is involved in chromosome organisation and segregation 
Besides limiting replication by oriC sequestration, binding of SeqA to newly 
replicated DNA seems to serve another major function. The ability of SeqA to 
contact other SeqA tetramers bound to hemi-methylated pairs of GATC sites in 
adjacent regions on the same DNA helix, resulting in looping out of intervening 
DNA, is proposed to organise and form a nucleoid structure, which can be 
maintained by other proteins (Brendler et al., 2000; Løbner-Olesen, Skovgaard & 
Marinus, 2005). SeqA foci, which are dependent on replication and have been 
observed in vivo in microscope studies by immunofluorescence and by a SeqA-
GFP construct support this suggestion. The foci probably show how SeqA trails the 
replication forks, forming clusters bound to the newly replicated and hemi-
methylated DNA (Brendler et al., 2000; Hiraga et al., 1998; Hiraga et al., 2000; 
Onogi et al., 1999). Also, in vitro, SeqA binding to DNA affects DNA topology 
resulting in a restraint of negative supercoils (Klungsøyr & Skarstad, 2004; 
Torheim & Skarstad, 1999). SeqA is also involved in proper chromosome 
segregation. The SeqA null mutant phenotype includes abnormal localisation of 
nucleoids concurrent with initiation asynchrony and over-initiations (Bahloul et al., 
1996; Boye et al., 1996; Lu et al., 1994). SeqA overproduction significantly 
increases the sequestration period of oriC and delays nucleoid segregation and cell 
division (Bach, Krekling & Skarstad, 2003). 
      Besides SeqA, the MukFEB proteins are essential for correct chromosome 
partitioning (Hiraga, 1992). MukFEB form a complex in vitro (Yamazoe, Onogi & 
Sunako, 1999) and MukB-GFP is localised in a similar pattern to SeqA in growing 
cells (Hiraga et al., 1998; Onogi et al., 1999).  MukB null mutant cells exhibit 
abnormally large SeqA clusters at abnormal cellular locations (Hiraga et al., 1998; 
Onogi et al., 1999). Homologues of Dam, SeqA and MukFEB only exist in E.coli 
and bacteria closely related to E.coli (e.g. Salmonella). Other gram-negative and 
gram-positive bacteria do not possess SeqA and MukFEB and most of them lack 
Dam (e.g. Bacilllus subtilis) (Hiraga et al., 2000). 
   Since SeqA is a multi-task protein it is difficult to discriminate the effects on 
chromosome organisation and segregation, observed in SeqA mutants or at 
abnormal concentrations of SeqA in the cell, from the effects on replication 
control. In comparison, to the ΔseqA strain, a strain where GATC sites in oriC had 
been changed to GTTC, showed only moderate over-initiations (Bach & Skarstad, 
2004). Because fast growing cells have overlapping cell cycles and the phase of the 
cell cycle varies at different growth rates in relation to the division cycle, the guess 
is that the function of SeqA in replication control (the mechanisms of oriC 
sequestration and its ending) is not coupled to certain steps of the other functions 
of SeqA in chromosome segregation and localisation prior to cell division.   19 
Control of initiation of chromosome replication 
Principally, initiation of replication is regulated so that multiple origins fire 
synchronously and with a frequency matching the current growth rate leaving each 
generation of daughter cells to inherit the same chromosome number. Synchrony 
requires a boost in the initiation potential within a narrow time interval, which 
remains high until all replication origins have initiated once and only once. A 
higher affinity of DnaA to DnaA boxes outside oriC and a higher density of DnaA 
binding sites close to oriC to ensure that replication of binding sites outside oriC 
does not interfere with a raising initiation potential, should contribute to synchrony. 
Following initiation no replication of boxes or binding of DnaA to boxes outside 
oriC, must take place to ensure a high initiation potential until all origins have 
initiated and there must be a period of origin sequestration immediately following 
initiation to prevent a newly fired origin to reinitiate while the initiation potential is 
still high.  
To maintain a well-defined initiation frequency, initiation synchrony is required. 
At a given growth rate the control mechanism must be able to adequately respond 
to deviations in initiation frequency by adjusting the frequency in a way that allows 
for the maintenance of a stable variation of the oriC concentration during each cell 
cycle. When the growth rate changes, so must the initiation frequency. There exists 
compelling experimental evidence that the initiation frequency is mainly regulated 
through the rate of demand and supply of DnaA. The DnaA demand is determined 
by the frequency of DnaA binding sites outside oriC appears during replication 
which depends on the position and the DnaA binding ability of the boxes on the 
chromosome and the rate of replication fork movement along the chromosome. 
The supply is controlled by the de novo synthesis of DnaA, where the regulation of 
dnaA expression may be central. 
 
Previous models 
Many models of initiation of replication in E.coli have been published suggesting 
different principles for its control. The two most interesting suggestions are the 
inhibitor dilution model by Pritchard, Barth & Collins (1969) and the initiator 
titration model by Hansen, Christensen & Atlung (1991), which may be regarded 
as the same principle.   
In the inhibitor dilution model, a fixed number of inhibitors are synthesised at the 
time of initiation. The inhibitor interacts with oriC or the initiator and inhibits de 
novo initiation of replication until it is diluted due to cell growth to half its 
concentration immediately following initiation. Then, the inhibitor has reached a 
threshold level allowing a new round of replication to start.  
In the initiator titration model, DnaA boxes are distributed either evenly along 
the chromosome or with higher density close to oriC. The main idea is that the 
binding affinity of the DnaA boxes in oriC is lower than for boxes located 
elsewhere. During the cell cycle the boxes outside oriC titrate DnaA and when 
saturated, DnaA starts to bind to the oriC boxes triggering initiation. It is further 
suggested that synchrony is promoted by a release of DnaA with retained activity 
followed by rebinding to unfired origins and each origin is refractory to initiation a 
period after initiation.   20
The inhibitor dilution model and the initiator titration model are basically the 
same principle. In the latter model the inhibitor is the DnaA box, which prevents 
initiation as long as there are unsaturated boxes outside oriC. When boxes are 
assumed to be located with high density around oriC, and therefore become 
replicated shortly after initiation, the analogy between the two models becomes 
even clearer. 
 
 
Results and discussion 
A stochastic model of the regulation of initiation of replication 
Despite extensive studies during decades a consensus of the basic principals behind 
replication control in E.coli is still lacking. Chromosome replication is controlled 
by a number of molecular mechanisms acting together within a growing and 
dividing cell. In order to fully understand these coordinated interactions between 
the regulatory units, they must be integrated into a global description of a cell. 
Further, a low copy number of discrete molecules call for a stochastic description, 
where fluctuations of chemical reactions are taken into account (van Kampen, 
1997). We have developed a global stochastic model of the initiation control of 
replication (I) based on the initiator titration model. The chromosome model 
describes the regulation of replication in a single cell, followed during several 
generations of exponential growth and division. Initiation at individual oriCs and 
elongation of individual forks moving along the chromosome is carefully followed. 
We assume that a Markov process models the system and realisations are simulated 
using the Gillespie algorithm (Gillespie, 1976). The time of the next reaction, tevent, 
is exponentially distributed and the inverse of the sum of all reaction rates ri. The 
probability of a certain event is then ri/∑ri. In the model the chromosome is divided 
into 1000 segments, with oriC in segment 1, the dnaA gene in segment 25, the datA 
locus in segment 200 and the ter sites in segment 1000 (Fig. 4). In addition to 
datA, about 300 groups of DnaA binding sites, one DnaA box and two DnaA-ATP 
boxes are equally distributed along the chromosome. DnaA-ADP and DnaA-ATP 
binds a DnaA box with equal affinity, while only DnaA-ATP binds to a DnaA-ATP 
box and only if the nearby DnaA box is bound. The datA locus is assumed to only 
bind DnaA-ATP, which is a critical assumption for the proposed regulation of 
dnaA gene expression (see below). Only one of the bi-directionally moving 
replication forks are modelled and a replication fork replicates one segment at a 
time with a rate constant corresponding to replication of 25 segments per minute on 
the average. Thus, the average time for completing one round of replication (C-
period) is 40 minutes and the dnaA gene and datA locus are reached after 1 minute 
and 8 minutes on the average, respectively. Division occurs 20 minutes after 
replication termination (D-period) implicating that initiation control regulates the 
cell size. Replication of a segment results in dissociation of all DNA-bound DnaA 
molecules on the segment and DnaA-ATP is converted into DnaA-ADP through 
RIDA. Re-methylation of oriC following initiation, is modelled by three different 
scenarios. In scenario I (SI) sequestration termination is modelled ad hoc, 
occurring when the in cis replication fork replicates segment 350, approximately 
14 minutes after initiation. Seven reactions can occur, (i) initiation of replication,  
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Figure 4. A schematic of the modelled chromosome. Replication initiates at oriC and ends 
at ter 40 minutes later, passing the dnaA gene and the datA locus 1 minute and 8 minutes 
after initiation, respectively. In scenario III a hypothetical seq locus is reached 14 minutes 
following initiation, which while hemi-methylated can bind a high number of SeqA 
molecules. In addition to datA (which is assumed to only bind DnaA-ATP) approximately 
300 groups of DnaA binding sites (one DnaA box and two DnaA-ATP boxes) are evenly 
distributed along the chromosome. 
 
(ii) replication of a segment, (iii) synthesis of a DnaA molecule in the ATP form, 
(iv) association of DnaA in either of the nucleotide forms to a DnaA box, (v) 
dissociation of a DnaA molecule from a DnaA box, (vi) association of a DnaA-
ATP molecule to a DnaA-ATP box and (vii) dissociation of a DnaA-ATP molecule 
from a DnaA-ATP box. In scenario II (SII) the eleven GATC sites are re-
methylated in a sequence, either in a specific order or a random order. In scenario 
III (SIII) we have introduced a hypothetical seq locus in segment 350 (Fig. 4), 
which while hemi-methylated, can bind a high number of SeqA molecules, 
drastically lowering the free concentration of SeqA and largely increasing the 
probability of oriC methylation. In scenario II-III two more reactions can occur 
(viii) methylation of the GATC sites in oriC step-wise (scenario II) or by one rate-
limiting step (scenario III) and (ix) methylation of unmethylated GATC sites in 
segments outside oriC. The sequestration period of oriC and the dnaA promoter 
start by replication of segment 1 and 25, respectively, and are assumed to end 
simultaneously in all scenarios. Also, the dnaA promoter is either constitutively 
expressed or dnaA expression is regulated by the free concentration of DnaA-ADP 
in all scenarios. 
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Factors determining the initiation mass 
That initiation takes place at a constant initiation mass has long been a prevailing 
idea (Donachie, 1968). We investigated what exactly is required to maintain a 
constant initiation mass under different growth conditions when dnaA is 
constitutively expressed. We then used a simplified version of scenario I; the datA 
locus close to oriC provided the dominating number of DnaA binding sites and the 
sequestration period of the dnaA promoter following initiation was disregarded. 
Also, the constitutive expression per dnaA promoter was such that the total 
synthesis of DnaA increased strictly proportionally to the growth rate, so that the 
total DnaA concentration was constant, irrespective of the growth medium. This 
means that the expression per dnaA promoter must increase less than 
proportionally to an increasing growth rate since the fraction of dnaA genes 
increases with decreasing generation times. With these assumptions the initiation 
mass or initiation volume were kept constant as seen by the expected increase in 
cell volume by a factor of 4 when decreasing the generation time from 60 minutes 
to 20 minutes (Fig. 4 in I). 
   However, whether the initiation mass is constant or not is probably less relevant 
than how different factors affect the initiation mass (Herrick et al., 1996). We 
therefore investigated how the positioning of additional DnaA binding sites along 
the chromosome, besides the datA locus, affects the initiation mass as well as the 
length of the sequestration period of the dnaA promoter. Additional evenly 
distributed DnaA binding sites will lower the initiation mass with increasing 
growth rate because the number of the additional scattered binding sites will 
decrease at generation times below 40 minutes with overlapping rounds of 
replication. Additional DnaA binding sites close to oriC do not affect the initiation 
mass. If the dnaA promoter is sequestered a constant fraction of the generation time 
the initiation mass stays unchanged while a sequestration period a constant number 
of minutes irrespective the generation time will increase the initiation mass with 
increasing growth rate. The assumptions above of the constitutive expression of 
dnaA implicates that if instead the expression per promoter is strictly proportional 
to the growth rate the initiation mass decreases with increasing growth rate. 
 
Regulation of the expression of the dnaA promoter 
To maintain regulated and synchronous initiations of replication the total 
concentration of the activator should be constant, which is generated by a 
constitutive dnaA promoter perfectly proportional to the growth rate. However, it is 
far from obvious that a neutral expression of the dnaA promoter prevails. Many 
genes are strongly growth regulated (Bremer & Churchward, 1991). One solution 
to this problem would then be a regulated expression of dnaA by the total 
concentration of DnaA. Usually, it is the free concentration of a repressor that 
controls the fraction of promoter-controlling operators. Both DnaA-ATP and 
DnaA-ADP can repress dnaA expression (Speck, Weigel & Messer, 1999), but a 
regulated  dnaA expression by the free concentration of DnaA-ATP poses two 
principle problems, if DnaA-ATP is the key-regulator of initiation. The first 
problem is that an initiator protein, rate limiting for the initiation of replication 
along with a control locus that binds and sequesters the initiator to control 
initiation is inconsistent with an auto-regulated gene expression of the initiator   23 
gene. Titration of the initiator by the control locus counteracts adequate regulation 
of the initiator gene. Binding to the control locus reduces the free concentration of 
the initiator and relieves the auto-repressed initiator gene to compensate for the 
reduction. This has been named the auto-regulation-sequestration paradox 
(Chattoraj, Mason & Wickner, 1988). One solution to this problem has been 
proposed for plasmid P1, where looping of DNA with DNA-bound initiators can 
interact with the promoter of the initiator gene so rather the total than the free 
concentration of the initiator controls initiator gene expression (Chattoraj, Mason 
& Wickner, 1988; Das et al., 2005). The second problem is that if the free 
concentration of DnaA-ATP regulates dnaA expression it strives to keep the free 
concentration of DnaA-ATP constant, inconsistent with a rapid increase in the free 
DnaA-ATP concentration at initiation. Consequently, synchronous initiations are 
precluded.  
    Although,  dnaA expression regulated by the total DnaA concentration 
principally can control replication initiation, the datA locus and RIDA offers 
another solution where the free concentration of DnaA-ADP regulates dnaA 
expression. The principle of the idea is that with one dominating binding locus 
(datA) which predominately binds DnaA in the ATP form and with RIDA 
converting the bound DnaA-ATP at the control locus into free DnaA-ADP, the free 
concentration of DnaA-ADP reflects the flow of DnaA-ATP to DnaA-ADP 
proportional to the total DnaA-ATP concentration and the dilution of DnaA-ADP 
by cell growth. This means that by a dnaA expression controlled by the free 
concentration of DnaA-ADP, the total concentration of DnaA-ATP in the cell can 
be regulated. This way the free concentration of DnaA-ADP will also be 
proportional to the oriC concentration, why another way to understand this 
regulation is by an expression of dnaA striving to keep the free concentration of 
DnaA-ADP constant and thereby a constant concentration of oriC. Fig. 5 shows 
DnaA-ADP regulated dnaA expression for a cell growing with a generation time of 
20 minutes (scenario I). 
 
Two tentative molecular mechanisms ending oriC sequestration 
The time of replication initiation must be well separated from the time of oriC 
methylation to avoid immediate re-initiations or asynchronous initiations. We have 
modelled two principal mechanisms for the re-methylation of oriC following 
initiation. Either the GATC sites became step-wise methylated in a specific or 
random order (scenario II) or methylation occurred in one rate-limiting step after 
replication of a hypothetical seq locus downstream of datA (scenario III). While 
hemi-methylated, the seq locus can bind a high number of SeqA molecules, 
drastically lowering the free concentration of SeqA and largely increasing the 
probability of oriC methylation. Fig. 7 in I illustrates the principles. Both the 
suggested mechanisms generated a wild-type regulation of chromosome 
replication, for the simulated generation times between 60 and 20 minutes either 
with a constitutively expressed or a DnaA-ADP regulated dnaA promoter. The re- 
methylation pattern of individual GATC sites in oriC is presently studied 
experimentally. 
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Figure 5. Regulation of dnaA expression by DnaA-ADP. The cell is born with two 
complete chromosome copies. On each copy replication is halfway through (position 500 in 
A) and another round is about to start. Initiation is triggered (from 4 origins synchronously) 
as a result of the free DnaA-ATP concentration boosting at 20 minutes intervals (C). The 
total DnaA concentration declines during the sequestration period of the dnaA promoter due 
to dilution by cell growth but increases back to a maximal value at the time of initiation (D). 
When the datA locus at position 200 (A) is replicated, the free concentration of DnaA-ADP 
peaks (D). The cell volume varies slightly between generations (B). An early initiation 
results in a somewhat smaller cell at division, which is corrected back by a somewhat later 
initiation the next generation and vice versa. 
 
Future modelling 
We have performed one first critical testing of the chromosome model. The datA 
locus was deleted resulting in a smaller cell and a partial lost of initiation 
synchrony, while the initiation frequency and DNA content virtually remained the 
same (Fig. 5 in I) in accordance with experimental observations from datA deletion 
(Morigen, Molina & Skarstad, 2005). We believe there are three further key tests 
of the model; the observed compatibility of as many as 30 mini-chromosomes per 
oriC with only minor changes in initiation mass or cell size (Løbner-Olesen, 1999), 
the introduction of extra datA loci on plasmids which delays initiation and 
increases cell size (Morigen, Løbner-Olesen & Skarstad, 2003) and finally 
observed responses to a higher or lower total DnaA concentration than wild-type, 
where a low DnaA concentration generates an increased initiation mass and 
increased initiation asynchrony and a high DnaA concentration results in a 
decreased initiation mass and potentially increased initiation asynchrony (Løbner-
Olesen et al., 1989; Skarstad et al., 1989; Atlung & Hansen, 1993). We expect the 
same manipulations within our present model with a DnaA-ADP regulated dnaA   25 
expression to generate virtually the same responses (see Discussion in I). There 
also seem to exist an intricate feedback between the replication fork elongation rate 
dependent on the synthesis of deoxyridonucleotides (dNTPs) by ribonucleotide 
reductase (RNR) and the replication dependent conversion of DnaA-ATP to DnaA-
ADP by RIDA (Gon et al., 2006). The nrd operon encodes RNR and both DnaA 
and DnaA-ATP boxes are found in the promoter region similar to the promoter 
region of the dnaA gene. An important extension of the present model would be to 
include a DnaA auto-repressed expression of RNR connected to the rate of 
replication fork elongation, which may reproduce the observed changes of the rate 
of replication fork movement in the presence of excess DnaA and in the presence 
of extra datA loci on plasmids (Skarstad et al., 1989; Morigen, Løbner-Olesen & 
Skarstad, 2003). 
   The principle for an auto-regulated expression of an initiator presented in I, may 
be represented in a more pure form by gram-positives, e. g. Bacillus subtilis, which 
contain a DnaA binding locus with many more binding sites than datA, next to its 
origin, suggesting the capacity of titrating a high number of DnaA molecules 
(Boye, Løbner-Olesen & Skarstad, 2000; Messer, 2002). Also, the dnaA promoter 
region in B. subtilis contains more DnaA binding sites than in E.coli suggesting 
DnaA-dependent regulation to more important (Ogura et al., 2001). A model of the 
regulation of replication initiation applicable to B. subtilis is in progress. 
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Macrolide antibiotics 
Introduction 
Naturally occurring macrolides are produced by actinomycetes, a group of gram-
positive bacteria, which contains the soil-living subgroup Streptomyces important 
in antibiotic production (Lim, 1989). The common structure of all macrolides is a 
14-, 15- or 16-membered lactone ring, with one or more sugar residues attached to 
it (Fig. 6). Biosynthesis of macrolides is carried out by polyketide synthases 
(PKSs), which is exceptionally large, multifunctional proteins organised into 
coordinated groups of active sites, modules. Each module is responsible for one 
cycle of polyketide chain elongation and associated group modifications in a 
sequence similar to an industrial assembly line. For example, the 6-
deoxyerythronolide B synthase synthesises the macrolactone ring precursor of 
erythromycin antibiotics (Cane, Walsh & Khosla, 1998). The mode of action of 
macrolide antibiotics is to bind to the large ribosomal subunit (50S) close to the 
peptidyl-transferase center (ptc) and interfere with protein synthesis, causing 
growth arrest (Vázquez, 1979). Thus, macrolides belong to bacteriostatic 
antibiotics, which only inhibit growth but do not kill the bacteria in contrast to 
bactericidal antibiotics. Macrolides are often classified together with lincosamide 
and streptogramin B antibiotics (Fig. 6), referred to as MLSB-antibiotics. The 
classification is based on observations that resistance to one class often results in 
resistance to the two other classes (Weisblum, 1995a). Although structurally 
heterogeneous, the classes have overlapping binding sites on the 50S subunit 
(Schlünzen et al., 2001; Hansen et al., 2002; Tu et al., 2005), which explains the 
observed co-resistance within the group. Macrolides are clinically important 
antibiotics for treating respiratory tract infections caused by gram-positive bacteria 
such as the pathogens Staphylococcus aureus and Streptococcus pneumoniae. The 
drugs are also effective to some gram-negative bacteria and Mycoplasma species 
(Alvarez-Elcoro & Enzler, 1999; Zhong & Shortridge, 2001). 
 
Four generations of macrolides 
The history of macrolide antibiotics in clinical use started in 1952, when the 
macrolide erythromycin A was extracted from Saccharopolyspora erythraea 
(formely Streptomyces erythreus), isolated from Philippine soil samples, and its 
antibiotic activity was discovered (Flynn, Powell & Smith, 1952). One year later, 
in 1953, erythromycin was introduced into the clinics but soon inducible MLSB-
resistant isolates of S. aureus appeared (Weisblum, 1995a). Two other macrolides 
were introduced, oleandomycin and megalomicin, which showed only slightly 
improved pharmacokinetics and as in the case of erythromycin exhibited inducible 
resistance. The first generation of 14-membered ring macrolides was followed by 
16-membered ring macrolides such as carbomycin, spiramycin and josamycin in 
the second generation. Initially inducible erythromycin strains remained 
susceptible to 16-membered macrolides. However, erythromycin-inducible strains 
rapidly mutated to a high level resistance of both 14- and 16-membered ring 
macrolides, as well as of lincosamide and streptogramin B antibiotics. Another  
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Figure 6. Chemical structures of some MLSB-antibiotics. 
 
group of resistant strains based on antibiotic efflux also started to spread. The third 
generation is semi-synthetic, more acid-stable and shows a broader activity 
spectrum than the originally 14-membered ring macrolides. Examples from this 
generation of macrolides are clarithromycin, roxithromycin and the 15-membered 
ring macrolide azithromycin. However, the third generation is as effective as the 
first generation in inducing resistance. The broader activity spectrum of the third 
generation, including Mycobacterium intracellulare and Mycobacterium 
tuberculosis, selected for intrinsic MLSB-resistance. The two bacteria only contain  28
a single copy of the 23S rRNA gene, why mutations in the 23S rRNA gene will 
dominate the phenotype and change macrolide binding (see below) (Weisblum, 
1998). The ketolides constitute the fourth generation of macrolides. Ketolides are 
14-membered, semi-synthetic derivatives of erythromycin A (Ackermann & 
Rodloff, 2003). The cladinose sugar residue at position C3 on the lactone ring is 
replaced by a keto-group, which may be the reason why this type of drug does not 
induce MLSB-resistance (“erm” resistance, see below) (Ackermann & Rodloff, 
2003; Tenson & Mankin, 2006). Teliothromycin is the first developed ketolide and 
was introduced for clinical use in 2001 (Ackermann & Rodloff, 2003). 
 
Macrolide binding and mode of action 
Binding site and binding kinetics 
Already in the 1960s it was discovered that erythromycin binds to the large 
ribosomal subunit (Vázquez, 1979 and references therein). In the past few years, 
crystal structures of several MLSB-antibiotics bound to the large ribosomal subunit 
have been published. The large ribosomal subunit from two different organisms 
were used, the eubacterium Deinococcus radiodurans (Dra) and the 
archaebacterium Haloarcula marismortui (Hma) (Schlünzen et al., 2001; Hansen 
et al., 2002; Tu et al., 2005). The published location of the binding sites on the 
ribosome of the antibiotics for the two species is by and large the same. All 
macrolides bind in the nascent exit tunnel between the ptc and the constriction of 
the tunnel exerted by the L4 and L22 proteins (Fig. 7). However, some surprising 
differences in detail have been pointed out (Hansen et al., 2002; Tu et al., 2005). 
The exact binding to the ribosome of the very same drug molecule may be different 
in different organisms (Tenson & Mankin, 2006) and there is one important 
difference in position 2058 (E. coli numbering) in 23S rRNA between the species. 
Dra, as most eubacteria, has an A at position 2058, while Hma, as most 
archaebacteria, carries a G at that position. An A2058G mutation confers resistance 
to MLSB-antibiotics why Hma are intrinsically resistant (Vester & Douthwaite, 
2001). Further, methylation of this very base is the main resistance mechanism 
against drugs of the MLSB-group (see below). However, recently published 
structures of erythromycin, azithromycin and teliothromycin bound to the Hma 
ribosome containing a G2058A mutation, is consistent with previously published 
structures of azithromycin, spiramycin and carbomycin A bound to wild-type Hma 
ribosomes. In all cases, the lactone ring, the central structure of all macrolides, 
show the same orientation. The ring lies flat against the tunnel wall with the 
hydrophobic side of the ring facing a hydrophobic part of the wall and the 
hydrophilic side of the ring faces the lumen of the tunnel. Apart from the lactone 
ring, the sugar residues, different for different macrolides, also interact with the 
tunnel wall. In the case of erythromycin and josamycin (exemplified by very 
structurally similar carbomycin A) their sugar residues are pointing towards the 
ptc, but the sugar of josamycin reaches further than the sugars of erythromycin 
because of differences in size (Hansen et al., 2002; Tu et al., 2005). Interestingly, 
the desoamine sugar of erythromycin makes a single hydrogen bond with base 
2058 which may explain why erythromycin binding is so sensitive to mutations or 
modifications of that base (Tu et al., 2005). In contrast, for example the   
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Figure 7. Inhibition of protein synthesis by macrolides, exemplified by erythromycin. 
(A) shows a cross-section of the large ribosomal subunit along the nascent peptide exit 
tunnel. A few rounds of peptidyltransfer can be carried out in the presence of a bound 
macrolide (B). When the peptide reaches the macrolide molecule, protein synthesis stalls 
(C), followed either by peptidyl-tRNA drop-off ending protein synthesis (D) or spontaneous 
dissociation of the macrolide resuming protein synthesis (E). The L4 and L22 proteins make 
up a constriction in the tunnel, PTC = peptidyltransferase center. 
 
hydrophobic side of the lactone ring of 14-membered macrolides are reported to 
face the hydrophilic lumen of the tunnel in the Dra structure and seven hydrogen 
bonds mediate the binding of the macrolide to the ribosome. Therefore the 
published structures of MLSB-antibiotics bound to Hma seem more reliable than 
the reported corresponding structures in Dra.  
The location of binding and chemical interactions with the 50S subunit is only 
one side of macrolide binding. To further understand the antibiotics mode of action 
it is important to know how they interact with the ribosome on a dynamical level 
described by their kinetic properties. Recent measurements of erythromycin and 
josamycin binding (the macrolides used in the studies in this thesis) show that the 
dissociation constant (KD) of the two antibiotics is fairly similar; KD is 10.8 nM for 
erythromycin and 5.5 nM for josamycin (Lovmar, Tenson & Ehrenberg, 2004). 
However, the rate constants of binding differ considerably. While, the association 
rate constant (ka) and the dissociation rate constant (kd) of erythromycin is 1.0 μM
-
1s
-1 and 10.8·10
-3 s
-1, respectively, the corresponding rate constants of josamycin 
binding is ka = 0.325 mM
-1s
-1 and kd = 0.18·10
-3 s
-1. The difference in kd probably 
explains the observed differences in the amount of formed full-length product in 
the presence of erythromycin or josamycin (Tenson, Lovmar & Ehrenberg, 2003; 
Lovmar, Tenson & Ehrenberg, 2004) (see below), and may be the reason behind 
the different mechanisms of peptide-mediated macrolide resistance for the two 
drugs (II; III) (see below).  
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Peptidyl-tRNA drop-off – the primary effect of macrolide binding 
That erythromycin causes an increased drop-off of peptidyl-tRNA has been known 
since the mid 1970s (see reference within Menninger & Otto, 1982). Peptidyl-
tRNA enhanced drop-off was also confirmed for other types of macrolides. 
Menninger & Otto (1982) conclude that, “It seems likely that stimulated 
dissociation of peptidyl-tRNA from ribosomes is the major mechanism of action of 
macrolide antibiotics”. However, they believed that macrolides stimulated 
peptidyl-tRNA drop-off at any step during translation rather than at a specific step. 
Later, it was shown in vivo that ribosomes are only susceptible to erythromycin 
during initial stages of translation while polysomes are refractory to the drug 
(Andersson & Kurland, 1987). The published structures of macrolides bound to the 
50S subunit along with biochemical experiments where the length of the 
synthesised oligopeptides were reported to vary depending on macrolide, suggested 
a tight relation between macrolide structure and length of dissociated peptidyl-
tRNA (Kirillov et al., 1997; Hansen et al., 2002). Tenson, Lovmar & Ehrenberg 
(2003) further clarified the dependence by using a cell-free translation system with 
components from E.coli and studying peptidyl-tRNA drop-off of MLSB-antibiotics 
from ribosomes translating naturally occurring peptide sequences. All the MLSB-
drugs caused dissociation of peptidyl-tRNA. Antibiotics with a structure which 
reaches the ptc (for example josamycin) caused dissociation of peptidyl-tRNAs 
containing two, three or four amino acids while antibiotics which do not reach ptc 
(for example erythromycin) caused dissociation of peptidyl-tRNA containing six, 
seven or eight amino acids. The data suggest a common mode of action of all 
MLSB-antibiotics, which is modulated by the space available between the drug and 
the ptc. The suggestion is that all antibiotics prevent a nascent peptide entering the 
ribosomal tunnel by steric hindrance (Tenson, Lovmar & Ehrenberg, 2003). 
Lovmar, Tenson & Ehrenberg (2004) showed that a bound antibiotic molecule 
actively stimulates dissociation of peptidyl-tRNA and thus peptidyl-tRNA is not 
merely an effect of ribosome stalling. It has been suggested that 16-membered 
macrolides, such as josamycin, inhibit the peptidyltransfer reaction directly 
(Poulsen, Kofoed & Vester, 2000). However, both di- and tripeptides can be 
formed in the presence of josamycin depending on the size of the amino acid in the 
second position (Tenson, Lovmar & Ehrenberg, 2003; Lovmar, Tenson & 
Ehrenberg, 2004). Further, a considerable amount of full-length products was 
formed in the presence of the MLSB-antibiotics except in the presence of 16-
membered macrolides (Tenson, Lovmar & Ehrenberg, 2003). This may suggest 
that the steric hindrance is incomplete for some macrolides (Tu et al., 2005). 
Structural modelling with erythromycin bound to the 50S subunit proposes that a 
peptide may pass the bound antibiotic molecule and that an eight amino acid long 
peptide would have past the drug while dissociated peptidyl-tRNA containing eight 
amino acids was observed in the presence of erythromycin (Tenson, Lovmar & 
Ehrenberg, 2003; Tu et al., 2005). The peptide was modelled in an extended 
conformation, which may not be the case in vivo (Fig. 7) (Lovmar, 2005). The 
seemingly contradiction between read-through and the suggested mode of 
macrolide action may be explained by the different kinetic properties of 
erythromycin and josamycin. Erythromycin stays bound on the ribosome during 1.5 
minutes on the average while josamycin stays bound 1.5 hours on the average. The   31 
rate constant of peptidyl-tRNA drop-off is approximately the same in the presence 
of either of the antibiotics, which in turn is approximately the same as the 
dissociation rate constant of erythromycin. If it is assumed that macrolides when 
bound completely prevent a nascent peptide to enter the exit tunnel but translation 
can continue if the macrolide spontaneously dissociates before the peptidyl-tRNA 
dissociates, the predicted level of read-through correspond well with the measured 
levels when ribosomes were titrated to saturation by erythromycin or josamycin 
(Lovmar, Tenson & Ehrenberg, 2004; Lovmar, 2005). Unlike “normal” 
competitive enzyme inhibitors, macrolides allow the substrate to bind to the 
enzyme but prevents the product to leave the enzyme (Lovmar, 2005). Only if the 
peptidyl-tRNA drops off before the macrolide dissociates, translation is inhibited 
otherwise translation is merely slowed down. The ability of inhibiting protein 
synthesis may then be a direct consequence of the value of the dissociation rate 
constant (Lovmar, 2005). 
 
Possible secondary effects of macrolide binding 
While the primary effect of macrolide action is straightforward, secondary effects 
are much more difficult to evaluate. Macrolides may indirectly slow down protein 
synthesis by a deficiency in peptidyl-tRNA hydrolase (pth), required for recycling 
of tRNA and amino acids. Even in the absence of macrolide antibiotics, translation 
is prematurely terminated to some extent by dissociation of peptidyl-tRNA. When 
the frequency of drop-off exceeds the capacity of pth to release tRNAs sequestered 
as peptidyl-tRNA, essential tRNA isoacceptors are starved leading to a decreased 
ribosome elongation rate and finally cell death. Drop-off induced by macrolides 
may therefore be anticipated to be toxic for bacterial cells because of accumulation 
of peptidyl-tRNA (Heurgué-Hamard et al., 1996; Tenson et al., 1999; Heurgué-
Hamard et al., 2000), which depletes the pools of free tRNA isoacceptors. It has 
also been shown that a strain with a temperature sensitive pth becomes 
hypersensitive to erythromycin at the non-permissive temperature (Menninger & 
Otto, 1982). It is however difficult to thoroughly validate macrolide-induced pth 
deficiency since manipulations over a wide range of expression levels of pth leads 
to cell death (Tenson T., unpublished results). It is also claimed that macrolides 
inhibit 50S subunit assembly since the amount of 50S subunits decrease in the 
presence of macrolides in comparison to 30S subunits (Usary & Champney, 2001; 
Champney, 2003). An alternative explanation may be that inhibition of protein 
synthesis by macrolides, disturbs the balance between ribosomal protein and rRNA 
synthesis. A ribosome is a multi-nucleo-protein complex and if some important 
factor is missing it may result in erroneous or incomplete assembly of the subunits. 
The observed difference between the 30S and 50S subunits may then just as well 
be an effect of different degradation rates of inactive subunits (Lovmar, 2005). 
Macrolides further affect stringent response, which co-regulates the synthesis of 
ribosomal RNA and ribosomal proteins through the regulatory nucleotide 
guanosine 5´, 3´-bis-diphosphate (ppGpp). Erythromycin induces the synthesis of 
ribosomal proteins and total RNA in response to a decreased concentration of 
ppGpp (Evers et al., 2001). 
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Resistance mechanisms 
Resistance mechanisms against antibiotics can generally be divided into three 
categories, (i) enzymatic destruction or modification of the antibiotic, (ii) 
resistance by efflux pumps lowering the intracellular concentration of the antibiotic 
and (iii) resistance by replacement or modification of the drug binding site (Walsh, 
2003). Examples from all three categories are found among the resistance 
mechanisms against macrolides. In addition, there is a fourth category, peptide-
mediated macrolide resistance. Three forms of macrolide resistance due to 
antibiotic modification are known, (i) esteratic ring cleavage, (ii) glycosylation and 
(iii) phosporylation but are limited to a small number of clinical isolates. Antibiotic 
efflux and target site modification are much more common (Weisblum, 1998). The 
clinical relevance of peptide-mediated resistance is not clear. 
 
Post-transcriptional modification of 23S rRNA 
The most common resistance mechanism found in pathogens resistant to macrolide 
antibiotics is a post-transcriptional modification of 23S rRNA by methylation of a 
specific single adenine base which drastically reduces the affinity of the antibiotics 
to the ribosome (Walsh, 2003). In retro-perspective the reported resistance against 
erythromycin shortly after its introduction into clinical practice in the 1950s can be 
ascribed to this modification of 23S rRNA (Weisblum, 1995a). This resistance,  
 
 
Figure 8. The 5’ end of the ermC transcript. (A) Secondary structure of the native form of 
the  ermC transcript. Translation of the ErmC ORF is inhibited by a hairpin structure 
(segments 3 and 4) containing the SD2 and the initiation codon. (B) An erythromycin-
carrying ribosomes stalls in the leader ORF and opens up the hairpin structure between 
segments 1 and 2. A new hairpin structure between segments 2 and 3 is formed which 
unmasks the SD2 and the initiation codon in segment 4 and allows translation of the ErmC 
ORF. Adapted from Mayford & Weisblum (1989b).   33 
first encountered in S. aureus, was originally referred to as the MLSB-resistance 
phenotype, since it also confers resistance to the other members of the MLSB-group 
(Vester & Douthwaite, 2001). Decades later, the molecular mechanism behind the 
MLSB-resistance phenotype was unravelled. Resistant strains carry a modified 23S 
rRNA, where a single base A2058 (according to E. coli numbering) located in 
domain V has been methylated (Lai & Weisblum, 1971; Skinner, Cundliffe & 
Schmidt, 1983) by an N-methyltransferase (Shivakumar & Dubnau, 1981). 
Reconstitution of 50S subunits, with 23S rRNA from a resistant strain, showed that 
the 23S rRNA modification indeed is fully responsible for the observed resistance 
(Lai  et al., 1973). The family of methylases, Erm (erythromycin resistance 
methylation) enzymes, responsible for the modification of nascent 23S rRNA, 
transfer methyl groups from S-adenosylmethionine to the N
6 of adenines, forming a 
mono- or dimethylated adenine. Approximately 40 members have been isolated 
and characterised from the homologues erm gene family (Leclercq, 2002). The 
natural erythromycin producer, S. erythraea, contains a constitutive production of 
ErmE, to protect its own ribosomes. ErmE may be a recent progenitor to other 
Erms found in resistant pathogens (Walsh, 2003). While ErmE is constitutively 
synthesised, the MLSB-resistance phenotype is usually inducible by erythromycin. 
The Erm synthesis is regulated through translational attenuation although one case 
of transcriptional attenuation (ermK) has been reported (Kwak, Choi & Weisblum, 
1991; Weisblum, 1995b). The most well studied example of an inducible Erm 
production is ErmC in S. aureus and a model for its induction has been proposed 
(Weisblum, 1995b). The ermC gene contain a 141-nucleotide long leader sequence 
which makes the mRNA in its native state form a hairpin structure with segments 1 
and 2 and another hairpin structure with segments 3 and 4 (Fig. 8). With the ermC 
mRNA is in this conformation, translation of the ErmC open reading frame (ORF) 
is low because its ribosome binding site and two first codons are sequestered by the 
secondary structure of the mRNA.  Only translation of the leader ORF occurs in 
the absence of erythromycin. Translation of the leader ORF by an erythromycin-
carrying ribosome changes the mRNA conformation to the induced state. The 
erythromycin-carrying ribosome stalls after melting the first hairpin, why a new 
hairpin structure is formed of segments 2 and 3, leaving the ribosome binding site 
and the start codon of the ErmC ORF readily accessible for other ribosomes 
(Weisblum, 1995b) (Fig. 8). The amino acid sequence at which the ribosome with 
erythromycin stalls in the leader ORF is important, since it must stabilise the 
ribosome:peptidyl-tRNA complex long enough for efficient induction (Weisblum, 
1995b). Usually, macrolide-induced ribosome stalling result in destabilisation and 
peptidyl-tRNA drop-off. Erythromycin allows formation of 6-8 amino acid long 
peptides before drop-off (Tenson, Lovmar & Ehrenberg, 2003) consistent with the 
observations that codons coding for the 5
th to the 9
th amino acid in the leader ORF 
of the ermC mRNA is critical for induction (Mayford & Weisblum, 1989a). 
Interestingly, amino acids 6-8, -Ile-Phe-Val-, corresponds well to be consensus 
sequence of the erythromycin resistance peptide (Tenson, DeBlasio & Mankin, 
1996; Tenson et al., 1997) (Fig. 8). The erythromycin resistance peptide 
destabilises erythromycin binding in the termination step of peptide synthesis 
presumably by interacting with either erythromycin or the tunnel wall (II). In the 
absence of a stop codon, a similar interaction in the ermC mRNA case may lead to 
a stabilisation of the ribosome:peptidyl-tRNA complex. The half-life of the ermC  34
mRNA has been reported to increase from 2 minutes to about 40 minutes during 
induction in B. subtilis (Bechhofer & Dubnau, 1987). 
 
Mutations in 23S rRNA and ribosomal proteins 
Generally, in pathogens with multiple rrn operons, e.g.  Streptococcus and 
Staphylococcus species, resistance is conferred by Erm methylation of A2058 or 
by drug efflux, while in pathogens with one or two rrn operons, e.g. Heliobacter 
pylori and Mycobacterium species, resistance is conferred by mutations at A2058 
or neighbouring nucleotides (Vester & Douthwaite, 2001). A low gene copy 
number of 23S rRNA makes a single mutation more likely to change the phenotype 
than a single mutated 23S rRNA gene at high copy numbers. The transition 
A2058G gives the highest level of resistance to 14-membered ring macrolides and 
is the most frequently clinically isolated mutation (Vester & Douthwaite, 2001). 
   The first reports of ribosomal structural changes generating resistance in E.coli 
described changes of the ribosomal proteins, especially in proteins L4 and L22 
(Wittmann et al., 1973) which supported the idea at that time of the ribosome as a 
multi-protein complex where the rRNA merely functioned as an inert scaffold 
(Weisblum, 1995a). L4 and L22 is not in direct contact with a bound macrolide but 
make up the constriction of the nascent exit tunnel, located below the macrolide 
binding site in the large ribosomal subunit (Fig. 7). The ribosomes of the strain 
with a mutated L4 protein showed a decreased affinity for erythromycin while the 
ribosomes of the L22 mutated strain exhibited an almost unchanged affinity for 
erythromycin but ribosomes with close to wild-type activity (Wittmann et al., 
1973). The genes for the erythromycin-resistant mutations of L4 and L22 have 
been cloned and sequenced (Chittum & Champney, 1994) and the structural 
implications of the mutations have been studied by cryo-EM (Gabashvili et al., 
2001). In the L4 mutant an A to G transition in codon 63 changes the amino acid 
from Lys to Glu and creates a substantial narrowing of the tunnel constriction. In 
the L22 mutant a 9-bp deletion of codons 82-84 removes amino acids Met-Lys-Arg 
from the protein and creates a widening of the tunnel constriction. If erythromycin 
only binds through the tunnel, a narrowing or widening of the constriction may 
result in changed association and dissociation rate constants of erythromycin, 
changing the inhibitory effect of the macrolide on protein synthesis (Lovmar, 
2005). A narrowed constriction may then slow down the association (and 
dissociation) of erythromycin and make the cells tolerant to an elevated 
concentration of the antibiotic. A widening of the constriction may instead increase 
the rate constants of association and dissociation of the macrolide to the same 
extent, but leave the dissociation constant unchanged (Lovmar, 2005), which could 
decrease the inhibitory effect on protein synthesis in line with the observations by 
Wittmann et al. (1973). 
 
Antibiotic efflux 
Macrolide efflux by transporters located in the membrane is a clinically important 
category of resistance mechanisms. Four different types of efflux transporters (or 
efflux pumps) have been described (Weisblum, 1998), (i) M-type, (ii) MS-type, 
(iii) “actinomycete”-type and (iv) broad-spectrum or multi-drug resistance (mdr) 
type. The first three types are specialist on a certain group of antibiotics while the   35 
fourth type may transport diverse categories of antibiotics as well as other 
compounds out of the cell. The M-type was first thoroughly described in 1996 by 
Suthcliffe, Tait-Kamradt & Wondrack. The transporter is mainly found in 
Streptococcus and is encoded by a mef gene (Clancy et al., 1996; Tait-Kamradt et 
al., 1997; Klaassen & Mouton, 2005). It confers low-level resistance to 14- and 15-
membered macrolides but not to the other members of the MLSB-group of 
antibiotics. The MS-type has been characterised from studies in Staphylococcus 
and is encoded by an msr gene. It confers resistance to 14-membered macrolides 
and streptogramin B, but resistance to 16-membered macrolides has also been 
reported (Weisblum, 1998). Ross et al. (1990) have suggested that the msrA-
mediated resistance is regulated by translational attenuation, as for ermC described 
above. The actinomycete-type has been characterised in macrolide-producing 
Streptomyces where the transporters confer resistance to the bacterium that 
produces the macrolide (Weisblum, 1998). The low permeable outer membrane 
and the mdr-type of transporters are responsible for the intrinsic resistance to 
antibiotics in gram-negatives. The E.coli genome encodes 37 (!) different 
transporters, but the pump responsible for the dominating part of the efflux is the 
AcrAB-TolC system. The AcrB is the efflux pump, residing in the inner 
membrane. AcrB is connected to a membrane fusing protein AcrA, which links or 
fuses the outer and inner membranes to the channel protein TolC in the outer 
membrane. The system displays unusually broad substrate diversity, including the 
majority of clinically important antibiotics and toxicants such as dyes, detergents 
and organic solvents (Zgurskaya & Nikaido, 1999; Li & Nikaido, 2004). The 
AcrAB-TolC system is important for peptide-mediated resistance (III, see below).  
 
Peptide-mediated macrolide resistance 
The discovery  
Tenson, DeBlasio & Mankin, coincidentally discovered peptide-mediated 
macrolide resistance in 1996. E.coli cells expressing random fragments of the rrnB 
operon, in search for fragments that can bind antibiotics, were screened for 
erythromycin resistant clones (Tenson & Mankin, 2001). All the found 
erythromycin resistant clones expressed rRNA fragments, which all contained the 
same sequence of 34 nucleotides ranging between positions 1235 and 1268 of 
domain II in 23S rRNA. The rRNA fragment comprises the characteristic features 
of an mRNA; it contains a Shine-Dalgarno sequence, an initiator codon (GUG), a 
terminator codon (UAA) and the open reading frame codes for the penta-peptide 
Met-Arg-Met-Leu-Thr. Further analysis showed that indeed expression of this 
mini-gene is both required and sufficient to confer resistance to low concentrations 
of erythromycin. In translation experiments in vitro, where the peptide or the 
resistance peptide mRNA (rpmRNA) were supplied, revealed the necessity of 
active translation of the rpmRNA for protection against erythromycin. It was 
therefore suggested that the resistance peptide acts in cis, on the ribosome (Tenson, 
DeBlasio & Mankin, 1996). 
 
Correlation between macrolide structure and peptide sequence 
In consequent studies, peptides conferring resistance against erythromycin and 
other macrolides were selected from in vivo expressed random peptide libraries  36
(Tenson et al., 1997, Tripathi, Kloss & Mankin, 1998; Vimberg et al., 2004). Only 
short peptides, 3-6 amino acids long, induce erythromycin resistance (Tenson et 
al., 1997). Sequence comparison of the 5-codon resistance peptides revealed a 
strong preference for leucine or isoleucine as the third amino acid and a 
hydrophobic amino acid in the C-terminus. Not only did these sequence signatures 
appear in majority but also corresponded to the resistance peptides with the highest 
activity against erythromycin. Further, clones grown at a very high erythromycin 
concentration (1.4·10
-3 M) showed a high tendency to contain a hydrophobic amino 
acid also in the second and fourth position and the hydrophobic Val in the C-
terminus (Tenson et al., 1997). A comparison between the amino acid sequence of 
the resistance peptides against erythromycin and a ketolide discovered a 
correspondence between the peptide sequence and the chemical structure of the 
macrolide. This was corroborated in vivo by comparing the resistance patterns of 
two very similar peptide sequences, one selected against erythromycin and the 
other selected against the ketolide. Only the resistance peptide against 
erythromycin rendered cells resistant to erythromycin and vice versa (Tripathi, 
Kloss & Mankin, 1998). Vimberg et al. (2004) also observed a strong correlation 
between peptide sequence and the structure of the macrolide when they further 
extended the search of resistance peptides to structurally different macrolides 
including for instance josamycin.  Interestingly, Vimberg et al. (2004) found 
resistance peptides against all the tested macrolides but were unable to find 
resistance peptides against the lincosamide antibiotic clindamycin or the 
streptogramin B antibiotic quinupristin. This suggests that although the MLSB-
antibiotics have overlapping binding sites on the ribosome, the way they interact 
with the ribosome is fundamentally different.  
 
The “bottle-brush” mechanism 
Based on the findings that resistance peptides act in cis and the correlation between 
peptide sequence and chemical structure of the macrolide, Tripathi, Kloss & 
Mankin proposed the “bottle-brush” model of peptide-mediated macrolide 
resistance in 1998. They suggested that synthesis of a resistance peptide, removes 
the macrolide from the ribosome by direct interaction between the antibiotic 
molecule and the resistance peptide. The resistance peptide acts as a “bottle-brush” 
and “cleans” the ribosome. This restores the protein synthesis capability of the 
ribosome but the effect should only be temporary since another macrolide molecule 
may rebind as long as the synthesised peptide has not reached a critical length and 
passed the macrolide binding site in the nascent peptide exit tunnel. 
 
 
Results and discussion 
Validation of the “bottle-brush” mechanism 
The aim in II was to test the proposed hypothesis and to study the details of the 
mechanism of peptide-mediated erythromycin resistance. The mechanism was 
studied in vitro in our cell-free mRNA translation system of E.coli components. 
The dissociation rate of erythromycin was measured by chasing with an excess of 
josamycin when either a control peptide (fMNAIK) or a resistance peptide   37 
(fMRLFV) was expressed. Since penta-peptides can be synthesised with an 
erythromycin molecule bound to the ribosome, peptide synthesis continues until 
erythromycin dissociates and is replaced by josamycin, which only allows di- and 
tri-peptidyl-tRNAs to be formed before drop-off (Tenson, Lovmar & Ehrenberg, 
2003). Erythromycin was found to dissociate faster in the presence of resistance 
peptide expression while expression of the control peptide did not change the 
dissociation rate constant but was the same as the spontaneous dissociation rate 
constant (Lovmar, Tenson & Ehrenberg, 2004). However, the most important 
finding in this set of experiments was that the resistance peptide ejects the 
macrolide every time it is expressed, which means that the resistance peptide 
indeed acts as a “bottle-brush” and “cleans” the ribosome as suggested by the 
“bottle-brush” hypothesis. In another set of experiment, we used [
14C]-labelled 
erythromycin to monitor labelled dissociation of erythromycin from the ribosome 
in conjunction with [
3H]-labelled fMet to simultaneously follow [
3H]-peptidyl-
tRNA or [
3H]-peptide release to further examine at what step during resistance 
peptide synthesis and with what rate, erythromycin is expelled from the ribosome. 
The macrolide is removed with the highest probability in the termination step when 
the penta-peptide is released from the peptidyl-tRNA by a class 1 release factor. 
Synthesis of a hexa- or a hepta-peptide with the same N-terminal as the resistance 
peptide did not increase the dissociation of erythromycin.  
To validate that the rate constant of resistance peptide synthesis by an 
erythromycin-infected ribosome can account for the resistance observed in cell 
populations we constructed a mathematical model. We set up a system of 
differential equations with ribosomes in 7 different states based on the scheme in 
Fig. 9A along with biochemical data of the resistance peptide action, binding 
kinetics of erythromycin and rate constants of protein synthesis obtained from our 
cell-free translation system (II; Lovmar, Tenson & Ehrenberg, 2004). The model 
also includes differential equations for the change in the total intracellular 
concentration of the macrolide by the inflow and outflow over the cell membrane 
as well as synthesis and degradation of mRNAs and rpmRNA. All components are 
diluted by cell growth. The system was solved numerically by Euler’s method 
(Heath, 1997), after the introduction of a certain concentration of erythromycin in 
the medium, and cell growth was recorded as volume expansion during 8 hours 
following induction. At the time of macrolide introduction the system resided at 
steady state for a certain synthesis rate of rpmRNA. A detailed description of the 
model is found in supplementary material online to II. Cell growth after the 
introduction of varying concentrations of erythromycin in the medium at varying 
synthesis rates of rpmRNA synthesis was simulated and compared to in vivo 
experiments. In the in vivo experiments we used a multi-copy plasmid with a 
regulated expression of rpmRNA through tac promoter control by IPTG. The 
IPTG and erythromycin concentrations in the growth medium were varied and cell 
growth was measured as bacterial mass (optical density) after 8 hours of growth 
following the addition of erythromycin in the medium. We found a good agreement 
between experimentally observed and modelled growth behaviour (Fig. 9B-C) but 
the model predicted significant resistance in the presence of resistance peptide 
expression only if we assumed a rapid equilibration between the erythromycin 
concentration in the growth medium and the intracellular concentration of the   
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Figure 9. A schematic of the peptide-mediated erythromycin resistance model (A) and 
cell growth, modelled (B), in vivo (C).  (A, left) Ribosomes without erythromycin 
synthesise proteins (state 3) while ribosomes with erythromycin (state 5) leads to peptidyl-
tRNA drop-off (and recycling of the 50S subunit (state 4)) or translation resumes (state 3) if 
the drug spontaneously dissociates before peptidyl-tRNA drop-off. (A, right) Translation of 
rpmRNA by ribosomes with erythromycin leads to dissociation of the drug (state 7). 
Calculated (B) and measured (C) cell growth 8 hours after addition of erythromycin for 
different concentrations of erythromycin in the growth medium and different expression 
levels of rpmRNA. 
 
macrolide. Since the growth experiments were done using gram-negative E.coli 
cells, which contain an outer membrane expected to generate a low permeability of 
macrolides, it was not apparent that the net exchange dynamics of the antibiotic 
over the cell membrane should be fast. A multi-drug efflux pump located in the 
inner membrane, the AcrAB-TolC system, offered a solution to the problem (see 
below). 
 
Different mechanism of peptide-mediated josamycin and erythromycin 
resistance 
Previous experiments in vivo and in vitro suggested that the action of peptide-
mediated josamycin resistance is different from the mechanism of erythromycin 
resistance. The formation of di- and tripeptides is inhibited resulting in synthesised 
peptidyl-tRNAs containing mainly 2 or 3 amino acids before drop-off in the   39 
presence of josamycin while the length of selected resistance peptides contains 4 or 
5 amino acids (Tenson, Lovmar & Ehrenberg, 2003; Lovmar, Tenson & 
Ehrenberg, 2004; Vimberg et al., 2004). The very low dissociation rate constant 
for josamycin implicates that the interaction between peptide and drug must be 
stronger than in the case of erythromycin to destabilize the binding of the drug to 
the ribosome (Lovmar, Tenson & Ehrenberg, 2004; II). The first objective of III 
was to understand the mechanism of peptide-mediated josamycin resistance. The 
mechanism was studied in vitro in our cell-free mRNA translation system of E.coli 
components. Ribosomes translating either an rpmRNA (coding for MFLV) or a 
control peptide mRNA (coding for MVSN) in the presence of josamycin were 
chased with erythromycin to reveal whether the dissociation of josamycin 
increased from rpmRNA expressing ribosomes. No significant increase of the 
dissociation rate was detected, but interestingly we observed an eight-fold lower 
drop-off rate of resistance di-peptidyl-tRNA (rate constant ~ 0.008 s
-1) compared 
to the drop-off rate of the control di-peptidyl-tRNA (rate constant ~ 0.06 s
-1). This 
difference between the drop-off rates may be the key for understanding peptide-
mediated josamycin resistance. The difference in resistance mechanisms was 
further demonstrated by length dependence of the rpmRNAs for the two drugs. We 
let E.coli cells express peptides of lengths varying between 2 and 10 amino acids. 
Besides sequence dependence (Tenson et al., 1997), erythromycin resistance 
peptides also showed length dependence in agreement with previous experiments 
that removal of erythromycin occurs at termination of penta-peptide synthesis and 
that shorter or longer peptides either does not reach far enough to interact with or 
loses the interaction with the bound erythromycin molecule, respectively (II). In 
contrast, josamycin resistance peptides showed no length dependence. All peptides, 
which contained a phenylalanine as second amino acid, conferred the same degree 
of josamycin resistance. This is in line with previous experiments which show that 
josamycin inhibit formation of peptides longer than two (or three) amino acids 
(Lovmar, Tenson & Ehrenberg, 2004). The only important feature of josamycin 
rpmRNAs appears to be a sequence coding for phenylalanine or tyrosine in the 
second position (Vimberg et al., 2004). 
We also wanted to see if josamycin resistance in vivo, monitored as cell growth 
in the presence of resistance peptide expression and josamycin could be 
reproduced within the model previously developed for peptide-mediated 
erythromycin resistance (II) but now adapted for resistance peptide expression 
against josamycin. A bacterial population containing a plasmid-borne resistance 
peptide gene, coding for peptide MFLV, and under the control of the tac promoter 
was grown in media with varying IPTG concentrations to regulate the level of 
resistance peptide expression combined with varying josamycin concentrations. 
The increase in bacterial mass after 8 hours of growth after induction was 
monitored by optical density as a function of the IPTG concentration in the 
medium. The mathematical model was changed to account for josamycin resistance 
by modelling a delayed di-peptidyl-tRNA drop-off from a josamycin-carrying 
ribosome expressing the resistance peptide while the antibiotic stays bound to the 
ribosome. By assuming a low rate of degradation of mRNAs with a stalled 
ribosome in the 5’ end instead of full protection against degradation, we obtained 
growth curves mimicking the in vivo observed growth curves.  40
The apparent explanation to why a decreased drop-off rate of resistance di-
peptidyl-tRNA in comparison to the drop-off rate of other di-peptidyl-tRNAs may 
confer resistance is that it reduces the demand of a factor required for translation 
elongation or recycling of ribosomes, which has become limiting. The importance 
of the modelled mRNA degradation can be understood as follows. The 
concentration of protein mRNAs in a cell is much lower than the concentration of 
ribosomes. Thus, only a small fraction of drug-inhibited ribosomes, stalled on an 
mRNA can potentially severely slow down protein synthesis. When protein 
mRNAs with a stalled ribosome is slowly degraded as opposed to fully protected 
from degradation, the free concentration of protein mRNAs on which a ribosome 
can initiate translation drastically declines. The delay at initiation increases the 
impact of the macrolide since 50S subunits exist in a josamycin-susceptible state a 
longer period of time. The result is a larger fraction of free and infected 50S 
subunits as well as a larger fraction of ribosomes stalled on mRNAs, which 
contributes to further lowering the concentration of free mRNAs. The feedback 
between the low concentration of free protein mRNAs and concentration of 
inactivated 50S subunits makes the growth rate severely reduced within a narrow 
range of antibiotic concentrations. When rpmRNA is present in the cell, josamycin-
infected ribosomes are “absorbed” on the rpmRNA. The free concentration of 
protein mRNAs remains high and ribosomes can initiate translation at a higher rate 
and escapes josamycin to a larger extent. The concentration of active, translating 
ribosomes increases, thereby raising the cell growth rate. The predicted resistance 
by mRNA limitation in the model critically depends on a low rate constant of 
resistance peptidyl-tRNA drop-off compared to the rate constant for drop-off of 
other peptidyl-tRNAs, which absorbs josamycin-carrying ribosomes on rpmRNA 
and lowers the concentration of josamycin-ribosomes on other mRNAs. 
Increased drop-off induced by macrolides may also lead to pth saturation and 
depletion of free tRNA isoacceptors followed by ribosome stalling at certain 
codons. This slows down the overall translation rate per ribosome and may in turn 
lead to a delay at initiation, which leaves 50S subunits in a josamycin-susceptible 
state a longer period of time. Synthesis of rpmRNA may reduce pth saturation, by 
decreasing the concentration of josamycin-ribosomes on other mRNAs. It is 
difficult to manipulate the expression level of pth within a wide range, why there 
may be a problem of thoroughly validating macrolide induced pth deficiency. An 
increased or decreased expression level lead to cell death probably because fMet-
tRNA is hydrolysed or because pth is not recycled, respectively (Tenson T., 
unpublished results). It has previously been reported that in E.coli, in the absence 
of translation, binding of a 30S subunit to the 5´ region of the lacZ mRNA, does 
not protect the full-length mRNA against degradation by RNaseE  (Joyce & 
Dreyfus, 1998). The increased degradation of mRNA in the presence of josamycin 
is presently under investigation in our laboratories. We also plan to measure the 
drop-off rate of several mRNAs coding for different amino acids in the second 
position and to further investigate possible unanimous of pth expression levels and 
sensitivity to josamycin along with modelling of pth saturation.  
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Peptide-mediated macrolide resistance requires a fast outflow rate of the 
antibiotic over the cell membrane 
The second objective of III was to validate the previous model prediction from II, 
that peptide-mediated erythromycin resistance requires a high outflow rate of the 
drug over the cell membrane. In gram-positive bacteria the cell wall does not offer 
much resistance to diffusion of small molecules and the rate of exchange of 
macrolides over the cell membrane is expected to be rapid, but previous in vivo 
experiments were done with gram-negative E.coli cells (Tenson, Lovmar & 
Ehrenberg, 2003; II). In gram-negatives the outer membrane confers an efficient 
barrier of permeation and the entrance rate of antibiotics are expected to be slow, 
but as described above, gram-negative bacteria also harbour broad-specific 
multidrug pumps in their inner membrane, which may generate a considerably 
higher outflow rate of the antibiotics in comparison to the inflow rate by passive 
diffusion. Since the AcrAB-TolC pump system has been reported to be the major 
contributor for raising erythromycin tolerance in gram-negatives (Ma et al., 1995), 
we decided to study peptide-mediated resistance within a TolC mutant. To validate 
the model prediction we grew wild-type and TolC mutant E.coli cells containing 
either a resistance peptide expressing plasmid or a control plasmid in the presence 
of varying concentrations of erythromycin or josamycin in the growth medium. 
Growth was recorded by optical density after 4 hours following addition of the 
antibiotic and was registered as a function of the macrolide concentration and at an 
IPTG concentration corresponding to maximal resistance in the wild-type as seen 
in previous in vivo growth experiments (II;  III). The in vivo experiments 
confirmed the model prediction for both antibiotics. No resistance was observed in 
the TolC mutant, although the resistance mechanism clearly differs for the two 
drugs. The TolC mutant is as sensitive to macrolides as the AcrB mutant (Tenson 
T., personal communication), why we modelled the TolC mutant without pumps. 
The models reproduced the in vivo growth curves. The TolC mutant tolerated a 
lower concentration of macrolide than the wild-type and resistance was 
substantially reduced for both erythromycin and josamycin. Fig. 10 shows in vivo 
and modelled growth of the wild-type and TolC mutant in the presence of 
erythromycin. In the case of erythromycin, where expression of a resistance peptide 
actively removes a bound drug molecule from the ribosome (II) resistance is a 
consequence of an increased dissociation of erythromycin. Such a resistance 
mechanism is sensitive to the fate of the drug molecule after ejection. It can either 
leave the cell (by passive diffusion over the membrane or be actively transported 
by efflux pumps) or it re-associates to a ribosome. The value of the rate constant 
for leaving the cell in relation to the association rate constant of the antibiotic 
becomes very important. The requirement of a fast outflow rate for the 
erythromycin resistance mechanism to work is then rather a requirement of a fast 
enough rate constant of the antibiotic for leaving the cell compared to the 
association rate constant for ribosome binding of the drug. We argue that the 
AcrAB-TolC efflux pump system provide the required high efflux rate. Thus, a 
macrolide with a lower association rate constant but with the same or lower 
dissociation rate constant of erythromycin is predicted by the model to confer 
resistance also in the TolC mutant, if resistance is mediated by active removal of 
the drug by the same rate as of erythromycin.   42
 
Figure 10. Peptide-mediated resistance in the wild-type but not in a pump mutant. Cell 
growth 4 hours after induction by erythromycin in vivo (A-B) or as modelled (C-D) in the 
wild-type (A and C) and a TolC mutant (B and D). Adapted from III. 
 
The details of josamycin resistance need to be further clarified by experiments. 
The absence of modelled peptide-mediated josamycin resistance in the TolC 
mutant is also a consequence of a too slow efflux rate constant in relation to the 
association rate constant of the drug, which creates a boost in the intracellular 
concentration of josamycin followed by a sharp decline in the growth rate within a 
very narrow range of concentrations of the macrolide in the growth medium and 
leaves the mechanism of peptide-mediated josamycin resistance ineffective since it 
can not remove josamycin bound to a ribosome. 
 
Erythromycin-induced methylation of 23S rRNA by ErmC 
To study the erythromycin-induced ErmC synthesis by translational attenuation 
described above we set-up a model. The synthesis of ErmC preceding an increased 
concentration of ribosomes with a methylated 23S rRNA (methylated ribosomes) 
and a decreasing concentration of unmodified (unmethylated) ribosomes following 
induction by erythromycin was modelled by a system of differential equations. 
Induction of resistance occurs in three consecutive steps in the model; (i) 
erythromycin binds to free unmethylated ribosomes, (ii) an erythromycin-carrying 
ribosome stalls in the leader sequence of an ermC mRNA and induces synthesis of 
ErmC and (iii) ErmC methylates nascent ribosomes. Each of these steps of   43 
induction is modelled by a probability. The probability that a ribosome carries 
erythromycin is a function of the concentration and the dissociation constant of the 
drug. The probability that an ermC mRNA is in an induced state is a function of the 
concentration of free unmethylated ribosomes with erythromycin and the 
dissociation constant of erythromycin-ribosomes to the leader region of the ermC 
mRNA at the site of stalling. The probability of methylating a newborn ribosome is 
a function of the concentration and activity of ErmC. The cell growth rate was 
modelled as a function of translationally active ribosomes. See the Appendix in IV 
for a detailed description of the model. We studied the time of transformation and 
the degree of transformation (the fraction of methylated ribosomes) after 
erythromycin induction as a function of the dissociation constant of a stalled 
ribosome in the leader region of an ermC mRNA (KQ), the activity of ErmC (KQM) 
and the intracellular concentration of erythromycin (e), where transformation refers 
to the conversion from an erythromycin susceptible cell to an MLSB-resistant cell. 
The time of transformation decreases and the final fraction of resistant ribosomes 
increases with a decreasing value of KQ and an increasing value of KQM. The 
suggested stabilisation of the ermC transcript during induction makes the induction 
mechanism respond more strongly to the antibiotic, and thus increases the 
sensitivity of the resistance mechanism to the drug. The transformation time is 
reduced and the fraction of methylated ribosomes at steady state is raised, 
compared to when the half-life of the ermC mRNA is unaffected. The most 
conspicuous feature of the induction dynamics is the appearance of an optimal 
erythromycin concentration at which the induction response rate is maximal as 
observed by the fastest boost in synthesis of both ErmC and methylated ribosomes 
(Fig. 3(a) in IV). Induction depends critically on the presence of ribosomes both 
with and without a bound erythromycin molecule. At low concentrations of the 
antibiotic the concentration of erythromycin-carrying ribosomes are low, why only 
a low fraction of ermC mRNAs are in the induced state. At high concentrations of 
the antibiotic, on the other hand, the fraction of ermC mRNAs in the induced state 
are high but the concentration of ribosomes without erythromycin is low. The 
maximal response rate corresponds to an optimal blend of ribosomes with and 
without erythromycin. However, the optimal inducing concentration of 
erythromycin may not be of any biological significance. When cell growth was 
monitored during the transformation phase, instead of the concentration of ErmC 
and methylated ribosomes, the initial reduction in growth rate and the time of its 
recovery monotonically decreased with an increasing concentration of 
erythromycin (Fig. 3(b) in IV). The maximal response rate appears to be a 
consequence of the mechanism of induction but of less relevance for cell growth, 
the expected parameter genuinely subjected to selection pressure. Therefore, cell 
growth was also studied during the induction phase as a function of KQ, KQM and e, 
and related to selection pressures on the resistance mechanism. For instance may a 
certain combination of KQ- and KQM-values generate a higher total cell growth 
during the transformation phase than another combination of KQ- and KQM-values 
but a lower growth rate at steady state after transformation is complete. The time 
periods and frequency bacteria are exposed to a certain drug concentration should 
than select for the KQ- and KQM-values, which gives the highest total cell growth. 
Also, the model shows how an increased antibiotic concentration although in short- 44
term is rewarding, creates a high selective advantage to change the KQ- and KQM-
values to generate a yet more competent resistance mechanism. 
 
Bi-stable growth rates generated by antibiotics with low membrane 
permeability 
The use of gram-negative E.coli with a low entrance rate of macrolides over the 
outer membrane in the studies of peptide-mediated resistance gave us the idea of 
bi-stable growth rates. The principle of how bi-stable growth rates may emerge is 
described in V. Bi-stable growth rates means that exponentially growing bacteria 
subjected to a fixed concentration of an antibiotic will show different growth rates 
in the presence of the drug depending on the bacterial growth rate at the time of 
introduction of the drug. During fast growth, the intracellular concentration may 
remain small by rapid cell volume expansion and dilution of the antibiotic why the 
growth rate remains high. During slow growth, on the other hand, the intracellular 
concentration may be become high due to a slow volume expansion and slow 
dilution why the growth rate may drastically decrease. The requirement for bi-
stability to emerge is low membrane permeability and a sensitive response of the 
growth rate to the intracellular concentration of the antibiotic. A relevant group of 
antibiotics, which may generate bi-stability is drugs with low membrane 
permeability in gram-negatives. 
The future objective is to experimentally validate the existence of bi-stable 
growth rates in response to antibiotics, supported by modelling. For instance, 
modelling of josamycin in the TolC mutant predicts bi-stability given that the 
permeability of the drug is slow enough over the outer membrane. 
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Personal reflections on modelling 
Here follows some personal reflections on modelling put into the context of my 
experience of modelling during my time as a Ph D student. 
A model is a simplification of the system it is describing. There are two types of 
simplifications, “physical” and “biological” assumptions of the system. Some 
common physical assumptions are to let the copy number distribution of a 
molecule be characterised by an average value or assuming reactions to be quickly 
equilibrated. These assumptions can be justified by mathematical methods to find 
the limits within the assumptions are valid.  Biological assumptions are the features 
of the system, which is believed to be important for its function while other 
features, which is believed to be unimportant, are disregarded. Biological 
assumptions can only be justified by experimental observations, why assumptions 
not known should be regarded as predictions, which can be validated or falsified by 
later experimental observations.  
To formulate a model of a biological system in terms of mathematics the precise 
interactions between molecules and values of parameters must be defined. This is 
the strength of a mathematical model since it creates well-defined predictions 
based of well-defined assumptions of the system in comparison to a mere verbal 
description. It pinpoints the critical assumptions for the system to function and at 
the same time rules out features that do not. A “good” model is a simple and 
comprehensive model, which still captures the relevant characteristics of the 
system in a way that it clarifies the function of the system. 
Mathematical models can be powerful tools in at least four ways: (i) outline 
possible principles (e. g. bi-stable growth rates in response to antibiotics with a low 
membrane permeability (V)), (ii) make well-defined predictions (e. g. peptide-
mediated resistance requires a fast outflow rate of the macrolide) (II, III), (iii) 
strengthen experimental observations (e. g. that the dissociation rate constant of 
erythromycin by rpmRNA translating ribosomes observed in vitro may generate 
the in vivo observed resistance (II)) and (iv) separate mechanistic units and study 
its effect in the global context (e. g. to understand the factors determining the 
initiation mass in I).  
I hope and believe that the full potential of modelling will be recognized in the 
future where experimental observations along with modelling mutually stimulate 
and drive biological knowledge forward. 
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ABSTRACT
We have developed a stochastic model of the regulation of initiation of chromosome 
replication in Escherichia coli, which automatically generates the correct initiation 
frequency and chromosome number, synchronous initiation at multiple origins and 
varying cell size as functions of the growth rate. Expression of the dnaA gene for the 
activator, DnaA, of chromosome replication is more strongly auto-repressed by 
DnaA-ATP than by DnaA-ADP. However, we demonstrate that repression of dnaA by 
free DnaA-ATP is inconsistent with adequate regulation of dnaA gene expression and 
propose that DnaA-ADP is the main regulator of dnaA expression, while DnaA-ATP 
is the key-activator of replication initiation. This suggests that the conversion of 
DnaA-ATP to DnaA-ADP by RIDA is essential for chromosome copy number 
control. We also clarify what is required for an invariant cell volume at initiation for 
exponentially growing cells in different growth media and propose two alternative 
molecular mechanisms that define the sequestration period of the oriC following 
initiation. Experimental observations in relation to the model and future experiments 
are discussed. 2
INTRODUCTION
The E. coli genome consists of a single circular chromosome and replication starts 
from the unique oriC site (Marsh and Worcel, 1977). The DnaA protein binds oriC
and builds up a nucleoprotein complex promoting DNA strand opening and thereby 
initiation of replication (Messer, 2002). The chromosome is replicated bi-directionally 
by two replisomes proceeding from the oriC to the ter sites in the terminus region 
(Hill, 1996). One round of replication, completed after the C-period of about 40 
minutes, is followed by cell division after the D-period of about 20 minutes. The C- 
and D-periods are approximately constant for generation times between 20 and 60 
minutes (Cooper and Helmstetter, 1968), implying that it takes about 60 minutes 
(C+D) for a cell to replicate its genome and divide. When the generation time, which 
can vary from about 20 minutes to infinity, is less than 60 minutes, replication is 
initiated in the mother, grandmother or grand-grandmother generation and the cells 
are born with 2, 4 or 8 origins, respectively (Fig. 1). When the generation time is 
longer than 60 minutes, there is also a B-period between cell birth and initiation of 
replication (Cooper and Helmstetter, 1968). Initiation occurs only once per generation 
and cells with multiple oriCs initiate synchronously (Skarstad et al., 1986; Boye et
al., 2000). Irrespective of growth rate, initiation takes place at an approximately 
constant cell mass (or cell volume) per origin, which has been named the “initiation 
mass” (Donachie, 1968). Just after initiation of replication the oriCs are hemi-
methylated and they become fully methylated after a delay time corresponding to 
about 30% of the generation time (Campbell and Kleckner, 1990).
DnaA initiates replication at fully methylated, but not hemi-methylated oriC
(Russell and Zinder, 1987). The methylation status of oriC is regulated by the SeqA 
protein (Lu et al., 1994) and the Dam methyltransferase (Løbner-Olesen et al., 2005). 
The SeqA protein binds and sequesters oriC thereby preventing immediate 
methylation by Dam (Lu et al., 1994; von Freiesleben et al., 1994). About eight 
minutes after initiation of replication the replication forks duplicate the datA locus, 
which can bind a large number of DnaA molecules, thereby lowering the free 
concentration of DnaA (Kitagawa et al., 1996; Kitagawa et al., 1998). DnaA exists in 
two forms, DnaA-ATP and DnaA-ADP, and DnaA-ATP is active at initiation 
(Messer, 2002; McGarry et al., 2004). Conversion of the active form into DnaA-ADP 
is stimulated by the replication fork and is called RIDA (regulatory inactivation of 
DnaA) (Katayama et al., 1998; Katayama and Sekimizu, 1999). Fig. 2 shows the 
molecules involved in the control of replication initiation. 
Although initiation of chromosome replication in E. coli has been extensively 
studied during decades, the basic principles by which the bacterium coordinates 
initiation of replication with the cell cycle and synchronizes initiation at multiple 
origins is still debated. One reason for this is that chromosome replication is 
controlled by a number of molecular mechanisms that act together in the global 
context of growing and dividing cells. In order to assess the function of these 
mechanistic units they must be integrated in a global description of the living cell, and 
such descriptions have been scarce as well as incomplete in the past.  Here, we have 
used stochastic modeling of the replication process in growing E. coli cells as a tool to 
test hypotheses regarding regulation of initiation of chromosome replication. The 
regulation problem is conveniently partitioned in two parts. The first relates to the 
control of the number of chromosome copies per cell of E. coli populations growing 
under different conditions and the second to the synchronization of initiation of 
replication at different origins. Our analysis shows that DnaA carries out copy number  3
Figure 1. Cell growth and division for a cell with a generation time of 60 or 20 minutes. The time 
for completing one round of replication is 40 minutes and cell division occurs 20 minutes after each 
round is terminated for both generation times. The 20 minutes generation cell is therefore born with 
two complete chromosome copies which replication was initiated in the beginning of the grandmother 
generation.
Figure 2. The regulation of replication initiation. The DnaA protein binds to boxes in oriC and 
DnaA-ATP triggers initiation. Following initiation the GATC sites in oriC become hemi-methylated 
and sequestered by the SeqA protein thereby preventing immediate re-methylation of oriC by the Dam 
methylase and re-initiation by DnaA. The replication fork reaches the dnaA gene after one minute and 
the datA locus after 8 minutes, when replication takes 40 minutes to complete. SeqA sequesters the 
dnaA promoters following initiation and both DnaA-ADP and DnaA-ATP can bind the promoters and 
repress dnaA expression. The datA locus can bind a high number of DnaA molecules, approximately 
370 in vitro.4
control and, accordingly, that regulation of the total concentration of DnaA is crucial
for the proper working of the mechanism. We will suggest that control of the total 
concentration of DnaA is likely to be carried out by DnaA-ADP acting as an auto-
repressor of expression from the dnaA gene, which may shed new light on the 
functional meaning of the conversion of DnaA from its ATP to its ADP form by 
RIDA. It seems clear that binding of DnaA to boxes along the chromosome and the 
relatively long sequestration period of newly fired oriCs contribute to synchronization 
of chromosome replication (Boye et al., 2000).  At the same time, the molecular 
mechanism that determines the sequestration period has remained unclear. Therefore 
we discuss three different molecular mechanisms, and show that each one of these can 
account for synchronization of initiation of replication. We also discuss future 
experiments to subject the theory to further experimental testing, and outline 
extensions of the theory to include (i) regulation of synthesis of deoxyribonucleotides 
by DnaA, affecting the rate of replication fork elongation and (ii) further model 
testing of critical experimental observations. 
THE MOLECULAR BASIS OF THE MODEL 
Regulation of dnaA expression
In the cell, DnaA exists either in the DnaA-ATP or DnaA-ADP form, and the former 
is essential for initiation of chromosome replication (Messer, 2002). The dnaA gene is 
expressed from two promoters, dnaAp1 and dnaAp2, with the majority of transcripts 
coming from dnaAp2 (Hansen et al., 1982; Chiaramello and Zyskind, 1990; Hansen et
al., 1991). The sequence between the promoters contains both 9-mer DnaA boxes and 
6-mer DnaA-ATP boxes (Speck et al., 1999; Messer, 2002). The 9-mer, “strong”, 
DnaA boxes bind the ATP and ADP forms of DnaA with equal affinity, while the 6-
mer boxes preferentially bind DnaA-ATP, conditional on occupation of an adjacent 
strong box with either form of DnaA (Messer, 2002).  Expression of dnaA is strongly 
and intermediately auto-repressed by DnaA-ATP and DnaA-ADP, respectively 
(Atlung et al., 1985; Speck et al., 1999). As oriC, the dnaA promoter region also 
contains GATC sites with a delayed remethylation (Campbell and Kleckner, 1990), 
implying that dnaA expression is temporarily shut-off after initiation of replication 
(Theisen et al., 1993). The functional meaning of this intermittent shutdown of DnaA 
synthesis has remained unclear. 
For performance comparison, we have modeled dnaA expression constitutive 
as well as regulated by the free concentration of either DnaA-ATP or DnaA-ADP. 
The constitutive scenario is motivated by the previous suggestion that the free 
concentration of DnaA-ATP is normally too small to inhibit dnaA expression (Bremer 
and Churchward, 1991), although more recent experiments suggest that DnaA is, 
indeed, an auto-repressor (Hansen et al., 1987; Christensen et al., 1999; Morigen et
al., 2001; Morigen et al., 2003). To simplify, we have assumed a dnaA gene per 
chromosme with a single promoter (dnaAp) modeled after dnaAp2, with two strong 
DnaA and three weak DnaA-ATP boxes (Speck et al., 1999). We define dnaA
expression as constitutive when dnaAp is always free from repressor and when the 
rate constants for initiation of transcription by RNA polymerase do not change 
(Bremer et al., 2003). This definition excludes stringent control of dnaA (Chiaramello 
and Zyskind, 1990), but allows for variation of promoter activity due to varying 
concentration of free RNA polymerase (Dennis et al., 2004). The number of DnaA 
molecules produced per cell volume under different conditions will always be 5
determined by the outcome of a competition between dnaA expression and the 
expression from all other genes in the chromosome. This means, for instance, that as 
long as the competition remains neutral with respect to varying growth conditions, 
constitutive dnaA expression per cell volume will be proportional to the current 
growth rate ȝ. In our modeling we have also taken into account that the dosage of 
dnaA compared to all other genes may vary with growth conditions, since dnaA is 
located close to oriC (Fig. 2).  It should, however, be kept in mind that such 
competition neutrality may be hard or even impossible to come by (Bremer and 
Churchward, 1991). In addition to the constitutive aspect of dnaAp, the promoter may 
also be regulated by DnaA-ATP or DnaA-ADP, since both forms of DnaA are known 
to inhibit initiation of dnaA transcription in vitro, with DnaA-ATP as the stronger 
auto-repressor (Speck et al., 1999). A newly formed DnaA molecule in vivo is 
assumed to rapidly bind ATP (Speck et al., 1999) and normally stay in the ATP form 
(Messer, 2002) until converted to DnaA-ADP by RIDA-induced ATP hydrolysis (see 
below).
Experimental data suggest that the population averaged total concentration of 
DnaA is constant over a wide range of growth rates for E. coli K-12 strains, but 
increases with growth rate for an E. coli B/r strain (Churchward et al., 1981; Wold et 
al., 1994; Herrick et al., 1996). Whether the total concentration of DnaA changes 
during the cell cycle is not known, but constitutive expression of dnaA on a plasmid 
can complement a dnaA(Ts) mutation at non-permissive temperatures (Løbner-Olesen 
et al., 1989). 
Initiation of replication and sequestering of DnaA in DNA boxes
The strong 9-mer DnaA and the weak 6-mer DnaA-ATP boxes are scattered along the 
chromosome (Roth and Messer, 1998; Messer, 2002) and both types of boxes are 
found within the oriC (Messer, 2002; Leonard and Grimwade, 2005) along with the 
recently discovered type I-sites, which are 9-mer sequences with weak binding 
affinity to DnaA-ATP (McGarry et al., 2004). At initiation of chromosome 
replication, two of the I-sites occupied by DnaA-ATP are required for DNA strand 
opening (McGarry et al., 2004) and in total 20-30 DnaA molecules are cooperatively 
bound to the oriC (Messer, 2002). 
We have modeled the rate of initiation of replication at oriC, the “initiation 
potential”, by, firstly, neglecting the binding of DnaA-ADP to oriC and, secondly, 
introducing a simplified scheme in which initiation requires a number of DnaA-ATP 
molecules cooperatively bound to oriC. The current rate of initiation per oriC is 
computed from the condition that oriC must be fully methylated (Russell and Zinder, 
1987), the rate constant when oriC is saturated by DnaA-ATP and the probability of 
saturation as determined by the concentration of free DnaA-ATP (Appendix).
The datA locus, reached by the replication fork around eight minutes after 
initiation, sequesters about 370 DnaA-ATP molecules in vitro (Kitagawa et al., 1996), 
but the exact number in vivo is uncertain and may be somewhat lower. The datA locus 
has been suggested to synchronize initiation of replication at different oriCs by 
regulating the fraction free DnaA-ATP during the cell cycle. While deletion of datA
confers asynchronous and excessive initiations, simultaneous disruption of seven 
other major DnaA binding sites appears to preserve the synchrony of initiation of 
replication (Kitagawa et al., 1998; Ogawa et al., 2002). However, recently Morigen et 
al. (2005) demonstrated that the previously reported extensive initiation asynchrony 
observed by datA deletion is caused by rifampin-resistant initiations. Addition of a 6
high concentration of rifampin in replication run-out experiments largely decreases 
initiation asynchrony. 
  In the model, we have used 370 (in vitro estimate) (Kitagawa et al., 1996) 
independent, strong binding sites for DnaA-ATP in datA. In addition, we have 
positioned approximately 300 binding clusters, consisting of one strong DnaA box 
together with two weak DnaA-ATP boxes along the chromosome. To simplify, we 
have assumed that the boxes are equally spaced (Appendix).
Conversion of DnaA-ATP to DnaA-ADP by RIDA   
A newly synthesized DnaA molecule is assumed to rapidly bind ATP and then stay in 
the ATP form until ATP hydrolysis is stimulated on chromosome bound DnaA-ATP 
by Regulatory Inactivation of DnaA (RIDA), i.e. by the “sliding clamp” E-subunit of 
DNA polymerase III in complex with the Hda protein (Katayama et al., 1998; 
Su’etsugu et al., 2004). Interestingly, in spite of the great excess of ATP in the 
cytoplasm (Bochner and Ames, 1982) there is a slow nucleotide exchange on DnaA 
(Messer, 2002). The experimental data supporting the suggestion that acidic 
phospholipids may interact with DnaA-ADP and regenerate the ATP-form of the 
protein (Sekimizu and Kornberg, 1988) are unclear (Aranovich et al., 2006). 
  In the model we have therefore assumed that DnaA is synthesized in the ATP 
form, where it remains until ATP is hydrolyzed by RIDA, and that the ADP form of 
DnaA is stable (Appendix). If assumed that DnaA-ATP is the main auto-repressor of 
dnaA, then the system will strive to keep the free concentration of DnaA-ATP 
constant during the major part of the cell cycle when oriC is not sequestered, which 
would make synchronous initiation of replication at different oriCs problematic. 
However, ATP hydrolysis by RIDA and DnaA-ADP as the main repressor of dnaAp
may solve this problem, by effectively controlling the total, rather than the free, 
concentration of DnaA-ATP in E. coli and other bacteria.
Sequestration and methylation of oriC
The chromosome is dispersed with GATC sequences (Urig et al., 2002), in which the 
adenine is methylated by the Dam methyltransferase (Løbner-Olesen et al., 2005), and 
there are eleven GATC sites within the oriC (Messer, 2002). During chromosome 
replication, unmethylated adenine nucleotides are incorporated resulting in hemi-
methylated DNA with one (old) methylated and one (new) unmethylated strand 
(Løbner-Olesen et al., 2005). Most GATC sites are methylated by Dam within a few 
minutes after their synthesis, but GATC sites within oriC and the dnaA promoter 
region remain hemi-methylated much longer (Campbell and Kleckner, 1990; Lu et al.,
1994). This methylation delay depends on the presence of the SeqA protein (Lu et al.,
1994; von Freiesleben et al., 1994), which binds with high affinity to hemi-
methylated GATC sites in oriC (Slater et al., 1995; Messer, 2002). Initial binding of 
SeqA to two sites in oriC, one on each side of the DnaA box R1, leads to cooperative 
binding of SeqA to adjacent sites (Skarstad et al., 2000; Skarstad et al., 2001). This 
results in a multi-SeqA complex, in which one SeqA tetramer is associated with two 
hemi-methylated GATC sequences (Han et al., 2003; Han et al., 2004), which 
effectively inhibits the binding of DnaA to oriC (Skarstad et al., 2000; Taghbalout et
al., 2000; Skarstad et al., 2001). What triggers re-methylation and ends sequestration 
of oriC has remained obscure.  
In the model we have therefore used three, functionally equivalent, scenarios 
for the sequestration period of oriC after its replication. In the first scenario (SI), we 
have inserted experimental observations for the sequestration period in the model 7
without providing a molecular mechanism. In the second scenario (SII), we have 
postulated sequential re-methylation of the GATC sites in oriC, which also leads to 
resolution of the multi-SeqA complex at a well-defined time when the concentration 
of free DnaA-ATP is small. Scenario SII is presently studied experimentally in our 
laboratories. In the third scenario (SIII), we have postulated the existence of a seq
locus, situated downstream from the datA locus, which greatly reduces the 
concentration of free SeqA molecules and thereby resolves the multi-SeqA complex 
in oriC at a time point when there is little free DNA-ATP in the cell (Appendix).   
Simulation of the whole chromosome replication cycle and the timing of cell 
division
The number of oriCs in a single E. coli cell ranges between one and eight depending 
on growth condition and time point in the cell cycle (Cooper and Helmstetter, 1968) 
and the per cell numbers of molecules involved in replication control are small. This 
motivates a stochastic description (van Kampen, 1997) of chromosome replication 
and timing of cell division, which accounts for the random nature of these processes. 
The time (tevent) of any event changing the replication state of the cell is statistically 
sampled and followed by sampling of which event that has occurred according to the 
Gillespie algorithm (Gillespie, 1976). We have divided the chromosome into 1000 
segments, starting with oriC, with the datA locus in segment 200 and one DnaA box 
combined with two DnaA-ATP boxes in approximately every third segment (Fig. 3). 
Replication starts at oriC, ends at ter and the replication fork jumps from one segment 
to the next with a first order rate constant (kR) set at 25 min
-1, so that the average 
chromosome replication time (C-period) is equal to 40 minutes (C=1 000/kR) and the 
datA box is reached on the average 8 minutes after initiation. At a fixed time of 20 
minutes after termination of replication (D-period) the cell divides, implicating that 
the timing of cell division and thus the cell size are regulated by the control of 
initiation of replication. Whenever a chromosome segment containing DnaA-ATP is 
replicated, the ATP is hydrolyzed by RIDA and DnaA in the ADP form dissociates to 
the free state from which it may rebind to any unoccupied DnaA box. There are 7 
events in the model that change the replication state of the cell. These are (i) initiation 
of replication with rate r1 (ii) movement of the replication fork one step with rate r2
(iii) synthesis of one molecule of DnaA (rapidly turned into DnaA-ATP) with rate r3
(iv) association of DnaA-ADP or DnaA-ATP to DnaA boxes with rate r4 ( v)
dissociation of DnaA-ADP or DnaA-ATP from DnaA boxes with rate r5 ( vi)
association of DnaA-ATP to DnaA-ATP boxes with rate r6 (vii) dissociation of DnaA-
ATP from DnaA-ATP boxes with rate r7. The exponentially distributed tevent is the 
inverse of the sum of all rates ri and the probability of an event “i” is ri multiplied by 
tevent.
In scenario SI, oriC and the dnaA promoter are sequestered from the time of 
replication until the replication fork reaches segment 350, which takes 14 minutes on 
the average. In this scenario, we have studied control of initiation of replication both 
when dnaA is constitutively expressed and when it is auto-regulated by DnaA-ADP 
and DnaA-ATP (Appendix).  
In scenario SII, the sequestration of oriC after replication is over when the 
eleven GATC sites in oriC have been methylated either in a specific or a random 
order. Scenario SII has two state changing events, in addition to those in scenario SI,
i.e. (viii) methylation of an unmethylated GATC site in oriC with rate r8 and (ix)
methylation of unmethylated GATC sites in other chromosomal segments with rate r9.8
Figure 3. A schematic of the modelled 
chromosome. Only one replication fork is 
followed. Replication initiates at oriC (segment 1) 
and ends at ter (segment 1000), on the average 40 
minutes later. The replication fork reaches the 
dnaA gene and the datA locus 1 minute (segment 
25) and 8 minutes (segment 200) on the average 
after initiation at oriC, respectively. In addition to 
datA, the chromosome contains 307 evenly 
distributed groups of DnaA binding sites 
(illustrated as black boxes), each group consisting 
of one DnaA box which binds DnaA-ADP and 
DnaA-ATP with equal affinity, and two DnaA-
ATP boxes which only binds DnaA-ATP. The datA
locus only binds DnaA-ATP. In scenario III the 
replication fork passes a hypothetical seq locus, at 
segment 350, reached by the fork 14 minutes on the 
average after leaving oriC. The seq locus has a 
high affinity of the SeqA protein when hemi-
methylated.
In scenario SIII, sequestration of oriC after replication depends on a putative seq locus 
in segment 350 of the chromosome (Fig. 3).  Upon replication of the seq locus the 
concentration of free SeqA decreases strongly, which activates the rate of Dam-
methylation of GATC sites in oriC and other chromosomal segments. In this scenario, 
additional state changing events are (viii) methylation of hemimethylated oriC with 
rate r8 and (ix) methylation of unmethylated GATC sites in other chromosomal 
segments with rate r9. In scenario SII-III dnaA expression is either constitutive or 
regulated by DnaA and dnaA sequestration ends when oriC methylation is complete. 
See Appendix for details of the model.
RESULTS
Regulation of chromosome replication under different growth conditions 
The size of the E. coli cell increases with increasing growth rate (Donachie and 
Robinson, 1987), but the cell volume or cell mass per oriC at which replication starts 
(“initiation volume” or “initiation mass”) remains virtually (Wold et al., 1994) or 
approximately (Churchward et al., 1981) constant.  In this section, we study 
regulation of chromosome replication under different growth conditions with a 
simplified version of SI.
To illustrate principles, we will initially assume that the datA locus close to 
oriC provides the dominating number of binding sites for DnaA-ATP on the 
chromosome. Second, DnaA-ATP is constitutively expressed with a rate that is 
strictly proportional to the growth rate ȝ, so that the total DnaA concentration is 
constant, irrespective of the growth medium and the increasing fraction of dnaA to all 
chromosomal genes with increasing growth rate. Third, the sequestering of the dnaA9
gene after replication of oriC is disregarded. We will also disregard the conversion of 
DnaA-ATP to DnaA-ADP by RIDA, which under the above assumptions has no 
effect on the initiation mass. Just after replication of the datA loci in the cell, the 
concentration of datA binding sites for DnaA-ATP supersedes the number of DnaA-
ATP molecules by a factor of two so that the free concentration of DnaA-ATP is very 
low. As the cell volume grows, the concentration of datA sites is diluted, the 
concentration of total DnaA molecules remains unaltered, and the fraction of filled 
datA sites increases while the concentration of free DnaA-ATP remains low. Just 
when all datA sites have become occupied, the total concentrations of datA sites and 
DnaA-ATP molecules are almost equal. Thereafter, the free concentration of DnaA-
ATP increases sharply, rapidly leading to a new round of replication. Accordingly, 
initiation of chromosome replication is triggered at a time point in the cell cycle when 
the concentrations of DnaA-ATP molecules and datA sites are approximately equal, 
irrespective of the value of the growth rate ȝ. Since, by assumption, the total number 
of DnaA-ATP molecules per cell is proportional to the cell volume and, since the 
concentrations of datA and oriC are the same at the initiation event, this simplified 
version of SI leads to synchronous initiation once and only once per generation time at 
a constant initiation mass and initiation volume at varying growth rates.  
To further illustrate these properties of the model we have simulated a series 
of up-shifts leading to step-wise increases in the growth rate. The model accounts for 
the well-known increase in cell volume with increasing growth rate for generation 
times between 20 and 60 minutes by, first, fixing the time to complete one round of 
replication (C-period = 40 minutes) and, second, by fixing the minimal time between 
termination of replication and cell division (D-period = 20 minutes). When a cyclic 
steady state with synchronous initiations has been established, then the initiation age 
ai, that separates cell division of a mother cell from the first initiation round in the 
daughter cell is given by  ( )/ iG anC D W    , where  G W  is the generation time and n is 
the next largest integer of  / G CDW   (Cooper and Helmstetter, 1968; Bremer and 
Churchward, 1991). In the basic form of the model, initiations of chromosome 
replication occur when > @ > @
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the volume at which initiation occurs, V0is the volume of a newly born cell, nori is the 
number of oriCs per cell, equal to the number of datA loci, and Ndat is the number of 
DnaA binding sites per datA. From this follows that, in our model,  0 V  is determined 
by the generation time  G W  through 
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W    , and that the initiation 
volume VI =V/nori= Ndat/[DnaA] is determined by the total DnaA concentration, so far 
assumed to be constant. 
 In Fig. 4 the cells initially grow in a medium associated with a generation 
time of 60 minutes. Chromosome replication starts at oriC (position 1 in Fig. 4A) in 
the newly born cell and reaches ter (position 1000) after an average time of 40 
minutes. Cell division is modelled to occur 20 minutes after termination of 
replication, and the varying cell volume is shown in Fig. 4B. The model generates a 
cyclic steady state, where the free concentration of DnaA-ATP sharply rises in 60 
minutes intervals, stays large until it drops to a small value when the datA locus is 
duplicated 8 minutes after initiation (Fig. 4C). In the beginning of fourth division 
cycle, there is an up-shift so that the generation time decreases from 60 to 40 minutes, 
which by assumption, results in a 50% increase of the total dnaA expression. After the 
up-shift, oriC is as before duplicated in the newly born cell, but due to the increased  10
Figure 4. Cell size increases with increasing growth rate. At time 0 the cell is growing at a rate 
corresponding to a 60 minutes generation time. After 3, 8 and 13 generations the growth rate increases, 
corresponding to a generation time of 40 minutes, 30 minutes and 20 minutes, respectively. (A) 
Position of replication forks, oriC is located in segment 1 and the datA locus is positioned in segment 
200. (B) Normalised cell volume. (C) The free concentration of DnaA-ATP, which peaks at initiation. 
(D) The total concentration of DnaA (both bound and free). Simplified version of scenario I with no 
RIDA, no DnaA binding sites besides datA, constitutive expression of dnaA and no sequestration of the 
dnaA promoter are assumed. Total expression of dnaA is strictly proportional to the growth rate.
rate of synthesis of DnaA, so that the datA locus is more rapidly filled, the two oriCs
in the cell are now replicated after 40 minutes and soon the free DnaA-ATP 
concentration peaks at 40 minutes, rather than 60 minutes, intervals (Fig. 4C) and the 
cell volume is approximately 50% larger than before (Fig. 4B). In the beginning of the 
9
th generation and in the beginning of the 14
th generation there are further up-shifts 
leading to a generation time of 30 minutes and 20 minutes, respectively. The total 
dnaA expression is further increased by 33% and 50% percent, respectively. The 
increased expression of DnaA, to keep the total DnaA concentration constant during 
the division cycle, makes the datA loci saturated faster, at a rate generating an 
initiation frequency of 30 and 20 minutes, respectively. Since the C and D periods are 
fixed, the next cell division lags behind initially after each up-shift, resulting in a 
further increased cell volume by a factor of 2 and 4, respectively, compared to the cell 
volume at the initial 60 minutes generation time. Thus, by allowing one round of 
replication to take 40 minutes and cell division to occur 20 minutes later the proposed 
regulation of replication initiation generates a well-defined cell size for a certain 
generation time.  
Both the conversion of DnaA-ATP to DnaA-ADP by RIDA and sequestration 
of dnaA after replication of oriC decrease the total concentration DnaA-ATP in the 11
cell. It has therefore been suggested that RIDA and dnaA sequestration (Boye et al.,
2000) contribute to synchronous initiation of replication by decreasing the initiation 
potential after oriC replication. Our modelling shows, in contrast, that neither RIDA 
nor dnaA sequestration contributes to synchrony by this type of effect. Given that 
oriC is sequestered by SeqA, DnaA titration by binding sites, e.g. datA, is enough to 
sustain synchronous initiations. Thus, by introducing RIDA or dnaA sequestration 
during 14 minutes in the model and increasing the constitutive rate of synthesis of 
DnaA-ATP per promoter virtually the same synchronous replication pattern as before 
is obtained at all studied growth rates. It is, however, still possible that RIDA or dnaA
sequestration could facilitate rapid sequestration of oriC after its replication but, as 
will be argued below, the main function of RIDA is to allow for DnaA as an activator 
of chromosome replication to function also as a repressor of its own synthesis. 
  As we have seen, the basic version of SI generates a constant initiation mass 
when the chromosomal sites that titrate the free concentration of DnaA-ATP are 
positioned close to oriC, as in the datA locus. However, when there are DnaA binding 
sites evenly scattered around the chromosome, in addition to those in datA, then the 
initiation mass decreases with increasing growth rate at generation times smaller than 
40 minutes.  The reason is that at such short generation times the number of scattered 
DnaA binding sites will decrease in relation to the number of datA loci and oriCs per 
cell due to overlapping rounds of replication as the growth rate increases. For a 
constant total DnaA concentration this will then decrease the initiation mass. If, 
however, the extra chromosomal binding sites are positioned sufficiently close to 
oriC, then the initiation mass will remain unaltered as the growth rate changes. The 
sequestration period of the dnaA promoter also affect the initiation mass, which is 
neutral or increases as the growth rate increases if the sequestration period is a fixed 
fraction or a fixed number of minutes of the generation time, respectively. 
When the datA locus is removed from a chromosome with additional DnaA 
binding sites (SI), a period of adjustment follows where the cell decreases in size (Fig. 
5). Then the cell is smaller than before but initiates with the same frequency and 
harbors the same amount of DNA as before (i.e. a higher concentration of DNA). The 
initiation mass will increase considerably and synchronisation of replication will be 
partially lost, as observed experimentally (Morigen et al., 2005). Increased 
asynchrony is a result of less distinct peaks of the free concentration of DnaA-ATP at 
the time of initiation. The total concentration of DnaA is approximately the same as 
before datA deletion while the free concentration of DnaA-ADP has decreased. 
Regulation of dnaA expression 
As we have seen in the previous section, constitutive expression of dnaA, such that 
the fraction of total protein synthesis devoted to DnaA is always the same, leads to a 
constant concentration of total DnaA, allowing for precise control of oriC replication 
at constant initiation mass under different growth conditions (Fig. 4). It is, however, 
not obvious how such neutral expression of dnaA can prevail, since it will depend on 
a competition with the expression of all other genes in the cell, many of which are 
strongly regulated up or down depending on the current growth habitat (Bremer and 
Churchward, 1991). It is, furthermore, known that DnaA can function as an auto-
repressor of dnaA; more strongly as DnaA-ATP but also as DnaA-ADP (Speck et al., 
1999). It has therefore been suggested that DnaA-ATP represses the synthesis of 
DnaA by direct binding to the dnaA promoters (Nordström and Dasgupta, 2006). If, as 
we propose here, DnaA-ATP is the key-regulator of initiation of replication at oriC,12
Figure 5. Adjustment after deletion of the datA locus. The datA locus is deleted after the 5
th division 
cycle for a cell growing with a generation time of 40 minutes (scenario I, see text). (A) Position of the 
replication forks. (B) Normalised cell volume. (C) The free concentration of DnaA-ATP. (D) The total 
concentration of DnaA and the free concentration of DnaA-ADP.
the proposal that DnaA-ATP inhibits its own synthesis leads to a principal problem 
(Bremer and Churchward, 1991), later named the auto-regulation-sequestration 
paradox in the context of P1 plasmid copy number control (Chattoraj et al., 1988). 
The problem arises since normally it is the free, rather than the total, concentration of 
an active repressor that determines the occupied fraction of a promoter-controlling 
operator. Ideally, this would mean that the free concentration of DnaA-ATP is always 
constant, which would lead to a constant initiation potential, except when dnaA is 
sequestered. Accordingly, synchronous initiation of multiple oriCs in a cell would be 
precluded and, furthermore, chromosome copy number would fail, since the 
sequestration of free DnaA-ATP by datA and other DnaA binding boxes on the 
chromosome would be over-ruled by the condition of a constant free concentration of 
DnaA-ATP. If the resulting constant initiation potential would, on the average, lead to 
more than, less than or exactly one initiation per generation time there would be, 
respectively, run-away, dwindling or randomized chromosome copy numbers in the 
cell. A less precise and perhaps more realistic version of this type of control system 
will have features intermediate to those of constitutive dnaA expression and precise 
control of the free concentration of DnaA-ATP. Stochastic modelling of such a 
mechanism shows expression of dnaA to be maximal until datA is saturated. 
Subsequently, when the free DnaA-ATP concentration starts to rise, expression of 
dnaA is attenuated, leading to large variation in initiation time and loss of initiation 
synchrony (not shown). 13
These considerations and the results of the previous section show that 
regulation of the gene for an activator of initiation of replication should be based on 
the total, rather than the free, concentration of the activator. One solution to this 
principal problem has been suggested for the iteron-controlled plasmid P1, where the 
activator for plasmid duplication represses its synthesis. The proposal here is that 
iteron-bound activators can interact with the promoter for the activator by DNA-
looping, which effectively controls the total, rather than the free, activator 
concentration (Chattoraj et al., 1988; Das et al., 2005). In principle, a similar 
mechanism for bacterial chromosome copy number control is conceivable, but we 
propose instead that the ATP to ADP conversion on DnaA by RIDA is the key to 
chromosome copy number control in E. coli.
When the replication fork passes datA and other DnaA boxes along the 
chromosome, DNA-bound DnaA-ATP is converted to DnaA-ADP by the Hda protein 
in PolIII (Su’etsugu et al., 2004) by RIDA, resulting in an increased concentration of 
free DnaA-ADP in the cell.  To illustrate principles, we assume that datA dominates 
DnaA-ATP binding to the chromosome and note that the number of converted DnaA-
ATPs in datA loci approximates the total number of DnaA-ATP molecules in the cell. 
Accordingly, the free concentration of DnaA-ADP in the cell will reflect the flow of 
DnaA-ATP to DnaA-ADP, proportional to the total DnaA-ATP concentration, and the 
dilution of DnaA-ADP by volume growth. This implies that if dnaA expression is 
regulated with DnaA-ADP, rather than DnaA-ATP, as the auto-repressor, the total 
concentration of DnaA-ATP in the cell can be regulated. Note the critical assumption 
that DnaA-ADP has a lower affinity to the datA locus than DnaA-ATP, to generate a 
free concentration of DnaA-ADP, which in the case of only one dominating DnaA 
binding site on the chromosome will approximately always be proportional to the 
oriC concentration. Deviations in the initiation mass is corrected by a slightly slower 
or higher expression level from the dnaA promoter, since the free DnaA-ADP 
concentration reflects the oriC concentration. If, by such a feed-back system, the free 
concentration DnaA-ADP is adjusted to the value KR and the DNA-bound fraction of 
DnaA-ADP is neglected, initiation of chromosome replication will occur virtually as 
in the previous section with KR replacing the total concentration of DnaA in the 
expressions for the volume V0 of a newly born cell and for the initiation volume VI.
The important difference between the two cases is that the control of initiation of 
replication is expected to be much more robust against internal parameter changes and 
varying growth conditions when the total DnaA concentration is regulated than when 
it is determined by constitutive expression of dnaA.  Note that even if DnaA-ATP is 
an intrinsically stronger repressor of dnaA than DnaA-ADP, its free concentration will 
be so small that its effect on dnaA expression can be neglected.
  Apart from the datA locus, the modelled chromosome contains uniformly 
positioned groups of DnaA binding sites along the chromosome (Fig. 3). Each group 
contains one DnaA box, which can bind both forms of DnaA with equal affinity and 
two DnaA-ATP boxes, which only bind DnaA-ATP. When a segment becomes 
replicated, bound DnaA dissociates from the DNA and DnaA-ATP is simultaneously 
converted to DnaA-ADP through RIDA. While newly replicated DnaA boxes are 
quickly rebound by DnaA-ADP, the DnaA-ATP boxes are filled with the rate of 
DnaA-ATP synthesis, implying that a large fraction of the DnaA-ADP in the cell will 
be free while the free concentration of DnaA-ATP is practically zero until all DnaA-  14
Figure 6. Regulation of dnaA expression by DnaA-ADP. (A) Position of replication forks. The 
generation time is 20 minutes and the cell is born with two complete chromosome copies. On each 
copy one round of replication is halfway through (position 500) and another round is about to start. (B) 
Normalised cell volume. (C) The free concentration of DnaA-ATP. (D) The total concentration of 
DnaA and the free concentration of DnaA-ADP. The total concentration of DnaA is reduced during the 
sequestration period of the dnaA promoter. The free concentration of DnaA-ADP peaks when the forks 
replicate the datA locus and bound DnaA-ATP is converted to DnaA-ADP through RIDA (scenario I, 
see text).
ATP boxes are saturated. With only the uniformly located groups of DnaA binding 
sites (and no datA locus), replication will generate a free concentration of DnaA-ADP 
in the cell, which reflects the flow of DnaA-ATP to DnaA-ADP proportional to the 
synthesis of DNA and the dilution of DnaA-ADP by cell growth.  
  Fig. 6 depicts a cell growing with a generation time of 20 minutes. Initiation is 
triggered from 4 origins synchronously (A) as a result of the free DnaA-ATP 
concentration rising from virtually zero to a high initiation potential every 20 minutes 
(C). The free concentration of DnaA-ADP, which regulates dnaA expression, varies 
much less during the division cycle and peaks (D) when the datA locus at position 200 
(A) is replicated. The total concentration of DnaA changes during the division cycle 
as a result of the period of dnaA promoter sequestration following initiation (D). The 
cell volume varies slightly between generations. An early initiation results in a 
somewhat smaller cell at division, which is corrected back by the copy number 
control mechanism the next generation and vice versa (B). The sharp peak in the free 
concentration of DnaA-ATP occurs when the number of DnaA-ATP boxes outside 
oriC are saturated. The datA locus can be removed without completely disrupting the 
regulation of replication. As for constitutive expression of DnaA, the cell size 
decreases and initiation synchrony is partially lost. Distinct from constitutive 15
expression of DnaA the free concentration of DnaA-ADP stays approximately the 
same after datA deletion while the total DnaA concentration increases. 
Sequestration and methylation of oriC
So far we have used an ad hoc description of the sequestration period (SI) after 
replication of oriC, during which oriC in its hemi-methylated form cannot be 
replicated and dnaA cannot be expressed. Without DnaA boxes close to oriC and
dnaA promoter sequestration, the hemi-methylated state of oriC must prevail longer 
than the time of about 8 minutes for the replication fork to reach and duplicate datA,
so that when sequestration ends, the concentration of free DnaA-ATP is low enough 
to prevent pre-mature re-initiation of oriC. At the same time, oriC must be fully 
methylated and ready for a new round of replication in a window significantly shorter 
than a generation time. For cells with a generation time of 20 minutes the methylation 
time window is then only 12 minutes, but with dnaA promoter sequestration and 
DnaA boxes close to oriC, besides datA, the initiation potential is reduced earlier, 
increasing the methylation time window to about maximally 20 minutes. Experiments 
(Campbell and Kleckner, 1990) have shown that the average re-methylation time for 
two of the GATC sites in oriC is about 13 minutes in a synchronised cell culture, 
almost exactly as required to maximally separate the initiation event from the re-
methylation event of oriC in time. The SeqA protein has high affinity to the 11 hemi-
methylated GATC sites in oriC and strongly inhibits their methylation by Dam (Slater 
et al., 1995). Although the molecular basis for the sequestration period of oriC has 
remained obscure, we will here model two tentative molecular mechanisms, each of 
which could lead to a sequestration time sufficiently well-defined to result in one and 
only one initiation of oriC per generation time. The first molecular mechanism (SII) is 
based on the testable hypothesis that the 11 hemi-methylated GATC sites in oriC are 
Dam-methylated step-wise in a specific or random order. The second mechanism is 
based on the hypothesis that there exists a “seq” locus for SeqA binding downstream 
from but near datA, leading to sequestration of SeqA and rapid GATC methylation 
when the free DnaA-ATP concentration is small.  A third possibility is that the 
activity of Dam itself increases with time after replication of oriC, e.g. due to a gene 
dosage effect. Although this third option, which requires rapid turnover of Dam or 
another unknown regulation of Dam-activity, will not be modelled here, it may be 
kept in mind and explored at a time when other hypotheses have failed.  
  The time at which all 11 GATC sites have been sequentially methylated in a 
unique order is gamma distributed whereas the time has the distribution of the largest 
value of 11 independent, exponentially distributed methylation events when 
methylation occurs in a random sequence (Appendix). Our modelling shows that 
methylation of the 11 GATC sites both in a specific and a random order in 
conjunction either with a constant or a DnaA-ADP regulated total concentration of 
DnaA lead to wild-type regulation of chromosome replication for all generation times 
between 60 and 20 minutes. However, to generate wild-type regulation for cells with 
a generation time of 20 minutes the probability of an unbound GATC site (pfree) had 
to be large (0.9) and thereby insensitive to changes in the concentration of free SeqA 
(Appendix). Changes of the free concentration of SeqA created by the stochastic 
variation in initiation mass threatens to counteract proper regulation of replication 
initiation by slowing down oriC methylation when initiation takes place at a time later 
than average (increased free concentration of SeqA) instead of speeding up 
methylation for a slightly earlier initiation the next generation and vice versa. Fig. 7  16
Figure 7. Putative mechanisms of oriC methylation. (A) and (C) Methylation occurs by a step-wise 
methylation in an specific or random sequence (scenario II, see text) After the free concentration of 
DnaA-ATP is diminished following initiation (A), methylation of the oriC GATC sites is completed 
(C). (B) and (D) Methylation occurs when a hypothetical seq locus, downstream of datA,  becomes 
hemi-methylated by passage of the replication fork (scenario III, see text). When hemi-methylated the 
seq locus binds a high number of SeqA molecules, lowering the free concentration of SeqA (B) and 
triggering re-methylation of oriC (D).
(A) and (C) illustrates the principle of a step-wise methylation of the oriC GATC 
sites.
  As the replication forks proceed from oriC to ter, hemi-methylated GATC 
sites are created along the chromosome, and these may in principle serve to reduce the 
concentration of free SeqA and thus stimulate re-methylation of oriC with a suitable 
time-delay after initiation of replication. In spite of an extensive modeling search we 
have failed to identify conditions under which this type of mechanism with scattered 
SeqA sites around the chromosome can lead to synchronous initiation at multiple 
oriCs for all growth rates. To illustrate principles, we have therefore introduced a 
putative SeqA sequestration locus (seq) at 14 minutes from oriC (SIII, Fig. 3 and Fig. 
7 (B) and (D)). When the replication fork reaches seq, the concentration of free SeqA 
decreases sharply, which by hypothesis activates rapid re-methylation of oriC. Also 
this mechanism (SIII), which requires a constant total concentration of SeqA in the 
cell, leads to synchronous initiation of replication at all growth rates, as for the above 
described SI.17
DISCUSSION 
We have developed a stochastic model with all known major features of the 
regulation of initiation of chromosome replication in E.coli. The model automatically 
generates the correct initiation frequency and chromosome number, synchronous 
initiation of multiple origins and changing cell size when the cell growth rate is 
changed (Fig. 4 and 6). 
Factors determining the initiation mass 
Donachie (1968) combined the findings of a constant C- and D-period for cells with 
generation times between 60 and 20 minutes (Cooper and Helmstetter, 1968) with cell 
mass measurements of Salmonella typhimurium grown in different media (Schaechter 
et al., 1958) to introduce the concept of a constant initiation mass, defined as cell 
mass/#chromosome origins, at the onset one round of replication. Later measurements 
of the initiation mass in different strains of E.coli indicate that the initiation mass may 
be constant (K-12) or increasing with increasing growth rate (B/r) (Churchward et al.,
1981; Wold et al., 1994; Herrick et al., 1996). Therefore, whether the initiation mass 
is constant or not is probably not crucial for a proper initiation control. Instead one 
should focus on what the factors are that determine the initiation mass (Herrick et al.,
1996). Our modelling presented here shows what is required for the initiation mass to 
stay constant under varying growth conditions, given a constitutive expression of the 
dnaA promoter. The fraction of total protein synthesis devoted to DnaA must always 
be constant (which leads to a constant total concentration of DnaA), all DnaA binding 
sites must be located close to oriC and the sequestration period of the dnaA promoter 
must be a constant fraction of the generation time as the growth rate ȝ changes. Boxes 
located further away from oriC than half the way to the ter region will lead to a 
decreased initiation mass when the growth rate increases beyond 40 minutes while a 
sequestration period of the dnaA promoter a fixed number of minutes generates an 
increased initiation mass with increasing growth rate. The net outcome on the 
initiation mass of many boxes located far away from oriC and of sequestration of 
dnaA expression a constant time is therefore not obvious. 
Regulation of dnaA expression 
Although, a modelled constitutive expression of the dnaA promoter proportional to 
the growth rate can sustain a proper regulation of initiation it may be difficult to 
achieve in vivo. Adequate regulation of dnaA expression on the other hand is expected 
to generate a much more robust control of initiation. The dnaA promoter contains both 
DnaA boxes and DnaA-ATP boxes and dnaA expression is repressed by both DnaA-
ADP and DnaA-ATP in vitro (Speck et al., 1999). A number of experimental 
observations also suggest that the dnaA promoter become derepressed when 
additional DnaA binding sites located on plasmids are introduced in a cell (Hansen et 
al., 1987; Christensen et al., 1999; Morigen et al., 2001; Morigen et al., 2003). As 
emphasised, there are principal problems facing DnaA-ATP of both being the key-
regulator of replication initiation and repressor of its own synthesis. Sequestration of 
synthesised DnaA-ATP to binding sites along the chromosome generates an 
inadequate dnaA expression denoted the auto-regulation-sequestration paradox, and 
dnaA repression by free DnaA-ATP is inconsistent with a rapid boost of the free 
DnaA-ATP concentration to generate a high initiation potential at the time of 
initiation.
Our solution to the problem is that the two forms of DnaA perform each of the 
two tasks. DnaA-ATP triggers strand opening while DnaA-ADP regulates dnaA18
expression. Two key factors are required for generating a free DnaA-ADP 
concentration, which adequately regulates dnaA expression. One is RIDA, which 
couples replication to dnaA expression. Therefore we propose that RIDA is a central 
process for producing DnaA-ADP and an adequate auto-regulation of dnaA
expression rather than for preventing immediate re-initiations by lowering the 
concentration of DnaA-ATP. Two, binding of DnaA-ADP to binding sites along the 
chromosome must be such that the free concentration of DnaA-ADP still reflects the 
DNA concentration in the cell. Specifically, it requires that DnaA-ADP posses a much 
lower binding affinity to datA than DnaA-ATP. In the most pure form of this 
principle, the chromosome only contains one DnaA binding locus outside oriC, which 
is located close to the origin. Passage of the replication fork converts all bound DnaA-
ATP to the binding locus to DnaA-ADP, which cannot rebind. This way the free 
concentration of DnaA-ADP will always be proportional to the oriC concentration. 
Thus, when the oriC concentration becomes lower than normal the dnaA expression 
will increase and DnaA-ATP synthesis boosts and vice versa, correcting the initiation 
mass back to its ideal value. Gram-positives, e.g. Bacillus subtilis, may be a better 
representative for this proposed principle of how to adequately auto-regulate an 
initiator. Bacillus subtilis contain a binding locus with many more binding sites than 
datA, next to its origin, suggesting the capacity of sequestering a high number of 
DnaA molecules (Boye et al., 2000; Messer, 2002). To demonstrate that control of 
initiation can be maintained even when datA is deleted for the suggested regulation of 
dnaA expression, we also included groups consisting of one DnaA box and two 
DnaA-ATP boxes equally scattered along the chromosome. As in the case of a 
constitutive expression of dnaA, the cell size decreased and initiation synchrony was 
partially lost (Fig. 5) in line with experimental findings (Morigen et al., 2005). 
Sequestration of oriC and the dnaA promoter 
The molecular details behind the initiation and termination of the prolonged 
sequestration period of oriC and the dnaA promoter following initiation of replication 
is yet to be discovered. Sequestration is terminated by a process either acting in trans
or in cis. We have modelled two tentative molecular mechanism of methylation of 
oriC. One, sequential methylation of the eleven GATC sites in oriC ending 
sequestration in cis or two, methylation takes place when a hypothetical seq locus 
positioned downstream of datA is replicated, lowering the free concentration of the 
SeqA protein and ending oriC sequestration in trans. Both processes are plausible as 
suggested by modelling. However, one may argue that both the processive activity of 
Dam, where 55 GATC sites on Ȝ-DNA have been estimated to become methylated at 
each binding event of the enzyme (Urig et al., 2002) and the co-operative binding of 
SeqA protein (Skarstad et al., 2000; Han et al., 2004) suggest that all GATC sites are 
quickly methylated after SeqA has quickly left oriC as in the case of a seq locus 
abruptly lowering the free concentration of SeqA. Whether methylation occurs in a 
sequence or not can be found out experimentally (see below). Of principle interest is 
also the length of the sequestration period, whether it is a constant fraction of the 
generation time or a constant time independent of the growth rate. It is often stated 
that the sequestration period is one third of a generation time referring to calculations 
based on average values of two hemi-methylated GATC sites in oriC for 
asynchronous cell cultures growing in two different growth media (Campbell and 
Kleckner, 1990). We argue, that it is far from validated that oriC sequestration makes 
up a constant fraction of the generation time. The sequestration period is not exactly 
one third of the generation time in any of the two cases and while the sequestration 19
period of the two GATC sites in oriC and the GATC site in the dnaA promoter 
studied coincide in a synchronised culture, the period is very different as calculated 
from the asynchronous cultures. 
Previous models 
The most well-known, previous stochastic model is the initiator titration model 
presented by Hansen et al. in 1991. The model is based on four main assumptions; (i)
the initiator (DnaA) has a higher affinity for binding sites outside oriC than (ii) for 
binding sites located within oriC, (iii) each oriC is refractory to further initiation for 
some time period following initiation and (iv) bound DnaA protein is released from 
oriC after initiation, keeping its activity and promoting initiation by binding at not yet 
initiated oriCs. With DnaA boxes clustered around oriC the model generates 
synchronous initiation while evenly distributed boxes gives asynchronous initiation. 
However, by including the methylation of ten GATC sites, the model generates 
synchronous initiations even for uniformly distributed DnaA boxes along the 
chromosome. Our model share the first three assumptions of the initiator titration 
model, while we question the fourth since RIDA is expected to inactivate DnaA-ATP 
to DnaA-ADP upon initiation, which was not known at the time Hansen et al.
published their model. However, further comparisons are difficult to make since the 
initiator titration model never was published along with the mathematics it is based 
on. Hansen et al. did not clarify the connection between the location of DnaA boxes 
on the chromosome or how the length of the sequestration period of the dnaA
promoter affect the initiation mass. Neither did they clarify the fundamental problems 
behind an initiator with auto-regulated synthesis merely note that auto-repression of 
the dnaA promoter confer a problem. 
Bremer and Churchward (1991) are in doubt about DnaA as the protein 
regulating replication initiation while Donachie and Blakely (2003) question the 
DnaA concentration as controlling initiation. The most serious objections against 
DnaA models according to Bremer and Churchward are the observations that 
initiation continuous synchronously in excess DnaA and that oversupply of DnaA 
only stimulates a single round of replication. However, although it was known that 
initiation required methylation of oriC GATC sites at that time the SeqA protein was 
not yet discovered. As long as SeqA sequestering of oriC after each initiation stays 
unaffected, we do not see why prevention of immediate re-initiations and initiation 
synchrony should not prevail. Also, the observation regarding initiation synchrony in 
DnaA over-expressing strains, diverge in the literature (Løbner-Olesen et al., 1989; 
Skarstad et al., 1989; Atlung and Hansen, 1993). The arguments against the 
accumulation of an initiation potential, through an elevating concentration of free 
DnaA-ATP, triggering initiation are that initiation requires de novo synthesis or cell 
growth, that a five-fold increase of the total DnaA concentration shows minor effects 
on the time of initiation and that extra oriC copies on plasmids, mini-chromosomes, 
exhibit synchronous initiations with the chromosome at a normal cell size (Donachie 
and Blakely, 2003). We believe that all these experimental observations can be 
explained within the idea of a high enough free DnaA-ATP concentration triggering 
initiation. De novo protein synthesis is required to saturate DnaA binding to DnaA 
boxes along the chromosome, e.g. the datA locus, which become duplicated following 
the movement of the replication fork. It is also required for building up a high 
concentration of DnaA-ATP, since DNA-bound DnaA-ATP is converted to DnaA-
ADP by RIDA during replication. The second argument originates from a paper by 
Atlung et al. (1987). However, what Atlung et al. report are an increased copy 20
number of mini-chromosomes as well as an increase in chromosomal gene dosage of 
oriC proximal DNA. Both these observations are in line with an initiation frequency 
stimulated by an elevated concentration of DnaA. The increased gene dosage around 
oriC, observed in other reports as well (Skarstad et al., 1989; Atlung and Hansen, 
1993), rather indicate a slowed down movement or premature abortion of replication 
forks following over-initiations. The third argument about the minor effect of mini-
chromosomes is probably explained by the low number of DnaA molecules over the 
total number of DnaA molecules synthesised each cell cycle, which is required to bind 
to oriC, in order to promote strand opening. There is definitely a correlation between 
the number of extra binding sites and the number of DnaA molecules that bind to each 
site a cell can handle. Many more oriC sites can be introduced than datA loci 
(Kitagawa et al., 1996; Messer, 2002). The datA locus binds approximately ten times 
more DnaA than oriC (Løbner-Olesen, 1999; Morigen et al., 2003). 
As an alternative to free DnaA-ATP concentration controlled initiation 
Donachie and Blakely suggest control through the DnaA-ATP/DnaA-ADP ratio in 
cell. They describe in broad outline how this ratio may vary during each cell cycle 
through RIDA and de novo synthesis of DnaA in the ATP form, but they lack a 
detailed description for how a certain ratio can trigger initiation. Many different 
concentrations of DnaA-ATP and DnaA-ADP give the same DnaA-ATP/DnaA-ADP 
ratio. Although, the DnaA-ATP over total DnaA does indeed vary during the cell 
cycle in the model (not shown), which is supported by experimental observations 
(Kurokawa et al., 1999; Katayama et al., 2001) the ratio per se does not decide when 
initiation occurs in the model but a high enough free concentration of DnaA-ATP. 
We would also like to pinpoint that the principle for how an initiator (DnaA) 
at the same time can auto-regulate its own synthesis presented here is distinct from the 
Sompayrac-Maaløe auto-repressor model (Sompayrac and Maaløe, 1973). The auto-
repressor model couples the initiator gene with a gene encoding an auto-repressor 
regulating the expression of the operon, which corresponds to regulation of the dnaA
promoters by the total DnaA concentration. What we suggest is that the auto-repressor 
(DnaA-ADP) is produced during another process, replication, in a way that allows the 
free concentration of auto-repressor to adequately regulate and correct deviations of 
the synthesis of the initiator (DnaA-ATP). 
Future testing of the model 
The stochastic model presented here meets the basic demands of any model claiming 
to describe the regulation of replication initiation in E.coli. In addition, we suggest an 
elegant solution to a difficult problem; how an initiator of replication can at the same 
time regulate its own synthesis, which positions RIDA as central for replication 
control rather than merely contributing to prevent immediate re-initiations. We have 
performed one first critical test of the model, deletion of the datA locus, with 
constitutive or DnaA-ADP regulated dnaA expression and compared the model 
predictions with experimental observations. Experimental manipulations performed 
on the molecular set-up involved in initiation control are vast and further testing of the 
model wait. We believe there are three key tests of the model; the observed 
compatibility of mini-chromosomes where as many as 30 mini-chromosomes per oriC
can co-exist with the chromosome without drastically changing cell size or the 
initiation mass (Løbner-Olesen, 1999), the introduction of extra datA locus on 
plasmids which delays initiation and increases cell size (Morigen et al., 2003) and 
finally observed responses to a lower than wild-type concentration of DnaA 
(increased initiation mass and increased initiation asynchrony) or higher than wild-21
type concentration of DnaA (decreased initiation mass and potential increased 
initiation asynchrony) (Løbner-Olesen et al., 1989; Skarstad et al., 1989; Atlung and 
Hansen, 1993). We believe all these observations can be explained within the present 
model especially if dnaA expression is regulated. The increased initiation mass at a 
DnaA concentration below wild-type is expected to result from a longer time to fill 
the DnaA binding sites on the chromosome and asynchrony arise because a slowly, 
less distinct rise in the free concentration of DnaA-ATP. We expect a higher than 
wild-type concentration of total DnaA to fill datA and other binding sites more 
quickly, decreasing the initiation mass. Asynchrony may arise if the sequestration 
period of oriC is affected but initiation is otherwise expected to remain synchronous. 
Extra datA loci is expected to increase cell size because of a higher number DnaA 
binding sites to fill, and delays initiation until all datA loci are saturated with DnaA. 
Mini-chromosomes may co-exist with the chromosome in a high number and only 
increase cell size slightly if the extra oriC copies do not increases the free 
concentration of DnaA-ADP in the cell leaving the dnaA promoter slightly de-
repressed. The only experimental observation, which it is difficult to predict the 
model response to, is the increased total DnaA concentration after introduction of 
additional datA copies on plasmids (Morigen et al., 2003). 
Chain elongation of DNA requires a sufficient supply of deoxyribonucleotides 
(dNTPs), which are produced by ribonucleotide reductase (RNR). The nrd operon 
encodes the two RNR subunits and the promoter contains both DnaA boxes and 
DnaA-ATP boxes just as the dnaA promoter. Recently Gon et al. (2006) presented 
evidence that the replication dependent conversion of DnaA-ATP to DnaA-ADP 
(RIDA) is critical for coordinating DNA replication with dNTPs synthesis. This 
feedback probably explains the reported decrease of elongation fork movement in the 
presence of excess DnaA and the increased fork elongation rate in the presence of 
extra datA locus on plasmids (Atlung et al., 1987; Morigen et al., 2003; Skarstad et
al., 1989). An important development of our present model would be to incorporate 
the connection between dNTPs supply by DnaA regulated synthesis of RNR and 
replication fork movement, which regulates the rate of DnaA-ATP conversion. 
Future experiments 
The time and fraction of cells hemi-methylated at individual GATC sites can be 
studied in experiments with synchronised cell cultures (Campbell and Kleckner, 
1990). The anticipated pattern of hemi-methylation for individual GATC sites in oriC
following initiation of replication is then different for the different proposed 
principles of oriC methylation. The longer a particular GATC site stays hemi-
methylated, the higher is the fraction of cells in a hemi-methylated state and the 
longer is the average time of hemi-methylation. Thus, if methylation occurs in a 
specific order, the fraction of cells and the time of hemi-methylation increase with the 
position of the site in the methylation order. The first sites stay hemi-methylated a 
short time and the fraction of hemi-methylated cells at these sites is low, while the last 
sites in the methylation order are hemi-methylated a long time and the fraction of cells 
hemi-methylated at these sites may be close to one. If methylation occurs in a random 
order the pattern of hemi-methylation is the same for all sites. If re-methylation starts 
directly after initiation the fraction of cells hemi-methylated at any site will be far 
below one. If re-methylation is delayed the same time for all sites and then quickly 
methylated (as in the case of a seq locus) the re-methylation pattern is also the same 
for all GATC sites but the fraction hemi-methylated cells is expected to reach close to 
one before methylation occurs. To settle the question of whether re-methylation of 22
oriC GATC sites is sequential or occurs simultaneously at a certain time point 
following initiation, a systematic study of the re-methylation rate of a majority of the 
eleven GATC sites in oriC is in progress (S. Dasgupta, in preparation). 
 Whether  the  dnaA promoters during exponential growth are constitutively 
expressed or regulated is another major question to answer, although a feasible 
experiment which can settle the question if DnaA-ADP regulates dnaA expression 
seems hard to find. Both DnaA-ADP and DnaA-ATP can repress dnaA expression 
(Speck et al., 1999). If the dnaA promoters are constitutively expressed it suggests 
that the free concentration of both forms of DnaA is far below their regulatory 
concentration in the cell. One way to discriminate between constitutive and regulated 
dnaA expression may be through a moderate manipulation of the number of datA
locus, by introducing another datA site close to the already existing one on the 
chromosome. If dnaA expression is constitutive the total concentration of DnaA is 
predicted to be approximately constant while in the case dnaA expression is regulated 
by the free concentration of DnaA-ADP, the total concentration of DnaA is predicted 
to decrease while the free concentration of DnaA-ADP stays approximately the same 
(not shown). 
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APPENDIX
Stochastic chromosome model 
Discrete molecules at a low copy number motivate a stochastic description, which 
takes fluctuations of chemical reactions into account (van Kampen, 1997). We assume 
that a Markov process can describe the system and realisations are simulated using the 
Monte Carlo method presented by Gillespie (1976). The stochastic chromosome 
model describes the regulation of replication in a single cell, monitored during several 
cell generations of continuous growth and division. Initiation of replication at 
individual oriCs and the movement of individual replication forks along the 
chromosome are followed. The time, tevent, of the next reaction in the cell cycle is 
drawn from the exponential distribution tevent[1/kevent], where kevent is the sum of all 
reaction rates. The probability for a certain reaction to occur during tevent is the 
fraction its reaction rate makes up of the sum of all reaction rates. In scenario I (SI), 7 
reactions can occur, 
1) initiation of replication (r1),
 2) replication of a chromosome 
segment (r2),
3) synthesis of DnaA-ATP (r3),
4) association of DnaA-ADP or DnaA-
ATP to DnaA boxes  (r4),
5) dissociation of DnaA-ADP or DnaA-ATP from DnaA 
boxes (r5), 
6) association of DnaA-ATP to DnaA-ATP boxes (including the datA
locus) (r6),
7) dissociation of DnaA-ATP from DnaA-ATP boxes (including the datA
locus) (r7). In scenario II-III (SII-III) two more reactions can occur, methylation of oriC
GATC sites step-wise or by one rate-limiting step (r8) and methylation of 
unmethylated GATC sites in a segment outside oriC (r9).
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Replication. The chromosome is divided into 1000 segments. The current position of 
a replication fork is kept track of by the segment number and each fork is moving at a 29
constant average rate, kR. At replication one copy of a fully methylated segment 
becomes two hemi-methylated segments. Replication starts from oriC and a segment 
can only be replicated if the upstream segment next to it has already been replicated. 
Instead of two replication forks moving bi-directionally along the chromosome only 
one fork is taken into account. It takes 40 minutes to complete one round of 
replication and any ongoing replications on a fully replicated chromosome at cell 
division is carefully followed to the next generation. Approximately every 3
rd segment 
of the chromosome contains one DnaA box and two DnaA-ATP boxes binding one 
DnaA molecule each, in all 307 groups of boxes starting from segment 76. The DnaA-
ATP boxes are only accessible for DnaA-ATP binding if the adjacent DnaA box is 
bound, and dissociation of DnaA from the DnaA box results in simultaneous 
dissociation of bound DnaA-ATP molecules from the adjacent DnaA-ATP boxes. A 
datA locus, titrating DnaA-ATP molecules, is located in segment 200 (8 minutes from 
oriC). When methylation of oriC follows a change in the free concentration of SeqA, 
the model also includes a hypothetical sequestration (seq) locus (a cluster of GATC 
sites in segment 350) downstream of datA with the ability to bind a large number of 
SeqA molecules while hemi-methylated.  
Initiation of replication. The rate of initiation of replication is a function of the 
free concentration of DnaA-ATP, 
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The number of free DnaA-ATP molecules is followed by DnaA-ATP synthesis and 
association to/dissociation from DnaA-ATP binding sites along the chromosome 
except at oriC, which we do not explicitly model. During the cell cycle the 
concentration of free DnaA-ATP varies and reaches a peak at the time of initiation. A 
high concentration corresponds to a high rate of initiation and vice versa, given that 
oriC is fully methylated. At oriC, DnaA-ATP molecules bind cooperatively but we 
disregard the different types of DnaA binding sites. 
Regulation of dnaA transcription. The dnaA promoter is located in segment 25 
(one minute from oriC). Only one promoter is assumed for simplicity, motivated by 
one dominating promoter and that both promoters show similar expression patterns 
(Hansen et al., 1991; Speck et al., 1999). The promoter is auto-repressed by both 
DnaA-ADP and DnaA-ATP, when modelled regulated. We assume that the promoter 
contains two DnaA boxes which both forms of DnaA binds with equal affinity and 
cooperatively and three DnaA-ATP boxes which cooperatively is bound by DnaA-
ATP only. The number of free DnaA-ADP molecules, generated by conversion of 
bound DnaA-ATP molecules through RIDA and association to/dissociation from the 
DnaA binding sites is followed explicitly as well as the number of free DnaA-ATP 
molecules through synthesis and association to/dissociation from the DnaA-ATP 
binding sites. Only DnaA in ATP-form is synthesised with rate, 30
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When dnaA expression was modelled constitutively, ks is constant. Sequestration is 
induced by passage of the replication fork and ends simultaneously when the in cis
oriC becomes methylated. 
Methylation of GATC sites in a chromosomal segment and in oriC.  When 
replication of a seq locus ends oriC sequestration (SIII), both rates of methylation are a 
function of the free concentration of SeqA, 
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Free SeqA is calculated in a similar way as free DnaA. SeqA can bind to two different 
binding sites, base pairs in general with dissociation constant KS,bp and hemi-
methylated GATC sites with dissociation constant KS,hmin our hypothetical seq locus. 
Bound SeqA to other GATC sites than in the seq locus is disregarded. The 
concentration of free SeqA was calculated from the following system 
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The free concentration of SeqA is high during the cell cycle, except a short period of 
time directly after replication of the seq locus when the GATC binding sites are hemi-
methylated. A low concentration of free SeqA greatly increases the rate of 
methylation of hemi-methylated GATC sites, while a high concentration decreases the 
rate of methylation. When methylation of individual GATC sites in oriC was 
modelled (SII), the chromosome contained 19000 (Urig et al., 2002) evenly distributed 
GATC sites instead of the seq locus and the concentration of seq loci was replaced by 
the concentration of hemi-methylated chromosomal segments in eq. A5. The rate 31
constant of methylation, kmet, is described for the Markov processes in the section 
below.
Probability of completed oriC methylation within the methylation time window 
for a specific or random methylation order of individual GATC sites 
Methylation of oriC can be treated as an independent stochastic process, detached 
from the rest of the initiation control by DnaA. The maximum probability that 
methylation of an individual oriC is completed within the methylation time window 
of each cell cycle can be calculated and compared for methylation of the eleven 
GATC sites in an specific or random sequence. Given that binding by SeqA to the 
GATC sites equilibrates much faster than the rate of methylation of a site by Dam, 
each site is unbound and free for methylation with probability 
1/(1 [ ]/ ) free free Dmet pS e q A K    where KDmet is the dissociation constant of SeqA 
binding to a GATC site in oriC. If we further assume that the free concentration of 
SeqA and of Dam is approximately constant, then a GATC site becomes methylated 
with average rate or intensity  [] met total free kk D a mp    , where k is the maximum rate 
of methylation. The sequential methylation of eleven GATC sites in a specific order 
can then be described by a Markov process, formulated by the Master equations and 
initial conditions 
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where i=10,9,…,1. The time of completing methylation of oriC is gamma distributed, 
(11,1/ ) met k * , and the probability density function is 
10 ()
()
10!
met kt met
met
kt
ft k e
 
   . The 
maximal probability mass that can be fitted within a methylation time window of 14 
or 20 minutes is 0.87 and ~ 1, respectively. Methylation of eleven GATC sites in a 
random sequence can similarly be described by 
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where i=10,9,…,1. The time of completing methylation of oriC has the distribution of 
the largest value of eleven independent, exponentially distributed stochastic variables 
each with distribution Exp(1/kmet). The probability density function is 32
10 () 1 1( 1 )
met met kt kt
met ft e k e
       , and maximally 0.75 or ~ 1 of the probability mass 
can be placed within a methylation time window of 14 and 20 minutes, respectively.
Table A1. Parameters used in the chromosome model. 
Parameter Symbol  Value 
# of chromosome segments  N 1000 
# of base-pairs in the E.coli genome  Nbp 4*10
6
Cooperativity factor of DnaA binding to oriC nD 4 
Cooperativity factor of DnaA-ADP binding to the dnaA
promoter 
nA 2 
Cooperativity factor of DnaA-ATP binding to the dnaA
promoter 
nAT 3 
Cooperativity factor of  SeqA binding to oriC nS 4 
# of DnaA binding sites in datA locus  NdatA  370 ; 300
I)
# of SeqA binding sites in seq locus  NGATC 5000
 II)
Total concentration of SeqA  [SeqAtot] 1.1 PM
Dissociation constant of DnaA to oriC KD,oric 80  nM 
Dissociation constant of DnaA-ADP binding to the dnaA
promoter 
KD1 0.2 PM
Dissociation constant of DnaA-ATP binding to the dnaA
promoter 
KD2 0.1 PM
Dissociation constant of SeqA binding to oriC KS,oriC 1.0  nM 
Dissociation constant of SeqA binding to GATC sites  KS,hm 3.0  nM 
Dissociation constant of SeqA binding to base-pairs  KS,bp 0.5  mM   
Maximum initiation rate constant kI,max 1  s
-1
Association rate constant of DnaA-ADP binding to 
DnaA boxes 
ka1 10
8 (Ms)
-1
Dissociation rate constant of DnaA-ADP dissociation 
from DnaA boxes 
kd1 0.03  s
-1
Association rate constant of DnaA-ATP binding DnaA-
ATP boxes 
ka2 10
8 (Ms)
-1
Dissociation rate constant of DnaA-ATP dissociation 
from DnaA-ATP boxes 
kd2 0.003  s
-1
Maximum synthesis rate of DnaA-ATP  ks,max 3.5·10
-3 III);
3.5·10
-2 IV)
Maximum methylation rate constant of oriC km,oriC 100  s
-1 V)
Methylation rate constant of individual GATC sites in 
oriC
kmet 0.018  s
-1 VI);
0.005 s
-1 VII)
Dissociation constant of SeqA binding to oriC GATC 
sites
KDGATC 3  nM; 
40.5 PM (W=20
min) 
Maximum methylation rate constant of GATC sites 
outside oriC
km,GATC 1  s
-1
Replication rate constant kR 1/(40*60/N)  s
-1
Generation time  W 60-20 min 
Growth rate constant  P ln2/W*60 s
-1
Cell volume at initiation when W = 60 minutes  Vcell 10
-15 l 
Avogadro’s constant  NA 6·10
23
I) Simplified version of scenario I 
II) When methylation of individual GATC sites in oriC was modeled, the seq locus was replaced by 
19000 evenly distributed GATC sites along the chromosome 
III) With constitutive expression of dnaA
IV) With regulated expression of dnaA33
V) With seq locus 
VI) Specific sequence 
VII) Random sequence The Molecular Mechanism of Peptide-mediated Erythromycin
Resistance*□ S
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The macrolide antibiotic erythromycin binds at the entrance of
the nascent peptide exit tunnel of the large ribosomal subunit and
blocks synthesis of peptides longer than between six and eight
aminoacids.Expressionofashortopenreadingframein23SrRNA
encoding five amino acids confers resistance to erythromycin by a
mechanism that depends strongly on both the sequence and the
lengthofthepeptide.Inthisworkwehaveusedacell-freesystemfor
protein synthesis with components of high purity to clarify the
molecular basis of the mechanism. We have found that the nascent
resistance peptide interacts with erythromycin and destabilizes its
interaction with 23 S rRNA. It is, however, in the termination step
when the pentapeptide is removed from the peptidyl-tRNA by a
class1releasefactorthaterythromycinisejectedfromtheribosome
with high probability. Synthesis of a hexa- or heptapeptide with the
samefiveN-terminalaminoacidsneitherleadstoejectionoferyth-
romycin nor to drug resistance. We propose a structural model for
the resistance mechanism, which is supported by docking studies.
The rate constants obtained from our biochemical experiments are
alsousedtopredictthedegreeoferythromycinresistanceconferred
by varying levels of resistance peptide expression in living Esche-
richia coli cells subjected to varying concentrations of erythromy-
cin. These model predictions are compared with experimental
observations from growing bacterial cultures, and excellent agree-
ment is found between theoretical prediction and experimental
observation.
Erythromycinisaclinicallyimportantbroad-spectrumantibioticthat
belongstothemacrolideclass.Itbindstoasitein23SrRNAonthelarge
ribosomal subunit (50 S)
3 close to the peptidyl transferase center, near
the entrance to the nascent peptide exit tunnel (1). Erythromycin-
bound ribosomes can synthesize peptides with lengths between six and
eight amino acids, but further peptide elongation is inhibited, and pep-
tidyl-tRNA dissociates prematurely from the ribosome in the drop-off
pathway (2). Different macrolides allow formation of peptides with dif-
ferent lengths depending on the space available between the macrolide
andthepeptidyltransferasecenter.Thissuggeststhatmacrolidesactby
preventing the nascent peptide from entering the peptide exit tunnel in
the 50 S subunit (2). Once a nascent peptide has passed the erythromy-
cin binding site and entered the peptide exit tunnel of a drug-free ribo-
some, erythromycin cannot bind to the 50 S subunit, which makes the
ribosome refractory to the drug until peptide elongation is terminated
by a class 1 release factor (3).
The way nascent peptides interact with the exit tunnel is important
both for regulation of messenger RNA (mRNA) translation and protein
export (4). For example, expression of the ErmC methyltransferase,
which causes erythromycin resistance by methylating base A2058
(Escherichia coli numbering) at the erythromycin binding site in 23 S
rRNA,isregulatedbynascentpeptide-erythromycininteractionsinthe
peptideexittunnel.Thatis,whenthereiserythromycininacellcarrying
the ermC gene, ribosomes are stalled during translation of an open
reading frame present in the leader of the ermC mRNA. This causes
rearrangements of the secondary structure of the leader mRNA, which
make the ribosome binding site available for initiation of translation of
the ErmC encoding the open reading frame of the ermC mRNA. This
regulation requires a special sequence of the leader-encoded peptide,
suggesting the existence of specific interactions between the peptide,
the peptide exit tunnel, and erythromycin (5).
Another example of such specific interactions is the mechanism by
which expression of a small open reading frame buried in the E. coli 23
S rRNA and encoding a pentapeptide causes low level resistance to
erythromycin. This pentapeptide can only work in cis, meaning that
resistance is conferred only to a ribosome on which the peptide is syn-
thesized(6).Randomlibrarieshavebeenusedtodetermineaconsensus
sequence for peptides that cause erythromycin resistance, i.e. fMet-
(bulky/hydrophobic)-(Leu/Ile)-(hydrophobic)-Val (7). The random
library approach has also been used to select resistance peptides to
macrolides other than erythromycin. These studies have established
correlations between macrolide structures and resistance peptide
sequences, suggesting a unique peptide-drug interaction in the riboso-
mal tunnel for each tested macrolide (8–10). It has been suggested that
synthesisofthecis-actingpeptidethatconfersresistancetoerythromy-
cin removes the drug from the ribosome in an unknown manner (8).
However, there has been no direct experimental evidence to support
thisproposal,andthemolecularmechanismbywhichpeptidesynthesis
couldputativelyremoveerythromycinfromtheribosomehasremained
obscure.
Wehaveusedacell-freetranslationsystemwithpurifiedcomponents
from E. coli (11) to study the mechanism of peptide-mediated erythro-
mycin resistance. We have found that, indeed, translation of the resist-
ance peptide mRNA ejects the peptide, and we have identified the
very step where this occurs. Based on our biochemical data and with
support from docking simulations, we propose a structural model for
* This work was supported by the Swedish Research Council, the Wellcome Trust Inter-
national Senior Fellowship (070210/z/03/z), and the Estonian Science Foundation
(5311).Thecostsofpublicationofthisarticleweredefrayedinpartbythepaymentof
page charges. This article must therefore be hereby marked “advertisement”i n
accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
□ S The on-line version of this article (available at http://www.jbc.org) contains supple-
mental material.
1 These authors are equal contributors.
2 To whom correspondence should be addressed: Dept. of Cell and Molecular Biology,
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den.Tel.:46-18-471-42-13;Fax:46-18-471-42-62;E-mail:ehrenberg@xray.bmc.uu.se.
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release factor; IPTG, isopropyl--D-thiogalactopyranosid; EF, elongation factor;
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Supplemental Material can be found at: erythromycinejectionbypeptidesynthesis.Wehave,furthermore,used
our kinetic data in conjunction with mathematical modeling to make
quantitativepredictionsofthedegreeofresistanceconferredbyvarying
levelsofresistancepeptideexpressioninlivingcellssubjectedtovarying
externalconcentrationsoferythromycin.Thesemodelpredictionshave
been validated by observations from experiments in which the expres-
sion of resistance peptide was varied for bacteria growing in media
containing varying concentrations of erythromycin.
EXPERIMENTAL PROCEDURES
ChemicalsandBuffers
GTP, ATP, and [
3H]Met were from Amersham Biosciences. Putres-
cine, spermidine, phosphoenolpyruvate, myokinase, inorganic pyro-
phosphatase, erythromycin, and non-radioactive amino acids were
from Sigma-Aldrich. Pyruvate kinase was from Roche Applied Science.
[
14C]Erythromycin was from PerkinElmer Life Sciences, and josamycin
was from Alexis Biochemicals (Lausen, Switzerland). All experiments
wereperformedinpolymixbufferatworkingstrengthcontaining5mM
magnesiumacetate,5mMammoniumchloride,95mMpotassiumchlo-
ride,0.5mMcalciumchloride,8mMputrescine,1mMspermidine,5mM
potassium phosphate, and 1 mM dithioerythritol (12).
mRNA
The template DNAs for in vitro transcription were prepared by
annealing the following oligonucleotides at the complementary
sequences (underlined) and filling the gaps by PCR: forward oligo,
CTCTCTGGTACCGAAATTAATACGACTCACTATAGGGAATT-
CGGGCCCTTGTTAACAATTAAGGAGG;reverseoligoforMRLFV,
TTTTTTTTTTTTTTTTTTTTTTAAACAAACAGACGCATAGT-
ATACCTCCTTAATTGTTAACAAGGGCCCG; reverse oligo for
MRLFVA, TTTTTTTTTTTTTTTTTTTTTTATGCAACAAA-
CAGACGCATAGTATACCTCCTTAATTGTTAACAAGGGCCCG;
reverse oligo for MRLFVAN, TTTTTTTTTTTTTTTTTTTTTTA-
ATTTGCAACAAACAGACGCATAGTATACCTCCTTAATTGT-
TAACAAGGGCCCG; reverse oligo for MNAIK, TTTTTTTTTT-
TTTTTTTTTTTTATTTAATTGCATTCATAGTATACCTCCTT-
AATTGTTAACAAGGGCCCG.Invitrotranscriptionandpurification
of mRNAs containing a poly(A) tail were as described in Pavlov and
Ehrenberg (13).
TheComponentsofthePurifiedTranslationSystem
Components of the translation system were purified as described in
Tenson et al. (2), except for RF1, RF2, and RF3, which were purified as
describedinFreistrofferetal.(11),andRRF,asdescribedinMacDougall
et al. (14). All experiments were performed at 37 °C in polymix buffer
with the addition of ATP (1 mM), GTP (1 mM), and phosphoenolpyru-
vate (10 mM).
RecyclingExperiments
The initiation mixture contained ribosomes (0.24 M, 70% active),
[
3H]fMet-tRNA
fMet (5 M), mRNA (0.5 M), IF2 (0.5 M), IF1 (1 M),
IF3 (1 M), and erythromycin (0.6 M in the chase and 6 M in the
experimentswithonlyerythromycin).Therecyclingmixturecontained
EF-G(2M),EF-Tu(40M),EF-Ts(1M),RF2(2M),RF3(2M),RRF
(2 M), tRNA
bulk (0.18 mM), inorganic pyrophosphatase (5 g/ml),
myokinase (3 g/ml), pyruvate kinase (50 g/ml), the relevant amino-
acyl-tRNA synthetases (0.15 units/l) (defined in Ehrenberg et al. 15),
and amino acids (alanine 1.5 mM, leucine 300 M, and 100 M concen-
trationsofeachoftheothers).Josamycin(165M)wasalsoaddedtothe
recycling mix when relevant.
Bothinitiationmixandrecyclingmixwerepreincubatedfor10minat
37 °C to allow for formation of ribosomal initiation complexes and ter-
nary complexes, respectively. After mixing 10 l of the initiation mix
with10loftherecyclingmix,reactionswerequenchedatthespecified
time points by adding 135 l of 20% formic acid, and peptide formation
wasanalyzedusingreversephaseHPLCasdescribedinTensonetal.(2).
The amount of peptide P that is produced per time unit depends on
the ribosome recycling rate, k1, and the amount of active ribosomes, R,
dP
dt  k1R (Eq.1)
Without josamycin, which inhibits formation of these short peptides,
the amount of active ribosomes is constant, R  Rtot, and the recycling
rate can be determined from the slope of a curve where the amount of
peptides is plotted versus time, P  Rtotk1t.
However, if erythromycin is chased with a large excess of josamycin
when an erythromycin molecule dissociates from the ribosome, it is
immediately replaced by a josamycin molecule, which shuts down pro-
tein synthesis. Accordingly, the amount of active ribosomes becomes
R  Rtote
k2t (Eq.2)
where k2istherateconstantforerythromycindissociation.Insertionof
Equation 1 in Equation 2 leads to the differential equation
dP
dt  k1Rtote
k2t (Eq.3)
for peptide synthesis, which has the solution
P  Rtot
k1
k2
1  e
k2t (Eq.4)
Using the k1 value estimated from the experiment performed in the
absence of josamycin, the parameter k2 was varied to fit the Equation 4
model to experimental data with the help of the Marquardt algorithm
(16) implemented in Origin 7 (OriginLab Corp.).
ErythromycinandPeptideDissociationRates
The mixture for initiation of protein synthesis contained ribosomes
(1.4M,70%active),[
3H]fMet-tRNA
fMet(1M),mRNA(2.5M),IF2
(0.5 M), IF1 (1 M), IF3 (1 M), and when, relevant [
14C]eryhtromycin
(2 M). The protein elongation mixture contained EF-G (1.6 M),
EF-Tu (40 M), EF-Ts (1 M), and tRNA
bulk (0.18 mM), inorganic
pyrophosphatase (5 g/ml), myokinase (3 g/ml), pyruvate kinase (50
g/ml). Elongation was halted at the desired peptide lengths by exclu-
sionoftheaminoacidandtheaminoacyl-tRNAsynthetasenecessaryto
form the ternary complex that was reading next down-stream codon.
The concentrations of the added aminoacyl-tRNA synthetase were
(0.15 units/l) (defined in Ehrenberg et al. (15)), and the added amino
acidswere(alanine1.5mM,leucine300M,and100Mconcentrations
of each of the others). When stated, RF1 (3 M) or RF2 (3 M) was also
addedtotheelongationmix,andunlabelederythromycin(150 M)was
added to prevent rebinding of the [
14C]erythromycin. Both initiation
mix and elongation mix were preincubated for 10 min at 37 °C to allow
for formation of initiation and ternary complexes, respectively.
NitrocelluloseFilterBindingAssays—Ribosomessticktothenitrocel-
lulose filters, whereas erythromycin, peptides, and peptidyl-tRNA do
not.Hence,thenitrocellulosefilterassayallowsustoseparateribosome
boundfromotherlabeledmolecules.Aftermixing20loftheinitiation
ErythromycinResistancePeptides
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 mix with 20 l of the elongation mix, reactions were quenched by the
additionof1mlofice-coldpolymixandappliedtonitrocellulosefilters.
Thefilterswerewashedtwicewith1mlofpolymix,andboththe
3Hand
14C activity were counted for both the flow-through and the filters.
FormicAcidPrecipitationAssay—Aftermixing20loftheinitiation
mix with 20 l of the elongation mix, reactions were quenched by the
additionof150lof20%formicacid,andtheprecipitateswerepelleted
by centrifugation. The
3H activities in the supernatants, containing
releasedpeptideswerecounteddirectly,whereas160lof0.5mMKOH
was added to the pellets. After 10 min of incubation at room tempera-
ture, 10 l of 100% formic acid was added, and the precipitates were
pelleted again. The
3H activities in the supernatants at this second step
correspond to the peptides that were still bound to tRNA at the time
point when the reaction was quenched.
Data Evaluation—The dissociation rate constants for erythromycin
leavingtheribosomewereestimatedbyfittingthedatatoasingleexpo-
nential model. The corresponding peptide- and peptidyl-tRNA dissoci-
ationrateconstantswerealsoestimatedbyfittingtoasingleexponential
because the peptide synthesis was much faster than the dissociation
(datanotshown),andthus,thedissociationcouldbeapproximatedwith
a single step reaction. The fitting was performed using the Marquardt
algorithm (16) implemented in Origin 7 (OriginLab Corp.).
DockingofthePeptidestotheRibosome
Computational modeling was done to investigate the possible modes
of interaction between peptides and erythromycin in different stages of
peptide elongation. We used docking of the resistance peptide, fMet-
Arg-Leu-Phe-Val-Stop (fMRLFV), to find a specific pattern of interac-
tion with erythromycin. Furthermore, we used the peptide fMet-Asn-
Ala-Ile-Lys-Stop (fMNAIK) as the negative control, in line with the
experimental work (9). For this purpose we used GOLD 3.0 (CCDC,
Cambridge, UK) in combination with the crystal structure 1YI2 (1),
which contains the ribosome in complex with erythromycin. The
docked peptide was covalently constrained to tRNA in either the A
(acceptor) or the P (peptidyl) site. The position of the tRNA was taken
from the crystal structure 1QVG (17). The docking study was carried
out using 2,000,000 operations per docking. Atom c21 in erythromycin
was defined as the floodfill center, and a radius of 10 Å was used in the
floodfill. Thus an “active site” was defined around the erythromycin
facing the A and P sites. The two peptides were docked as tri-, tetra-,
penta- and hexapeptides (extended with Ala). Each peptide was docked
20times,andthe15bestsolutionsweresaved.WeusedtheChemscore
option in GOLD for scoring the generated binding poses (18).
SimulationsofPeptide-mediatedResistanceintheLivingCell
Basedonourmodelforerythromycinejectionfromtheribosomeand
biochemical data, we set up a system of differential equations of ribo-
somes in different states (see Fig. 3A). The model accounts for changes
in the total concentration of intracellular erythromycin by the inflow
and outflow of the macrolide over the membrane and the change of
resistance peptide mRNA and protein mRNA through synthesis and
degradation.Allcomponentsarealsodilutedbycellgrowth.Thesystem
wassolvednumericallybyEuler’smethod(26),aftertheintroductionof
a certain macrolide concentration in the medium. Cell growth was reg-
istered as volume expansion during the first 8 h after induction. Before
macrolide exposure, the system resided at steady state for a certain
synthesis rate of resistance peptide mRNA (rpmRNA). The used pro-
gram software was MATLAB 6.5 (The MathWorks, Inc., Natick, MA).
A detailed description of the model and the parameters used is pre-
sented in the supplemental material.
MeasurementsonCellCultures
Strains—E.coli DH5 strain (F80dlacZ (lacZYA-argF)U169 deoR
recA1 endA1 hsdR17 (rk,m k 	) phoA supE44 -thi-1 gyrA96 relA1/F
proAB	lacIqZM15 Tn10(tetr)) was used in all experiments.
Effects of Mini-gene Expression on Macrolide Resistance—Overnight
culturesofcellsexpressingresistancepeptide(9)weregrownat37 °Cin
LBmediumcontaining100g/mlampicillin.Culturesweredilutedinto
96-well plates with fresh LB medium containing erythromycin and
IPTG at different concentrations to final densities of A600  0.01.
The cell cultures were grown in the shaker at 37 °C for 8 h, and the
optical densities at A600 were recorded using the TECAN SUNRISE
instrument.
RNA Copy Number—Cells expressing the resistance peptide were
grown overnight in LB medium containing 100 g/ml ampicillin at
37 °C. Cultures were diluted with fresh LB medium containing IPTG
anderythromycinattheconcentrationsasindicated.Thecultureswere
grown for 2 h before 1-ml cultures were taken for total RNA isolation.
TotalRNAwaspurifiedwithNucleoSpinRNAIIkit(Macherey-Nagel).
Concentrations of the resistance peptide and EF-Tu mRNAs were
measured by reverse transcription real-time PCR using the TaqMan
Gold reverse transcription PCR kit (Applied Biosystems). The reverse
transcriptionreal-timePCRprogramwasasfollows;1)annealingofthe
forwardprimertomRNA(75 °Cfor2min,65 °Cfor5min,and53 °Cfor
5 min); 2) reverse transcription reaction, started by adding TaqMan
reverse transcription buffer, dNTPs, RNase inhibitor, and reverse tran-
scriptase followed by incubation at 45 °C for 10 min, 48 °C for 30 min,
and 95 °C for 30 min; 3) real-time PCR, started by the addition of PCR
buffer, dNTP, AmpliTaq Gold DNA polymerase, and the respective
reverse primers and Taqman probes followed by PCR steps (prePCR
(50 °Cfor2minand95 °Cfor10min)and40PCRcycles(95 °Cfor15s,
50 °C for 30 s, and 60 °C for 15 s). The final reaction volume was 25 l.
The concentrations of forward and reverse primers were 900 nM each,
and the probe concentration was 100 nM. Annealing and reverse tran-
scriptionstepsweredoneinGeneAmpPCRSystem2700(AppliedBio-
systems). Real-time PCR was run and monitored in Rotor-Gene 5.0.47.
Primers—SpecificprimersforresistancepeptideencodingmRNAwere:
forward, d(AAAAGCCCGCTCATTAGG), reverse, d(TGCTAGTCT-
TAAGGAGGTCACAT), and Taqman probe, d(CTAGAGAATTCA-
GCTAGTTAAACAAACAAAACCA).SpecificprimersforEF-TumRNA
were: forward, d(GAGATGGAGAATACGTCTTCGA), reverse, d(AC-
CAGAGCGTGCGATTG), and Taqman probe, d(CGGCAGCAG-
GAACGGCTT). Taqman probes had the 5 end modified with a FAM
fluorophore and the 3end modified with a TAMRA fluorophore.
RESULTS
Stoichiometric Removal of Erythromycin by Resistance Peptide
Synthesis—To study the effects of resistance peptide synthesis on the
rate of dissociation of erythromycin from the 50 S subunit, we took
advantage of a cell-free translation system with purified components
from E. coli (11). The resistance pentapeptide fMRLFV and a control
pentapeptide, fMNAIK, were synthesized (9) on ribosomes in recycling
mode(19).Erythromycininsignificantlyaffectedtherateofsynthesisof
resistance and control peptide, whereas their synthesis was shut down
by the presence of josamycin (Fig. 1). We took advantage of this by
chasing the erythromycin, originally on the recycling ribosomes, with
josamycin (Fig. 1). Because the two drugs have overlapping ribosomal
binding sites (1, 20, 21), josamycin cannot bind and shut down peptide
synthesisuntilafterdissociationoferythromycinfromthe50Ssubunit.
The josamycin concentration used in the chase (83 M) leads to an
association rate of 2.7 s
1 (21). Thus, the rate-limiting step in the josa-
ErythromycinResistancePeptides
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 mycin-inducedinhibitionofpeptideformationistheerythromycindis-
sociation. The value of the rate constant for dissociation of erythromy-
cin from ribosomes synthesizing the control peptide was estimated as
0.01s
1(Fig.1B),whichcorrespondstotherateconstantforspontane-
ous dissociation of erythromycin from empty ribosomes (21). In con-
trast, the value of the rate constant for dissociation of erythromycin
from ribosomes synthesizing the resistance peptide was estimated as
0.03s
1,avaluecoincidingwiththerate(s
1)ofpentapeptidesynthesis
per ribosome in the absence of josamycin (Fig. 1A). From these results
follows that erythromycin was removed with high probability from the
ribosome during each cycle of resistance, but not control peptide syn-
thesis. Identification of the step at which drug dissociation was induced
by the cis-acting peptide required further experiments, to be described
in the next paragraph.
Dissociation of Erythromycin during Different Stages of Resistance
Peptide Synthesis—To estimate the rate constants for dissociation of
erythromycinatdifferentstagesofresistancepeptidesynthesis,weused
nitrocellulose filtration techniques.
Ribosomes were initiated for synthesis of resistance (fMRLFV) or
control (fMNAIK) peptides. By selective exclusion of amino acids and
aminoacyl-tRNA synthetases in the peptide elongation assays, ribo-
somescarryingfMR,fMRL,fMRLF,orfMRLFVaswellasfMN,fMNA,
fMNAI, or fMNAIK peptides ester-bonded to the P-site tRNA were
produced. Subsequently, [
14C]erythromycin was chased from each one
oftheseribosomecomplexesbytheadditionofunlabelederythromycin
in excess, and the fraction of [
14C]erythromycin-containing ribosomes
was monitored by nitrocellulose filtration at different incubation times.
From these data, rate constants for the dissociation of erythromycin
were estimated, and the results are summarized in Table 1. The rate
constant for dissociation of erythromycin increased from its smallest
value (0.011 s
1) in the initiation complex with every amino acid that
was added, in accordance with the resistance peptide sequence to its
largestvalueof0.068s
1whenthepentapeptidewascompleted(Fig.2A
and Table 1). There was at the same time little effect on the rate of
erythromycin dissociation by amino acid addition, in accordance with
the control peptide sequence (Fig. 2B and Table 1).
It has been shown that active resistance peptides must have lengths
between four and six amino acids (7). To clarify why this is so, we
prepared mRNAs encoding the hexapeptide fMet-Arg-Leu-Phe-Val-
Ala-Stop, which is the resistance peptide with a C-terminal addition of
Ala,andtheheptapeptidefMet-Arg-Leu-Phe-Val-Ala-Asn-Stop,which
is the resistance peptide with a C-terminal addition of Ala-Asn. Both
these C-terminal additions reduced the rate constant for erythromycin
dissociation from 0.068 s
1 (in the presence of the authentic resistance
peptide) to 0.014 s
1 (in the presence of the C-terminal extension)
(Table 1).
Theseresultsshowthatwhentheresistancepeptidegrewfromtwoto
five amino acids, this led to successively faster dissociation of erythro-
mycin. Because, however, synthesis of the resistance peptide was con-
siderably faster than the largest rate of erythromycin dissociation, these
data cannot explain why every round of resistance peptide synthesis
resulted in near-stoichiometric removal of the 50 S-bound erythromy-
cin(Fig.1).Thispointedatclass1releasefactor-inducedpeptiderelease
from the ribosome as the critical step for resistance peptide action.
Experiments addressing this question follow.
Termination of Resistance Peptide Synthesis Drives Dissociation of
Erythromycin—The largest rate constant for erythromycin dissociation
(0.14s
1)wasobtainedwheneitheroneoftheclass1releasefactorswas
also present to terminate the synthesis of the resistance peptide at the
UAAcodonofitsmRNA(Fig.2C,Table2).Atthesametime,therewas
noeffectontherateoferythromycindissociationbyreleasefactoraddi-
tion in the case of the control peptide (Fig. 2C, Table 2). To further
investigate class 1 release factor action, we used nitrocellulose binding
to monitor the release of different peptides from the ribosome and
formicacidprecipitationfollowedbypeptideidentificationbyHPLCto
directly monitor hydrolysis of the ester bond connecting peptide and
P-site tRNA. The rate of dissociation from the ribosome and the rate of
ester bond hydrolysis were similar in the cases described below in this
sectionoftext,suggestingfastdissociationofpeptidesfromtheribosome
after the rate-limiting ester bond hydrolysis.
The rate of resistance peptide release from the ribosome, as induced
by either one of the class 1 release factors (0.073 s
1) as monitored by
theribosome-bound
3H-labeledfMet,wassignificantlysmallerthanthe
rate constant for dissociation of erythromycin (0.14 s
1). At the same
time,therateofcontrolpeptidereleaseasinducedbyRF2(0.22s
1)was
almost 30 times larger than the rate constant for erythromycin dissoci-
ation(Fig.2E).Theseresultsinconjunctionwiththeobservation(Fig.1)
that every cycle of resistance peptide synthesis removed the ribosome-
bound erythromycin with high probability suggest, first, that binding of
a class 1 release factor to an erythromycin-containing ribosome carry-
ing a resistance pentapeptide further destabilized the binding of the
FIGURE 1. Erythromycin chased with josamycin in a recycling experiment. The
amountsofresistancepeptide(MRLFV,panelA)andcontrolpeptide(MNAIK,panelB)are
plotted against time. Erythromycin (Eryt. (F) allows formation of both pentapeptides
almostaswellaswithoutanyantibiotic( ),whereasjosamycin(Josa.Œ)doesnotallow
any pentapeptide formation. When erythromycin dissociates in the chase experiment
(f) it is replaced by josamycin, and further pentapeptide formation is inhibited. The
dashed lines correspond to the amount of active ribosomes in the experiments (1.7
pmol). Translation of the resistance peptide (MRLFV, panel A) is inhibited already after a
singleroundoftranslation,whichmeansthatallerythromycinhasdissociatedandbeen
replacedbyjosamycinbeforethenextroundoftranslationinitiates.Thisisincontrastto
the several rounds of recycling that is allowed when expressing the control peptide
(MNAIK, panel B). The pentapeptide synthesis rate per ribosome in the absence of josa-
mycin(k1)is0.03s
1(3pmolmin
1/1.7pmolofribosomes1.8min
10.03s
1).The
erythromycindissociationrate(k2)canbeestimatedfromthevalueofk1andtheplateau
level in the josamycin chase experiments (see “Experimental Procedures”).
TABLE1
Erythromycin dissociation rate constants
Translated peptide Erythromycin dissociation rate constant
s
1
Initial complex 0.011 
 0.001
MR 0.017 
 0.005
MRL 0.025 
 0.004
MRLF 0.051 
 0.004
MRLFV 0.068 
 0.006
MRLFVA 0.014 
 0.001
MRLFVAN 0.014 
 0.001
MN 0.011 
 0.001
MNA 0.015 
 0.001
MNAI 0.016 
 0.001
MNAIK 0.017 
 0.001
ErythromycinResistancePeptides
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 drug to the ribosome and, second, that termination was slow enough to
allowdissociationoferythromycinfromtheribosomewithaprobability
close to one, in accordance with the results in Fig. 1. It cannot be
excludedthatdissociationoferythromycinwasstrictlyrequiredforter-
mination to occur, in which case the probability for drug rejection
would be exactly 100%. The reason for the ambiguity relates to the
experimentaldesigninwhich[
14C]erythromycinwaschasedwithunla-
beled erythromycin at a high concentration (75 M), which could allow
for rapid rebinding of an unlabeled erythromycin after dissociation of
the labeled one (21), before significant termination could occur. In this
latterscenario,whichleadstothesimplestinterpretationofthepeptide
release data, termination in our in vitro experiments occurred in the
presence of erythromycin.
TheadditionofRF2toribosomescarryingtheresistancepeptidewith
aC-terminaladditionofoneaminoacid(thehexapeptide)ledtopeptide
release with a rate constant of 0.015 s
1, virtually identical with the rate
constant of 0.014 s
1 for dissociation of erythromycin (Figs. 2, D and E
andTable2).TheadditionofRF2totheresistancepeptidewithaC-ter-
minal addition of two amino acids (the heptapeptide) led to peptide
release with a considerably smaller rate constant of 0.006 s
1 but to a
similarrateconstantof0.014s
1fordissociationoferythromycin(Figs.
2, D and E, and Table 2). This rate constant for dissociation of erythro-
FIGURE 2. Erythromycin and peptide dissociation rates. Panels A–D show the amount of ribosome bound (or released) [
14C]erythromycin as a function of time. Essentially all
ribosomes contain [
14C]erythromycin at time 0, and a 75-fold excess of cold erythromycin was added to the pre-initiated ribosome complexes together with the elongation mixt o
preventre-bindingof[
14C]erythromycin.PanelEshowsdissociationofthepeptidelabeledwith[
3H]fMetasafunctionoftime.TheblacksymbolsinpanelsA–Eshowtheamountthat
is bound to ribosomes and thereby stick to the nitrocellulose filters, whereas the gray symbols show the amount that have gone through the filters. Panel F shows the release
factor-mediated hydrolysis of the peptidyl-tRNA and the puromycin reaction as a function of time. The black symbols show the peptides that are still bound to tRNA and thereby
precipitable with formic acid, whereas the gray symbols show the peptides in the supernatant. All lines are obtained by simultaneously fitting the data shown by black and gray
symbols to single exponentials using least square fits. The estimated rate constants are collected in Tables 1 and 2.
TABLE2
Erythromycin and peptide dissociation rate constants
Translated peptide Releasing agent Erythromycin dissociation rate
constant
a
Peptide dissociation rate
constant
a
Peptidyl-tRNA hydrolysis
rate constant
b
s
1 s
1 s
1
MRLFV RF1 0.14 
 0.02 0.073 
 0.007
MRLFV RF1 No erythromycin 0.22 
 0.02
MRLFV RF2 0.13 
 0.01 0.074 
 0.01 0.10 
 0.01
MRLFV RF2 No erythromycin 0.25 
 0.01 0.26 
 0.03
MRLFV Puromycin 0.067 
 0.009 Not determined
c 0.23 
 0.02
MRLFV Puromycin No erythromycin Not determined
c 0.31 
 0.03
MRLFVA RF2 0.014 
 0.001 0.015 
 0.002 0.015 
 0.001
MRLFVA RF2 No erythromycin 0.29 
 0.03 0.32 
 0.03
MRLFVAN RF2 0.014 
 0.001 0.006 
 0.0004 0.004 
 0.0004
MRLFVAN RF2 No erythromycin 0.27 
 0.03 0.44 
 0.03
MNAIK RF2 0.015 
 0.001 0.26 
 0.03 0.28 
 0.02
MNAIK RF2 No erythromycin 0.25 
 0.02 0.27 
 0.02
a Measured by nitrocellulose filter binding.
b Measured by formic acid precipitation.
c Could not be determined because fMRLFV-puromycin bind to NC-filters.
ErythromycinResistancePeptides
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 mycin is similar to the corresponding rate constant for the peptide-
lacking initiation complex. These experiments show that release of the
extended peptides did not accelerate dissociation of erythromycin, in
line with the previous observation of a strong sequence length depend-
ence of resistance activity (7).
Treatmentofribosomescarryingfull-lengthresistancepeptideswith
puromycin, an antibiotic mimicking the aminoacylated 3-adenosine of
an aminoacylated tRNA (17), did not alter the rate of dissociation of
erythromycin (Fig. 2D and Table 2). It was not possible to monitor
release of the resistance peptide-puromycin complex from the ribo-
some, since it remained filter-bound in free as well as ribosome-bound
configuration. We could, however, monitor peptidyl transfer to puro-
mycin using HPLC after formic acid precipitation. We found that the
rate constant for transfer of the resistance peptide to puromycin (0.23
s
1) was much larger than the rate constant for dissociation of erythro-
mycin (0.067 s
1) (Figs. 2, D and F). This means that transfer of the
resistance peptide to puromycin was unhindered by the presence of
erythromycin,incontrasttothehydrolyticreactioninducedbyaclass1
release factor (Fig. 2C and Table 2). It is normally assumed that when a
smallpeptideistransferredtopuromycin,itrapidlyleavestheribosome.
However, if this were the case, one would expect that the rate constant
forerythromycinreleasewouldbereducedfromitsvalueof0.068s
1in
the absence of puromycin to its value of 0.011 s
1 in the absence of
peptide. The experiments show, in contrast, that in response to puro-
mycin treatment dissociation of erythromycin remained unaltered at
0.067s
1.Thissuggeststhattheresistancepeptide-puromycincomplex
remained ribosome-bound long enough to allow for dissociation of the
radio-labeled erythromycin.
Docking of the Resistance Peptide to the Ribosome—Previous genetic
studies(7)andthebiochemicaldatainthisworksuggesttheexistenceof
specific interactions between the resistance peptide and ribosome-
bound erythromycin. To test this, we performed docking simulations
witharesistanceoracontrolpeptideanchoredtoanA-site-oraP-site-
bound tRNA of a ribosome in complex with erythromycin. In 8 of the
top 15 simulations for the resistance pentapeptide anchored to the
P-site tRNA, the leucine in fMRLFV was bound to a small hydrophobic
cavity on the surface of erythromycin, between the cladinose and des-
osamine residues (see Fig. 4, E and F), and a similar result was obtained
for the tetrapeptide fMRLF. Similar, but less pronounced leucine bind-
ing patterns were observed also for fMRLFV and fMRLF anchored to
the A-site tRNA. At the same time, no distinct binding patterns were
observedforaminoacidsotherthanleucineintheresistancepeptideor
foranyoftheaminoacidsinthecontrolpeptidefMNAIK.Inthecaseof
the resistance tripeptide, the leucine did not reach into the erythromy-
cin cavity, and in the case of the resistance hexapeptide, the leucine
binding pattern was gone, possibly due to steric hindrance.
Validation of the Model for Resistance Peptide Action by Cell Popula-
tionExperiments—Fromthebiochemicalexperimentsdescribedabove,
kinetic constants for resistance peptide action were obtained (Table 2).
We constructed a model for erythromycin resistance in bacterial pop-
ulations (Fig. 3A) based on these and other parameters (listed in the
supplementalmaterial)forproteinsynthesisobtainedfromourcell-free
mRNA translation system (21). The model (detailed description in the
supplemental material) contains seven different states of the large ribo-
somal subunit (50 S) (Fig. 3A); it accounts for dilution of all compounds
duetocellvolumegrowthandforafiniterateofdiffusionacrossthecell
membrane, which reduces the intracellular concentration in relation to
theouterconcentrationoferythromycin.Furthermore,themodeltakes
intoaccounttheeffluxpumpsusedbyE. colitoactivelytransporteryth-
romycin and other antibiotic drugs from the membrane and cytoplasm
to the growth medium (22).
To validate the model, we varied the expression of rpmRNA under
tac promoter control from a multicopy plasmid by varying the concen-
tration of IPTG in an erythromycin-containing growth medium (6, 9).
Cell growth at different IPTG and erythromycin concentrations was
monitored along with reverse transcription real-time PCR analysis of
the intracellular concentration of rpmRNA relative to the concentra-
tion of EF-Tu mRNA (Fig. 3C, inset). The tac promoter was leaky, and
theresponseinrpmRNAsynthesistotheexternalIPTGlevelwaslinear.
AtthehighestIPTGconcentration(600M)inthemedium,themRNA
level was 3-fold higher than in the absence of IPTG (Fig. 3C, inset).
Increasing IPTG concentrations led to increasing erythromycin resist-
ance until a plateau, specific for each concentration of erythromycin,
was reached (Fig. 3C). The increase in bacterial mass (optical density)
during8ho fgrowth at varying concentrations of erythromycin and
IPTG in the medium were monitored, and there was excellent agree-
ment between the experimentally observed and model-simulated
growth behavior in which the measured, relative rpmRNA levels had
been taken into account (Fig. 3B).
DISCUSSION
Erythromycin binds in the nascent peptide exit tunnel close to the
peptidyl transferase center (1, 23) (Fig. 4A) and prevents synthesis of
peptides longer than eight amino acids (2). Expression of a mini-gene
buriedinthe23SrRNAcauseslowlevelresistancetoerythromycin(6),
and it has been suggested that synthesis of this resistance peptide on an
erythromycin-containing ribosome can clean it from the drug, thereby
making an erythromycin-free 50 S subunit available for a new round of
initiation of protein synthesis with another mRNA (8). When the nas-
cent peptide is longer than six to eight amino acids, it covers the eryth-
romycin binding site, which makes the ribosome refractory to further
inhibition by erythromycin, allowing for synthesis of full-length
proteins (3, 21).
The present experiments directly demonstrate that synthesis of a
resistance peptide can, indeed, remove erythromycin from the 50 S
subunit. During every cycle of resistance peptide synthesis erythromy-
cindissociateswithcloseto100%probability,whereasthesynthesisofa
control peptide does not induce dissociation of the drug (Fig. 1). As the
resistance peptide grows by successive amino acid additions, the rate
constant for dissociation of erythromycin increases in a stepwise man-
ner (Table 1). It is, however, not until class 1 release factor induced
termination of the full-length resistance pentapeptide, that erythromy-
cinisremovedfromtheribosomewithhighprobability.Terminationis,
in other words, the crucial kinetic step for erythromycin dissociation
and, therefore, the point at which resistance is conferred.
Tovalidatethemechanismforresistancepeptideaction,wemodeled
itinthecontextofthecytoplasmofalivingcell(Fig.3Aandsupplemen-
tal material) using kinetic data from the present (Table 2) and earlier
(21) work. We describe in particular the degree to which inhibition of
the growth rate of a bacterial population due to the presence of varying
concentrations of erythromycin in the cytoplasm is expected to be
relieved by the expression of the resistance peptide at varying levels
(Fig. 3B).
These simulations were compared with experimental observations
from a bacterial population containing the resistance peptide gene
under tac promoter control on a multicopy plasmid. The cells were
grown in media containing varying concentrations of erythromycin as
well as IPTG to control the level of resistance peptide expression. The
increaseinbacterialmassduring8hofgrowthwasmonitoredbyoptical
ErythromycinResistancePeptides
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 density (Fig. 3C) along with the level of resistance peptide mRNA nor-
malized to the level of EF-Tu mRNA (Fig. 3C, inset), as measured by
reverse transcription real-time PCR. The simulated growth rates in Fig.
3B, where the experimentally measured resistance peptide mRNAs are
taken into account, are in excellent agreement with the measured
growth rates in Fig. 3C. This shows that the mechanism we propose for
peptide-mediated low level resistance against erythromycin (Fig. 3A)
and the rate constants obtained from our cell-free in vitro translation
system(Table2andRef.21)aresufficienttofullyaccountfortheinvivo
induced resistance in a large interval of erythromycin concentrations
and peptide expression levels (Figs. 3, B and C (and inset)).
The structural basis of resistance peptide action is of considerable
interest, not the least because it is one special case of the general and
poorly understood phenomenon of peptide-specific interactions with
the ribosomal peptide exit tunnel (4, 24). Our data show that when the
controlpeptidegrowsfromadi-toapentapeptide,thereislittlechange
in the rate constant for erythromycin dissociation. When, furthermore,
RF2isaddedtoterminatepeptidesynthesis,hydrolysisoftheesterbond
in the peptidyl-tRNA proceeds with the same rate as in the absence of
erythromycin (Tables 1 and 2). For the resistance peptide, in contrast,
our data show that the rate constant for erythromycin dissociation
increases gradually by a factor of six as the peptide grows from just the
fMet to di- and then to pentapeptide. In addition, when RF2 is added,
the rate constant for erythromycin release is further enhanced by a
factoroftwo,andtherateofesterbondhydrolysisismuchsmallerthan
in the absence of erythromycin (Tables 1 and 2). We know from data
obtainedfromopenreadingframelibrariesthattheconsensussequence
for peptide-mediated erythromycin resistance has two outstanding fea-
tures;thereisaleucineorisoleucineinthethirdpositionandavalinein
the fifth, C-terminal position (7, 9). Resistance peptides for different
FIGURE 3. The model, simulation data, and data from cell culture experiments. Panel A shows a schematic of the model we have developed for simulating translation in the
presence of erythromycin and the effect of translating a resistance peptide in the context of a growing E. coli cell. The 50 S subunits are in seven different states in the model. Free
50 S subunit (state 1) is susceptible to erythromycin binding and likewise is the newly initiated ribosomes (state 2 and state 6), whereas elongating ribosomes with a longer protein
becomerefractorytomacrolidebinding(state3)and,thus,thisstatealwaysresultsinfull-lengthproduct.Iferythromycinisboundtothe50Ssubunit(state4)itcanstillinitiateand
translatethefirstcodonsbeforeproteinsynthesisisinhibited(state5).Theribosomeisstuckinstate5untileitherthepeptidyl-tRNAdropsoffandtheribosomeisrecycledtostate
4, or erythromycin dissociates and protein synthesis is resumed in state 3 and thus refractory to rebinding of erythromycin. If a ribosome with erythromycin (state 4) initiates on a
resistance peptide mRNA (rpmRNA) (state 7) it will be “cleaned” and recycled as an erythromycin free 50 S (state 1). The model also contains the cell membrane and erythromycin
effluxpumpspresentinE. colithatchangetheintracellularconcentrationincomparisontoerythromycinconcentrationinthegrowthmedia.Forfurtherdetailsaboutthemodel,see
thesupplementalmaterial.PanelB,simulatedgrowth(definedashowmanytimesthecellvolumehasincreased)duringthefirst8haftertheadditionoferythromycinplottedagainst
the rate of rpmRNA synthesis for different concentrations of erythromycin. Panel C, optical density (600 nm) measured 8 h after the addition of erythromycin plotted against the
concentration of IPTG. Inset, level of expression of rpmRNA in relation to EF-Tu mRNA plotted against the IPTG concentration.
ErythromycinResistancePeptides
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 typesofmacrolideshavedifferentconsensussequences,suggestingspe-
cific and perhaps direct interactions between the conserved residues
and each type of ribosome bound macrolide (9, 10). From the present
kinetic data (Tables 1 and 2) and docking simulations (Fig. 4F) along
with previous open reading frame library data (7), we propose a struc-
tural model for peptide-mediated erythromycin resistance (Figs. 4,
A–D).
OurdockingstudiesbasedonthecrystalstructureofaHaloarcula
marismortui 50 S subunit in complex with erythromycin (1) suggest
that the side chain of leucine in the resistance peptide binds to the
hydrophobic cleft between the two sugar moieties of erythromycin
(Figs. 4, E and F). To date, there is no crystal structure of an E. coli
50 S subunit in complex with erythromycin, but the similarity of the
50Ssubunitsfromthetwoorganismsneartheerythromycinbinding
site (1, 25) suggests that our docking data are relevant also for the
erythromycin-bound E. coli ribosome. Leucine binding to erythro-
mycin is observed both for resistance tetra- and pentapeptides, and
thebindingpatternismoredistinctforresistancepeptidesanchored
to the P-site than to the A-site tRNA. By hypothesis, the observed
interaction between the resistance tetrapeptide and the drug weak-
enstheaffinityoferythromycinfortheribosome,whichaccountsfor
the fact that a leucine (or an isoleucine) is critical for resistance
peptide action. Completion of the resistance pentapeptide by the
addition of valine further increases the erythromycin dissociation
rate constant, probably because the force by which the resistance
peptidepusheserythromycinoutfromitsbindingsiteincreases(Fig.
4B). When a class 1 release factor binds to the pre-termination ribo-
some containing a resistance pentapeptide ester-bonded to the
P-site tRNA, the rate constant for erythromycin dissociation
increases by another factor of two. At the same time, the rate con-
stant for ester bond hydrolysis of the peptidyl-tRNA decreases very
significantly (Table 2), which partially accounts for the fact that
every cycle of peptide synthesis led to erythromycin dissociation
with near 100% probability (Fig. 1). It is, furthermore, possible that
the resistance peptide forms a specific hydrophobic structure that
prevents it from leaving the ribosome through the peptidyl transfer-
ase center after its release from the P-site tRNA. The peptide is then
forced to leave the ribosome through the peptide exit tunnel, where
its hydrophobic C terminus could interfere with the hydrophobic
interactions between erythromycin and the exit tunnel wall and
chase the drug out through the L4/L22 constriction in the tunnel
(Fig. 4C). This would lead to 100% probability of drug ejection per
cycle of resistance peptide synthesis. When instead of termination,
anadditionalaminoacidisaddedtotheresistancepentapeptide,our
simulations suggest that the leucine interaction with erythromycin
becomes lost and that, accordingly, the hexa-peptide is expected to
behave like any other peptide. It will fill up the space available
between drug and peptidyl transfer center until further protein syn-
thesis is inhibited by crowding (Fig. 4D).
FIGURE4.Astructuralmodelforthemechanismofresistancepeptideaction.PanelAshowsaschematicofthelargeribosomalsubunitcutalongthenascentpeptideexittunnel
withanerythromycinmoleculebound(red).Thepeptidyltransferasecenter(PTC)andthetworibosomalproteins(L4andL22)constitutingtheconstrictioninthetunnelareindicated.
TheblackrectangleindicatesthesectionshowninpanelsB–Dwhereourhypothesisaboutthemechanismoftheresistancepeptideactionisshown.PanelBshowsthepentapeptidyl-
tRNA that interacts with erythromycin (Eryt). Panel C shows the resistance peptide that during termination of protein synthesis has removed erythromycin. Panel D shows the
hexapeptidyl-tRNA which has lost its contact with erythromycin and is trapped in a dead end that eventually leads to peptidyl-tRNA drop-off. Panel E shows the chemical structure
of erythromycin. Panel F presents the interaction between the conserved leucine residue (orange) in the resistance peptide and erythromycin as indicated by the docking studies.
ErythromycinResistancePeptides
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 SUPPLEMENTARY MATERIAL  
Model of peptide mediated erythromycin resistance or the “bottlebrush” model 
The model above is described by the following system of differential equations,  
        [ 1 ]  
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A large ribosomal subunit can exist in seven different states. The 50S subunit may be free without 
([50S]) or with ([50SM]) a bound macrolide. It may be a part of a ribosome ready to translate the first 
codons of a protein mRNA without ([R2]) or with ([R2M]) a bound macrolide or it may have translated the 
first codons and become temporarily immune to the drug ([R´2]). The subunit may also be a part of a 
ribosome ready to translate a resistance peptide mRNA (rpmRNA) without ([R1]) or with ([R1M]) a bound 
antibiotic molecule. The rate constant of association and spontaneous dissociation of the antibiotic is q
and q1, respectively. Association of the ribosomal subunits occurs with rate constant ka times the free 
concentration of protein mRNAs ([mRNAfree]) and free rpmRNA ([rpmRNAfree]). The first rounds of 
translation when the antibiotic can attack a ribosome (which is approximately the length of a resistance 
1peptide) occur with rate k1. The rate for completing synthesis of a protein beyond translation of the first 
codons is k3, the drop-off rate of a antibiotic-carrying, stalled ribosome on a protein mRNA is k4 and a 
resistance peptide is synthesised with rate k2 when the ribosome carries a macrolide. The system of 
equations also contains differential equations describing the change of the total concentration of the 
macrolide in the cell ([mtot]) and of the total concentration of protein mRNAs ([mRNAtot]) and rpmRNA 
([rpmRNAtot]), respectively. The inflow rate of the macrolide is rin and the outflow rate is denoted rout. The 
free intracellular concentration of the macrolide is defined by  12 [] [ ] [ 5 0 ] [] [ free tot mm S M R M R ] M     .
The synthesis rate of rpmRNA is ks1 and active degradation of free rpmRNA occurs with rate constant kd1.
The corresponding rates of synthesis and degradation of protein mRNAs are denoted ks2 and kd2,
respectively. It is also assumed that a stalled, macrolide-carrying ribosome on the 5´ end of an mRNA 
does not fully protect the mRNA from degradation, but it is degraded by a low rate constant, kd3. The free 
concentration of rpmRNA and protein mRNAs is defined by  11 [] [ ] [ ] [ free tot rpmRNA rpmRNA R R M]   
and , respectively. The system expands by expontential growth 
with cell growth rate ȝ, defined by 
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where ve is the average elongation rate of an uninhibited ribosome and ȡ0 is the concentration of amino 
acids incorporated in proteins. The total concentration of 50S subunits ([50Stot]) is kept constant and new 
50S subunits are thus synthesised by rate ȝ·[50Stot] and the free concentration of 50S subunits varies 
according to  .
'
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The system was solved numerically by Euler’s method. Cell growth was calculated for the first 8 hours 
after introduction of a certain macrolide concentration the growth medium, [mm] by 
,
dt
tt d t VV e
P
       [3]
where dt is a small time-step and Vt-dt and Vt is the volume prior and after time-step dt. Prior to 
macrolide exposure, the system resided at steady state for a certain synthesis rate of resistance peptide 
mRNA. The used program software was MATLAB 6.5 (The MathWorks, Inc., Natick, Massachusetts, 
U.S.A.).
The effect of the erythromycin ejection mechanism in relation to the exchange dynamics of 
erythromycin over the cell membrane 
For the in vivo experiments presented in the paper, the Gram-negative bacterium Escherichia coli was 
used. The entrance rate of macrolide antibiotics is expected to be slow in Gram-negatives because the 
outer membrane confers an efficient barrier of permeation. If the inflow rate is low, a high outflow rate is 
required to make the “bottlebrush” mechanism function for a macrolide with the kinetic properties of 
erythromycin (Nilsson et al., manuscript in preparation). Broad-specific efflux pumps in the inner 
membrane, mainly the AcrAB-TolC pump system, may provide the required high outflow rate (Li and 
Nikaido, (2004) Drugs 64(2), 159-204). We adjusted the influx rate constant (rin) and the efflux rate 
constant (rout) to reconstitute the pattern of the growth curves from the in vivo experiments in Fig. 3C. The 
efflux rate constant determines the general form of the curves and width of the antibiotic interval within 
which the “bottlebrush” confers resistance. The influx rate constant determines which erythromycin 
concentrations that lie within the interval of antibiotic concentrations that confer resistance (Nilsson et al.,
manuscript in preparation). See Supplement table 1 for used parameter values in the model. 
2Supplement table 1. Definitions and values of used parameters. 
Description Value Reference 
ka
association rate constant of ribosomal subunits at initiation 
of translation  2·10
6 M
-1s
-1 (1)
k1
rate constant for translation of the first codons when the 
ribosome is susceptible for the antibiotic or for translation 
of a resistance peptide by a drug-free ribosome 
1 s
-1 (2)
k2
rate constant for translation of a resistance peptide by an 
erythromycin-infected ribosome  0.1 s
-1 Present study
k3
rate constant for translation beyond the first codons of a 
protein mRNA and translation termination  0.03 s
-1 (2)
k4
drop-off rate constant of peptidyl-tRNA from a stalled 
ribosome on a protein mRNA  0.06 s
-1 Lovmar, unpublished 
results
q association rate constant of erythromycin  10
6 M
-1s
-1 (4)
q1 dissociation rate constant of erythromycin  0.01 s
-1 (4)
ks1 synthesis rate of resistance peptide mRNA (rpmRNA)  0-0.6·10
-8 Ms
-1
kd1 degradation rate constant of free rpmRNA  8.33·10
-3 s
-1
ks2 synthesis rate of protein mRNAs  8.33·10
-9-0.05·ks1 Ms
-1 (5)
kd2 degradation rate constant of free protein mRNAs  8.33·10
-3 s
-1 (3)
kd3
degradation rate constant of protein mRNAs with a drug-
inhibited, stalled ribosome  8.33·10
-4 s
-1
rin
rate constant of influx over cell membrane (membrane 
permeability constant)  3·10
-5 s
-1
rout
rate constant of efflux over cell membrane (membrane 
permeability or pump capacity)  0.18 s
-1 *
ve elongation rate of an uninhibited ribosome  20 s
-1 (2)
ȡ0 concentration of amino acids in proteins  2 M (2)
[50Stot] total concentration of 50S ribosomal subunits  4·10
-5 M( 2 )
[mm] concentration of macrolide in the growth medium  0.7 - 220 ȝg/ml (see Fig. 3B )
1. Antoun, A., Pavlov, M., Andersson, A., Tenson, T. & Ehrenberg M. (2003) EMBO J. 22, 5593-5601. 
2. Bremer, H. & Dennis, P. (1996) in Escherichia coli and Salmonella typhimurium Cellular and  Molecular 
Biology, ed. Neidhardt, F. C. (ASM Press, Washington, DC.), pp. 1553-1569. 
3. Kushner, S. R. (1996) in Escherichia coli and Salmonella typhimurium Cellular and Molecular Biology, ed. 
Neidhardt, F. C. (ASM Press, Washington, DC.), pp. 849-860. 
4. Lovmar, M., Tenson T. & Ehrenberg, M. (2004) J. Biol. Chem. 279, 53506-53515. 
5. Neidhardt, F. C. & Umbarfer, H. E. (1996) in Escherichia coli and Salmonella typhimurium Cellular and 
Molecular Biology, ed. Neidhardt, F. C. (ASM Press, Washington, DC.), pp. 13-16. 
* If the inflow rate is low as expected in Gram.negative bacteria such as Escherichia coli, which was used in the in 
vivo experiments presented in the paper, a high outflow rate is required to make the “bottlebrush” mechanism 
function for a macrolide with the kinetic properties of erythromycin. Broad-specific efflux pumps in the inner 
membrane, mainly the AcrAB-TolC pump system, may provide the high outflow rate (Nilsson et al., manuscript in 
preparation). 
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ABSTRACT
Macrolide antibiotics bind at the entrance of the nascent peptide exit tunnel of 
the large ribosomal subunit, inducing premature termination of translation by 
drop-off of peptidyl-tRNA. Expression of specific cis-acting peptides confers 
resistance to macrolides. Recently the molecular mechanism behind 
erythromycin resistance was revealed. The resistance peptide works like a 
“bottle-brush” and expels erythromycin from the ribosome upon termination of 
translation. Here, we have used a cell-free translation system to study the 
mechanism of peptide-mediated josamycin resistance. Distinct from 
erythromycin resistance peptides, expression of a josamycin resistance peptide 
did not lead to an increased dissociation of the drug. Instead, the rate of 
resistance di-peptidyl-tRNA drop-off is decreased by an order of magnitude 
compared to the control peptide. Further, the level of resistance is independent 
of the length of the josamycin resistance peptide mRNAs while erythromycin 
resistance peptides show strict length dependence. We propose therefore that 
josamycin resistance peptides work by “quarantining” the josamycin bound 
ribosomes. A quantitative model of the josamycin resistance was constructed and 
it mimics the degree of resistance in Escherichia coli cells expressing a resistance 
peptide and subjected to varying concentrations of josamycin. Both this model 
and the previous model for erythromycin resistance predict that an active efflux 
pump system is required for the resistance peptide mechanism to function. This 
prediction was tested using an E. coli mutant lacking a functional AcrAB-TolC 
efflux pump system and, indeed, no peptide mediated resistance was detected in 
the mutant. 
INTRODUCTION
Since the 1950s macrolide antibiotics have been used in the treatment of infections 
(Weisblum, 1995). Macrolides consist of several neutral or amino sugars attached to a 
14-, 15- or 16-membered lactone ring (Leclercq, 2002). The first generation contains 
naturally occurring 14-membered ring macrolides, and includes erythromycin, 
currently the best-known macrolide. Josamycin belongs to the second generation, with 
a 16-membered lactone ring (Weisblum, 1998). Macrolides bind to the large 
ribosomal subunit, in the vicinity of the peptidyl transferase centre (Hansen et al.,
2002; Schlunzen et al., 2001) and most likely inhibit protein synthesis by blocking the 
entrance to the tunnel through which nascent peptides exit the ribosome (Lovmar et 
al., 2004; Tenson et al., 2003). Resistance mechanisms to macrolide antibiotics 
include modifications of the drug-binding site, inactivation of the drug by degradation 
or modification and cellular efflux by specialized transporter proteins (Weisblum, 
1998). However, in the focus in this study is a unique resistance mechanism conferred 
by expression of specific cis-acting peptides (Tenson and Mankin, 2001). 
Peptides mediating macrolide resistance was first encountered in experiments where 
E. coli cells expressed random rRNA fragments of the rrnB operon (Tenson et al.,
1996). Biochemical and genetic studies revealed the presence of a 34 nucleotides long 
mini-gene ranging between positions 1235 and 1268 in domain II of the 23S rRNA in 
all resistant clones. Additional in vitro experiments, where resistance peptides or 
resistance peptide mRNA (rpmRNA
eryt) were supplied, showed the necessity of active 
translation of the rpmRNA
eryt for protection against erythromycin. Using selection 3
from random libraries it became clear that the resistance peptides require both specific 
length and sequence (Tenson et al., 1997). Tripathi et al. (1998) proposed a 
“bottlebrush” model based on these experiments and further library studies selecting 
resistance peptides against a ketolide. The “bottlebrush” model suggests that synthesis 
of a resistance peptide removes the drug molecule, by direct interaction between 
macrolide and resistance peptide, thus restoring the protein synthesis capability of the 
ribosome. The resistance peptide acts as a “bottlebrush” and “cleans” the ribosome. 
Recently, Lovmar et al. (2006) showed that synthesis of a cis-acting peptide indeed 
accelerates the rate of erythromycin dissociation by destabilizing the binding of the 
drug to the ribosome. In addition, it was shown that erythromycin was most probably 
always expelled from the ribosome during release factor mediated translation 
termination. The biochemical data was also used within the framework of a 
mathematical model to predict resistance and finally the predictions of the model 
could be validated by growth experiments in vivo.
It has been suggested that the “bottlebrush” mechanism is general and work for all 
classes of macrolides with modulated specific sequences (Tenson and Mankin, 2001; 
Tripathi et al., 1998; Vimberg et al., 2004). However, in the case of josamycin there 
are at least two major features suggesting a closer examination of the effects of 
rpmRNA
josa expression. First, peptidyl transfer is inhibited already after 2 or 3 amino 
acids in the presence of josamycin (Lovmar et al., 2004; Tenson et al., 2003), and the 
selected resistance peptides, containing 4 or 5 amino acids (Vimberg et al., 2004), 
will therefore never reach the stop codon and thus never reach the termination step 
which seems to be crucial for the “bottlebrush” mechanism. Secondly, josamycin is 
bound to the ribosome 1.5 h on the average (Lovmar et al., 2004). This means that a 
dissociation rate increase of josamycin by a factor of 10 as measured for rpmRNA
eryt
will still not render resistance since the peptidyl-tRNA drop-off rate would still be 
much higher (Lovmar et al., 2006). 
We begin this study with a biochemical characterization of the peptide mediated 
josamycin resistance. In combination with an examination of how the activities of 
rpmRNA
josa and rpmRNA
eryt depend on the length of the encoded peptides it enables 
us to conclude that they work through different mechanisms. Using the rate constants 
from the biochemistry in a mathematical model, similar to the previously published 
one (Lovmar et al., 2006), we propose that the effect of rpmRNA
josa is to “quarantine” 
a fraction of the josamycin containing ribosomes from the active pool of ribosomes. 
How expression of rpmRNA
josa can be connected to the growth and survival of cells 
at different concentrations of josamycin is examined in the model, and the result is 
compared to in vivo growth curves. 
Previous modeling of peptide-mediated erythromycin resistance resulted in one clear 
predicted requirement for the resistance mechanism to function; the intracellular 
concentration of erythromycin has to rapidly equilibrate with the surrounding media 
(Lovmar et al., 2006). However, all in vivo experiments were performed with gram-
negative Escherichia coli cells where the outer membrane offers an efficient barrier of 
permeation (Lovmar et al., 2006; Tenson and Mankin, 2001). It seemed therefore that 
either the prediction, and thus also the model, has to be wrong or there had to be more 
to the story than appreciated at first. In the previous paper we argued that broad-
specific multi-drug pumps located in the inner membrane, especially the AcrAB-TolC 
system (Zgurskaya and Nikaido, 1999), may account for the rapid antibiotic 4
equilibration required to confer peptide-mediated resistance (Lovmar et al., 2006). 
This prediction is tested in this study using a mutant without a working AcrAB-TolC 
system and both the resulting increase in sensitivity and the loss of peptide mediated 
resistance of the mutant corresponds well with the model predictions. 
EXPERIMENTAL PROCEDURES 
Chemicals and buffers 
GTP, ATP and [
3H]Met were from GE Biosciences (Uppsala, Sweden). Putrescine, 
spermidine, phosphoenolpyruvate (PEP), myokinase (MK), inorganic 
pyrophosphatase (PPiase), erythromycin and non-radioactive amino acids were from 
Sigma-Aldrich (St. Louis, MO, USA). Pyruvate kinase (PK) was from Boehringer-
Mannheim (Mannheim, Germany). Josamycin was from Alexis Biochemicals 
(Lausen, Switzerland). 
All experiments were performed in polymix buffer, at working strength containing 5 
mM magnesium acetate, 5 mM ammonium chloride, 95 mM potassium chloride, 0.5 
mM calcium chloride, 8 mM putrescine, 1 mM spermidine, 5 mM potassium 
phosphate and 1 mM dithioerythritol (DTE) (Jelenc and Kurland, 1979). 
In vitro transcribed mRNA for the cell-free translation system
The template DNAs for in vitro transcription were prepared by annealing the 
following oligonucleotides at the complementary sequences (underlined) and filling 
the gaps by PCR. 
Forward oligo: CTCTCTGGTACCGAAATTAATACGACTCACTATAGGGAATT 
CGGGCCCTTGTTAACAATTAAGGAGG.
Reverse oligo for MFLV: TTTTTTTTTTTTTTTTTTTTTTATACTAGGAACATAG 
TATACCTCCTTAATTGTTAACAAGGGCCCG
Reverse oligo for MVSN: TTTTTTTTTTTTTTTTTTTTTTAGTTAGAAACCATAG
TATACCTCCTTAATTGTTAACAAGGGCCCG
In vitro transcription and purification of mRNAs containing a poly(A) tail were as 
described in (Pavlov and Ehrenberg, 1996). 
DNA oligos used to create plasmids expressing peptides of variable lengths
DNA sequences of different length, designed were amplified by annealing the 
following oligonucleotides and fill the gaps with PCR. The PCR products were 
subsequently cut with EcoRI and AflII restriction enzymes and cloned into a 
pPOT1AE vector (Tenson et al., 1996). 
Forward oligo for rpmRNA
josa: ATACAATTGCTAGTCTTAAGGAGGTCACAT
ATGTTC
Reverse oligo for rpmRNA
josa+LLA: CTAGAGAATTCAGCTAGTTACGCCAG 
AAGTACTAGGAACATATGTGACCTC
Reverse oligo for rpmRNA
josa+LLASGS: CTAGAGAATTCAGCTAGTTAGCTGCC 
TGACGCCAGAAGTACTAGGAACATATGTGACCTC
Reverse oligo for rpmRNA
josaMF: CTAGAGAATTCAGCTAGTTAGAACAT
ATGTGACCTC)5
Forward oligo for rpmRNA
eryt: ATACAATTGCTAGTCTTAAGGAGGTCACAT
ATGGTT
Reverse oligo for rpmRNA
eryt+LL: CTAGAGAATTCAGCTAGTTACAGAAGAAC 
AAACAAAACCATATGTGACCTC
Reverse oligo for rpmRNA
eryt+LLASG: CTAGAGAATTCAGCTAGTTAGCCTGAC 
GCCAGAAGAACAAACAAAACCATATGTGACCTC
Reverse oligo for rpmRNA
erytMV: CTAGAGAATTCAGCTAGTTAAACCAT
ATGTGACCTC
Procedures 
The components of the purified translation system
Components of the translation system were purified as described in (Tenson et al.,
2003), except for RF1, RF2 and RF3 which were purified as described in (Freistroffer
et al., 1997), RRF as described in (MacDougall et al., 1997) and peptidyl-tRNA 
hydrolase (PTH) as described in (Dincbas et al., 1999). All experiments were 
performed at 37 °C in polymix buffer with addition of ATP (1 mM), GTP (1 mM) and 
PEP (10 mM). 
Recycling experiments
The initiation mixture contained ribosomes (0.2 μM, ~50% active), [
3H]fMet-
tRNA
fMet (5 μM), mRNA (0.5 μM), IF2 (0.5 μM), IF1 (1 μM), IF3 (1 μM) and 
josamycin (2.5 μMn). The recycling mixture contained EF-G (2 μM), EF-Tu (30 
μM), EF-Ts (1 μM), RF2 (2 μM), RF3 (2 μM), RRF (2μM), tRNA
bulk (~0.18 mM), 
PPiase (5 μg/ml), MK (3 μg/ml), PK (50 μg/ml), the relevant aminoacyl-tRNA 
synthetases (aaRS) (0.15 Units/μl) (defined in (Ehrenberg et al., 1990)) and amino 
acids (aa) (leucine 300 μM and 100 μM each of the others). Erythromycin (100 μM) 
was also added to the recycling mixture when relevant. 
Both initiation mixture and recycling mixture were pre-incubated for 8 minutes at 
37  °C to allow for formation of ribosomal initiation complexes and ternary 
complexes, respectively. At time zero, the initiation mixture (10 μl) and the recycling 
mixture (10 μl) were mixed and at the specified time points the reactions were 
quenched by adding 155 μl 20% formic acid, and peptide formation were analyzed 
using RP-HPLC as described in (Tenson et al., 2003). Peptidyl-tRNA hydrolase 
(~250 Units (hydrolysed tRNA/s) was added to the reaction mixture 15 s prior to 
quenching to allow detection of the drop-off products on the HPLC in parallel to the 
full-length peptide. 
Measuring the length dependence for josamycin- and erythromycin resistance peptides
Overnight cultures of cells expressing peptides of different length were grown in 
medium containing 100 μg/ml ampicillin. Cultures were diluted with fresh medium 
containing 100 μg/ml ampicillin, 1 mM IPTG, 75 μg/ml erythromycin or 200 μg/ml 
josamycin and in parallel with medium containing 100 μg/ml ampicillin, 1 mM IPTG 
to the final density of A600 = 0.01. Cells were grown until the optical densities of 
cultures grown in the absence of macrolide reached A600 of c.1. At this point the 
absorbance of the corresponding macrolide containing culture was measured, which is 
equal to the relative resistance because the absorbance of the culture grown without 
macrolide is one. 6
Measuring growth with varying josamycin concentration and rpmRNA
josa expression levels
Overnight cultures of cells expressing rpmRNA
josa (MFLV-peptide) were grown in 
medium containing 100 μg/ml ampicillin. Cultures were diluted to A600 = 0.01 into 
96-well plates with fresh medium containing josamycin and IPTG at different 
concentrations. IPTG concentrations for rpmRNA
josa expressing cells were 0  μM; 
50 μM;  75 μM;  100 μM;  125 μM;  150 μM;  175 μM;  200 μM;  500 μM;  1000 μM. 
Josamycin concentrations were 0  μg/ml; 100  μg/ml; 150  μg/ml; 200  μg/ml; 
250 μg/ml; 300 μg/ml; 500 μg/ml; 1000 μg/ml. The cell cultures were grown 8 hours 
and the absorbance at 600 nm were measured using a TECAN Sunrise instrument. 
Measuring the effect of efflux pump mutants on josamycin sensitivity and resistance
MG1655 cells and MG1655 TolC mutant cells, expressing rpmRNA
eryt (MVLFV-
peptide) or rpmRNA
josa (MFLVLLA-peptide), or possessing empty vector pPOT1 
(Tenson et al., 1996) were grown overnight in 2*YT medium in the presence of 
ampicillin (100 μg/ml) at 37 °C. Overnight cultures were diluted to A600 = 0.01 with 
fresh 2*YT medium containing 100 μg/ml ampicillin, 100 μM IPTG and different 
concentrations of erythromycin and josamycin respectively. Cultures were grown in 
the microtiter plate for 4 hours at 37 °C and A600 was measured using a TECAN 
Sunrise instrument. Expression of rpmRNA
josa encoding MFLVLLA-peptide was 
used instead of the classical MFLV-peptide, because MFVVLLA expression does not 
inhibit bacterial growth. 
RESULTS
Biochemical characterization of expression of josamycin resistance peptide 
Using a cell-free translation system with purified components from E. coli (Pavlov 
and Ehrenberg, 1996) we translated the rpmRNA
josa encoding fMet-Phe-Leu-Val 
(Vimberg  et al., 2004) and a control mRNA encoding fMet-Val-Ser-Asn. The 
ribosomes were pre-incubated with either josamycin or erythromycin and used in 
recycling mode (Pavlov et al., 1997), i.e. each ribosome produced several copies of 
the encoded peptide. In order to probe the dissociation of josamycin we chased it with 
an excess of erythromycin, which competes with josamycin binding but allows 
formation of tetrapeptides (Lovmar et al., 2006; Lovmar et al., 2004). The amounts of 
resistance- and control tetrapeptides produced at different time points are shown in 
Figs. 1A and 1B, respectively. As expected from the previous studies, josamycin 
blocked formation of both tetrapeptides, while erythromycin allowed tetrapeptide 
formation. From the chase experiments it is clear that translation of the rpmRNA
josa
does not significantly increase the josamycin dissociation rate over translation of the 
control peptide. From these chase experiments the josamycin dissociation rate 
constant could be estimated to 0.01 min
-1 which is similar to the previously estimated 
spontaneous dissociation rate constant (Lovmar et al., 2004). 
In parallel to the measurements of tetrapeptide formation we also studied the drop-off 
products formed during translation of rpmRNA
josa (Fig. 1C) or control mRNA (Fig. 
1D). Interestingly, josamycin-containing ribosomes produced much less dipeptidyl-
tRNA when translating the rpmRNA
josa rather than the control peptide. The 
“production” of drop-off products occurs at 0.28 min
-1 when josamycin containing 
ribosomes are translating rpmRNA
josa, compared to 2.1 min
-1 when translating the 
control mRNA. The reason for this difference is that josamycin inhibits the peptidyl 
transfer to the phenylalanine acceptor much more efficiently than to the valine 7
acceptor (Lovmar et al., 2004). This causes the rpmRNA
josa to block josamycin 
containing ribosomes as stable initiation complexes, while peptidyl transfer and 
subsequent josamycin induced peptidyl-tRNA drop-off is much faster for the control 
mRNA. 
FIGURE 1. Biochemical characterization of peptide mediated josamycin resistance.  The amounts 
of produced resistance peptide (MFLV, panel A) and control peptide (MVSN, panel B) are plotted 
against time. Erythromycin (Ÿ) allows formation of both tetra-peptides, while josamycin (Ɣ) does not 
allow any tetra-peptide formation. When josamycin dissociates in the chase experiment (Ŷ) it is 
replaced by erythromycin which enables tetra-peptide formation. In panels C and D the accumulation 
of dipeptidyl-tRNA drop-off products are plotted against time. The symbols in panels C and D is the 
same as the corresponding experiment in panels A and B. All experiments contain 1 pmol of active 
ribosomes. 
Erythromycin resistance is strictly dependent on the length of the encoded 
peptide while josamycin resistance is not 
The biochemical data propose that the mechanism of rpmRNA
josa is different to the 
previously described “bottle-brush” mechanism, and that it instead depends on the 
reduced rate of peptidyl tRNA-drop-off. The prediction is therefore that rpmRNA
josa,
in contrast to rpmRNA
eryt, is insensitive to the length of the encoded peptide. This 
prediction was tested by measuring the resistance activity in vivo of both rpmRNA
josa
and rpmRNA
eryt encoding peptides with varying lengths (Fig. 2). 8
The length of the open reading frames of both rpmRNAs where decreased to two 
codons and increased to seven or ten codons. Bacteria expressing the natural or the 
modified variants of rpmRNA
eryt and rpmRNA
josa were grown in the presence and in 
the absence of the corresponding macrolide. The ratios of the optical densities with or 
without the respective macrolide are plotted for these strains in figure 2. The length of 
rpmRNA
eryt is crucial for resistance against erythromycin (Fig. 2A), while josamycin 
resistance by rpmRNA
josa is solely dependent on the nature of the second codon and 
independent of the length in accordance with the prediction (Fig. 2B). 
FIGURE 2. The degree of erythromycin resistance is strictly dependent on resistance peptide 
length but not peptide-mediated josamycin resistance. Resistance is given as the ratio of bacterial 
growth as measured by optical density of resistance peptide expressing cells in the presence of (A) 
erythromycin (75 μg/ml) or (B) josamycin (200 μg/ml), respectively, and bacterial growth in the 
absence of the macrolide for the indicated peptide sequences. 
Expression of rpmRNA
josa “quarantines” ribosomes with josamycin and reduces 
peptidyl-tRNA drop-off
The biochemical experiments described above in combination with previous studies 
provide kinetic constants that allow modeling of the direct effects of expression of 
rpmRNA
josa (Table 1 in Appendix). We adapted our previously developed model of 
peptide-mediated erythromycin resistance to josamycin as illustrated in Fig. 3A (see 
Appendix for details), but because expression of rpmRNA
josa does not promote 
dissociation of josamycin it can not increase protein synthesis directly. 
Instead, expression of rpmRNA
josa “quarantines” josamycin containing ribosomes in 
form of initiation complexes encoded with rpmRNA
josa. The direct effect of this 
“quarantine” is that the amount of peptidyl-tRNA drop-off is reduced (Fig. 3B), and 
thereby there is a reduced risk of peptidyl-tRNA hydrolase (Pth) saturation leading to 
depletion of tRNA pools. The selectivity of the “quarantine” mechanism allows a 
large fraction of the josamycin-free ribosomes to continue translating cellular 
mRNAs, despite the competition with high concentration of rpmRNA
josa.9
FIGURE 3. Modeling the “quarantine” mechanism. Panel A show a schematic of the model. A 
josamycin-carrying ribosome stalls on a rpmRNA
josa (right) or on a protein mRNA (left) which results 
in drop-off of di-peptidyl-tRNA while josamycin stays bound on the ribosome. A drug-free ribosome 
completes both protein and resistance peptides synthesis (bottom). The uppermost part illustrates influx 
and efflux of josamycin in the cell (gram-negative bacterium). Panel B shows how the amount of 
peptidyl-tRNA drop-off is decreased by expression of rpmRNA
josa.
mRNA limitation might account for the observed resistance peptide action in 
vivo
In addition to the “quarantine” effects described above will expression of rpmRNA
josa
lead to an increase in the total number of ribosome binding sites (RBS) because of the 
small size of rpmRNA
josa (assuming a fixed capacity of the RNA polymerases). This 
increase may be important because josamycin-containing ribosomes block RBS, 
eventually leading to mRNA depletion. Further, an increased concentration of RBS 
may lead to more rapid initiation and thus josamycin will have a smaller time window 
for binding the josamycin-free ribosomes. It is therefore possible that expression of 
rpmRNA
josa indirectly can decrease the fraction of ribosomes that contains josamycin. 
We modeled the quantitative effects of rpmRNA
josa expression by focusing on mRNA 
supply. Especially, the degradation of a protein mRNA with a stalled josamycin-
ribosome in the 5’ end was modeled in detail. As previously, the model also described 
both synthesis and degradation of both mRNA and rpmRNA
josa as well as dynamics 
of the antibiotic exchange over the inner and outer cell membranes. In addition, the 
model accounts for the dilution of all compounds due to cell growth. Using this model 
we predicted the growth at 8 hours after expression of rpmRNA
josa at different levels 
in the presence of different concentrations of josamycin (Fig. 4A). It should be 
pointed out that modeled resistance by mRNA limitation crucially depends on a much 
slower drop-off rate of the resistance di-peptidyl-tRNA than of other dipeptidyl-
tRNAs.10
Peptide-mediated josamycin resistance demonstrated by cell population growth 
The expression of resistance peptide mRNA coding for peptide MFLV was under tac
promoter control on a multi-copy plasmid and the expression level could therefore be 
varied by varying the concentration of IPTG. Cell growth at different IPTG and 
josamycin concentrations was detected by optical density at 600 nm after 8 hours 
following the addition of josamycin to the growth medium (Fig. 4B). The results 
correspond well with the predicted behavior from the mRNA depletion model (Fig. 
4A).
FIGURE 4. Comparison between modeled and in vivo peptide-mediated josamycin resistance. A. 
Simulated growth (defined as how many times the cell volume has increased during the first 8 hours 
after the addition of josamycin) plotted against the rate of resistance peptide mRNA synthesis for 
different concentrations of josamycin. B. Optical density (600 nm) measured 8 hours after the addition 
of josamycin plotted against the concentration of IPTG. 
Peptides mediate macrolide resistance in wild-type E. coli cells but not in a pump 
mutant
It has previously been predicted that the resistance peptide mechanism requires rapid 
equilibration between the intracellular macrolide concentration and the concentration 
in the surrounding media. It was further proposed that this could be accomplished by 
a naturally occurring drug-efflux system (Lovmar et al., 2006). Therefore, the 
resistance models for josamycin and erythromycin were used with the more detailed 
description of the flows of the antibiotic over the cell membranes described here to 
study resistance with and without antibiotic efflux pumps (see Appendix). As 
expected, removal of the antibiotic efflux pump system makes the cells hyper-
sensitive to both erythromycin and josamycin, but in addition the model predicts that 
the peptide mediated resistance disappears (Fig. 5). 
To validate these results we studied growth in bacterial populations of both wild-type 
E. coli cells and E. coli cells (TolC) with a mutated efflux pump system, containing a 
multi-copy vector expressing rpmRNA or containing a control vector. Expression of 
rpmRNA was under the control of a tac promoter induced by 100 μM of IPTG which 
corresponds to maximal resistance as observed in Fig. 4B for josamycin and as 11
previously reported for erythromycin (Fig. 3C in (Lovmar et al., 2006)). Bacterial 
mass was monitored as absorbance at 600 nm 4 hours after addition of varying 
concentrations of erythromycin or josamycin to the growth medium. Both the 
increased sensitivity and the loss of resistance were observed in the TolC mutant (Fig. 
6).
FIGURE 5. Modeled peptide-mediated resistance with but not without pumps. Cell growth is 
given as volume expansion (defined as how many times the cell volume has increased) 4 hours 
following the introduction of the indicated macrolide concentrations in the growth medium in the 
model, with resistance peptide mRNA (rpmRNA) expression (solid line), without rpmRNA expression 
(broken line). The wild-type (A and C) is modelled with pumps in the inner membrane but not the TolC 
mutant (B and D). The rate constant of rpmRNA synthesis was 2 nMs
-1.
DISCUSSION 
Although the clinical relevance of peptide mediated resistance is not clear, it is still an 
interesting phenomenon that reveals more information about the mechanisms by 
which macrolide antibiotics inhibit cell growth. It was previously shown that 
rpmRNA
eryt works through a “bottle-brush” mechanism, i.e. expression of a resistance 
peptide “cleans” the nascent peptide exit tunnel from erythromycin (Lovmar et al.,
2006). Both the amino acid sequence and the length of the encoded peptide are 
essential parameters for the “bottle-brush” mechanism to work (Tenson et al., 1997) 
and, at least in the erythromycin case, the drug seems to be stoichiometrically 
expelled at the termination step (Lovmar et al., 2006). The “bottle-brush” mechanism 
has been proposed to be general for all classes of macrolides, albeit with modulated 12
sequence specificity (Vimberg et al., 2004). The 16-membered macrolide josamycin 
has been shown to in most cases only allow a single peptidyl transfer reaction to occur 
before the peptidyl-tRNA dissociates (Tenson et al., 2003) and it was therefore 
surprising that rpmRNA
josa expressing tetra- or pentameric peptides could be selected 
(Vimberg et al., 2004). The present study clearly shows that the “bottle-brush” 
mechanism is not responsible for the peptide-mediated resistance against josamycin; 
instead we propose a “quarantine” mechanism to be responsible for the observed 
resistance. 
FIGURE 6. Peptide-mediated resistance in vivo in the wild-type but not in a pump mutant. 
Absorbance (600 nm) of wild-type (A and C) and TolC (pump) mutant (B and D) Escherichia coli cells 
with a resistance peptide expressing vector (rpmRNA) or a control vector (no rpmRNA) after 4 hours 
of growth following addition of the indicated macrolide concentrations. 
Comparison between rpmRNA
josa and rpmRNA
eryt
Expression of rpmRNA
eryt increase the erythromycin dissociation rate constant by an 
order of magnitude in concordance with the suggested “bottle-brush” mechanism 
(Lovmar et al., 2006). In contrast, expression of rpmRNA
josa did not change the 
dissociation rate constant of josamycin (Figs. 1A and 1B), but instead it slowed down 
the rate of peptidyl-tRNA drop-off by an order of magnitude (Fig. 1C) compared to 
the control mRNA (Fig. 1D). Peptidyl-tRNA drop-off is not an issue during 
rpmRNA
eryt expression, because erythromycin leaves enough space in the tunnel to 
allow translation of the complete penta-peptide (Tenson et al., 2003). The present 
results on rpmRNA
josa suggest that it is never completely translated and thus the 
resistance mechanism for josamycin should be independent of the length of the 
encoded peptide. This is in contrast to the results on erythromycin resistance where 13
the peptide length was shown to be crucial for erythromycin resistance both in living 
cells (Tenson et al., 1997) and in a cell-free translation system (Lovmar et al., 2006). 
The prediction on the length dependence was tested by expressing peptides with 
lengths varying between 2 and 10 amino acids with sequences according to the 
consensus for rpmRNA
eryt and rpmRNA
josa respectively (Vimberg et al., 2004). The 
resistance activity of rpmRNA
eryt was shown to be strongly peptide length dependent 
in agreement with previous experiments (Fig. 2A). In contrast to rpmRNA
eryt, but in 
agreement with the prediction, is the activity of rpmRNA
josa not sensitive to the length 
of the expressed peptides (Fig. 2B). The reason that most of the selected rpmRNA
josa
encoded pentamers was simply that the mini-gene library encoded pentamers with 
randomized sequences (Vimberg et al., 2004). In conclusion, it seems that the only 
important feature of rpmRNA
josa appears to be that it encodes a phenylalanine or 
tyrosine in the second position (Vimberg et al., 2004). 
Josamycin resistance through “quarantining” josamycin containing ribosomes 
At first it might be hard to imagine how expression of an mRNA encoding 
phenylalanine or tyrosine in the second position can render resistance to josamycin. 
The key to understand the mechanism can be found in the slow peptidyl-tRNA drop-
off rate when expressing rpmRNA
josa compared to other mRNAs. Because 
rpmRNA
josa can not expel josamycin from the ribosomes, it instead works by 
minimizing the negative effects of josamycin bound ribosomes through 
“quarantining” them on rpmRNA
josa. The “quarantine” can be understood as follows; 
ribosomes containing josamycin will be stuck on the rpmRNA
josa ten times longer 
than on other mRNAs, while ribosomes without josamycin recycles much faster on 
the short rpmRNA
josa than on other mRNAs. These combined effects lead to an 
enrichment of josamycin containing ribosomes on rpmRNA
josa, while the ribosomes 
without josamycin are enriched on protein mRNAs where they continue synthesizing 
proteins with less interference from ribosomes containing josamycin. A requirement 
for the “quarantine” to work is a very slow exchange of josamycin between different 
ribosomes, so that most of the ribosomes keep their identity as “josamycin-
containing” or “josamycin-free” at least within the time range of ribosome recycling. 
The average recycling time for josamycin containing ribosomes on rpmRNA
josa is 4 
minutes, and josamycin stays bound to a ribosome for an average time of 1.5 hours 
(Lovmar et al., 2004) which clearly fulfils this requirement. It should further be noted 
that only very few natural mRNAs encodes phenylalanine or tyrosine in the second 
position, thus over-expression of rpmRNA
josa will have a strong impact on the fraction 
of mRNAs encoding these amino acids in the second position resulting in the 
“quarantine” effect. 
The apparent explanation to why “quarantining” josamycin containing ribosomes on 
rpmRNA
josa confer resistance is that it reduces the demand of a component necessary 
for translation or recycling of ribosomes, thus allowing the josamycin-free ribosomes 
to continue translation at a close to normal rate. For example, the josamycin induced 
peptidyl-tRNA drop-off may accumulate peptidyl-tRNA in the cells, thus the pools of 
free tRNA isoacceptors will be depleted when the capacity of peptidyl-tRNA 
hydrolase (Pth) is saturated (Heurgue-Hamard et al., 2000; Heurgue-Hamard et al.,
1996; Tenson et al., 1999). There are also some unpublished results indicating that 
depletion of tRNA pools contributes to the josamycin toxicity, i.e. suppression of Pth 
expression makes cells hyper-sensitive to josamycin, while a slight over-expression of 14
Pth leads to low-level resistance (Tenson T, unpublished results). However, a fraction 
of ribosomes containing josamycin might deplete other components of the translation 
machinery before the pools of tRNAs, and therefore the “quarantine” mechanism 
might render resistance also without saturated Pth. 
Resistance can occur through avoiding depletion of mRNA pools by 
“quarantining” the josamycin containing ribosomes 
A bacterial population containing a plasmid-borne rpmRNA
josa under control of the 
tac promoter was grown in media with varying IPTG concentrations to regulate the 
level of resistance peptide expression combined with varying josamycin 
concentrations. The increase in bacterial mass after 8 hours of growth after induction 
was monitored by absorbance as a function of the IPTG concentration in the medium. 
To test whether it is possible to reproduce the in vivo effects of rpmRNA
josa
expression without considering the tRNA pools we adapted the model previously 
developed for peptide-mediated erythromycin resistance (Lovmar et al., 2006) to the 
parameter values for josamycin. The mathematical model was changed to account for 
josamycin resistance by modeling a delayed di-peptidyl-tRNA drop-off from a 
josamycin-carrying ribosome expressing the resistance peptide while the antibiotic 
stays bound to the ribosome. By assuming a low rate of degradation of mRNAs with a 
stalled ribosome in the 5’ end (Joyce and Dreyfus, 1998), we obtained growth curves 
mimicking the in vivo observed growth curves (Fig. 4). 
The importance of the modeled mRNA degradation can be understood as follows. The 
concentration of protein mRNAs in a cell is much lower than the concentration of 
ribosomes. Thus, only a small fraction of drug-inhibited ribosomes, stalled on mRNA 
can potentially severely slow down protein synthesis. When protein mRNAs with a 
stalled ribosome is slowly degraded, the free concentration of protein mRNAs on 
which a ribosome can initiate translation drastically declines (not shown). The delay 
at initiation increases the impact of josamycin since 50S subunits exist in a 
josamycin-susceptible state a longer period of time. The result is a larger fraction of 
non-translating and josamycin bound 50S subunits as well as a larger fraction of 
ribosomes stalled on mRNAs (not shown), which contributes to further lowering the 
concentration of free mRNAs. The feedback between the low concentration of free 
protein mRNAs and increased concentration of inactivated 50S subunits makes the 
growth rate severely reduced at a certain antibiotic concentration. When rpmRNA
josa
is present in the cell, josamycin-infected ribosomes are “quarantined” on the 
rpmRNA
josa. The free concentration of protein mRNAs boosts and ribosomes can 
initiate translation at a higher rate and escapes josamycin to a larger extent. The 
concentration of josamycin-free translating ribosomes increases, thereby raising the 
cell growth rate. 
Peptide-mediated macrolide resistance requires a fast outflow rate of the 
antibiotic over the cell membrane 
Previous modeling of peptide-mediated erythromycin resistance predicted the 
requirement of a fast outflow rate of the drug over the cell membrane to confer 
resistance against a macrolide with the binding kinetics of erythromycin. In gram-
positive bacteria the cell wall does not offer much resistance to diffusion of small 
molecules and the rate of exchange of macrolides over the cell membrane is expected 
to be rapid, but previous in vivo experiments were done with gram-negative E. coli15
cells (Lovmar et al., 2006; Tenson and Mankin, 2001). In gram-negatives the outer 
membrane confers an efficient barrier of permeation and the entrance rate of 
antibiotics are expected to be slow. Gram-negative bacteria also harbor broad-specific 
multidrug pumps in their inner membrane, which together with the outer membrane 
may explain the “intrinsic” resistance that gram-negatives exhibit (Li and Nikaido, 
2004). The AcrAB-TolC pump system is the major contributor of erythromycin 
resistance (Ma et al., 1995). The efflux pump, AcrB, resides in the inner membrane 
and seems to form a complex with a periplasmic protein, AcrA, which links or fuses 
the inner and outer membrane. Then, the channel, TolC, most likely provides the exit 
path back to the medium for drugs, solvents, detergents etc. (Zgurskaya and Nikaido, 
1999). Very little is known about the capacity of the AcrAB-TolC pump system in 
general and for erythromycin and josamycin in particular. 
To validate the model prediction we grew wild-type and TolC mutant E.coli cells 
containing either a resistance peptide expressing plasmid or a control plasmid in the 
presence of varying concentrations of erythromycin in the growth medium. 
Corresponding experiments were done with varying concentrations of josamycin in 
the growth medium. Growth was recorded by absorbance after 4 hours following 
induction and was registered as a function of the macrolide concentration and at an 
IPTG concentration corresponding to maximal resistance in the wild-type as seen in 
previous in vivo growth experiments. The in vivo experiments confirmed the model 
prediction for erythromycin. No resistance was observed in the TolC mutant (Fig. 
6B). The in vivo experiments also showed no josamycin resistance in the TolC mutant 
(Fig. 6D), which resistance mechanism clearly differs from that of erythromycin. 
The TolC mutant is as sensitive to macrolides as the AcrB mutant, why we do not 
expect the pump to function in the TolC mutant. The TolC mutant was therefore 
modeled without pumps. The models reproduced the in vivo growth curves. 
Resistance was substantially reduced in the TolC mutant for both erythromycin and 
josamycin (Fig. 5B and D). In the case of erythromycin, where expression of a 
resistance peptide actively removes a bound drug molecule from the ribosome 
(Lovmar et al., 2006) resistance is a consequence of an increased dissociation of 
erythromycin. Such a resistance mechanism is sensitive to the fate of the drug 
molecule after ejection. It can either leave the cell (by passive diffusion over the 
membrane or be actively transported by efflux pumps) or it re-associates to another 
ribosome. The value of the rate constant for leaving the cell in relation to the 
association rate constant of the antibiotic becomes very important. The requirement of 
a fast outflow rate for erythromycin resistance mechanism to work is then rather a 
requirement of a fast enough rate constant of leaving the cell once inside compared to 
the association rate constant to a ribosome of the antibiotic. We argue that the AcrAB-
TolC efflux pump system provide the required high efflux rate. Thus, a macrolide 
with a lower association rate constant but with the same or lower dissociation rate 
constant of erythromycin is predicted by the model to confer resistance also in the 
TolC mutant, if resistance is mediated by active removal of the drug by the same rate 
as of erythromycin. For instance, a macrolide with an association rate constant of 
josamycin but with a dissociation rate constant of erythromycin confer resistance in 
the simulated TolC mutant (not shown), while a macrolide with an 100 times higher 
association rate constant than erythromycin gives almost no resistance in the wild-
type (not shown).16
In the case of josamycin, the absence of resistance in the modelled TolC mutant is 
also a consequence of a too high association rate constant compared to the rate 
constant of efflux of the drug. This creates a sharp boost of the intracellular 
concentration of josamycin within a very narrow interval of concentrations of the 
antibiotic in the medium accompanied by a dramatic reduction of the growth rate and 
leaves the resistance mechanism ineffective since it cannot remove josamycin once 
bound to the ribosomes. For example, if the association rate constant is increased 100 
times, resistance is greatly reduced even in the wild-type. 
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APPENDIX
Model of peptide-mediated resistance against josamycin 
Below is a detailed description of the different states of ribosomes in the model. 
The model is described by the following system of differential equations, 
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A large ribosomal subunit can exist in eight different states. The 50S subunit may be 
free without ([50S]) or with ([50SM]) a bound macrolide. It may be a part of a 
ribosome ready to translate the first codons of a protein mRNA without ([R2]) or with 
([R2M]) a bound macrolide or it may have translated the first codons and become 
temporarily immune to the drug ([R´2]). If the mRNA starts to degrade before di-
peptidyl-tRNA drop-off or spontaneous dissociation of the macrolide it ends up in 
state ([R´2M]). State [R´2M] provides a more detailed description of the fate of 
ribosomes with a degrading mRNA but was not included in the erythromycin model 
(Lovmar et al., 2006), where q1>>kd3. However, the same approximations as in the 
erythromycin model are also valid in the josamycin model although they are less 
intuitive. The subunit may also be a part of a ribosome ready to translate a resistance 
peptide mRNA (rpmRNA) without ([R1]) or with ([R1M]) a bound antibiotic 
molecule. The rate constant of association and spontaneous dissociation of the 
antibiotic is q and q1, respectively. Association of the ribosomal subunits occurs with 
rate constant ka times the free concentration of protein mRNAs ([mRNAfree]) and free 
rpmRNA ([rpmRNAfree]). The first rounds of translation when the antibiotic can attack 
a ribosome (which is approximately the length of a resistance peptide) occur with rate 
k1. The rate for completing synthesis of a protein beyond translation of the first 
codons is k3, the drop-off rate of an antibiotic-carrying, stalled ribosome on a protein 
mRNA is k4 and the rate of drop-off of resistance di-peptidyl-tRNA is k2. The system 
of equations also contains differential equations describing the change of the total 
concentration of the macrolide in the cell ([mtot]) and of the total concentration of 
protein mRNAs ([mRNAtot]) and rpmRNA ([rpmRNAtot]), respectively. The macrolide 
passively diffuses over the outer membrane with rate constant cI and over the inner 
membrane with rate constant cII. The antibiotic is actively transported out of the cell 
by pumps (either from the cytoplasm or the periplasm) with rate constant cIII. The free 
intracellular (cytoplasmic) concentration of the macrolide is defined by 
'
122 [] [ ] [ 5 0 ] [] [] [] free tot m m S M RM RM RM      . The macrolide concentration in the 
periplasm is assumed to be quickly equilibrated. The synthesis rate of rpmRNA is ks1
and active degradation of free rpmRNA occurs with rate constant kd1. The 
corresponding rates of synthesis and degradation of protein mRNAs are denoted ks2
and kd2, respectively. It is also assumed that a stalled, macrolide-carrying ribosome on 
the 5´ end of an mRNA does not fully protect the mRNA from degradation, but it is 
degraded by a low rate constant, kd3. The free concentration of rpmRNA and protein 
mRNAs is defined by  11 [] [ ] [ ] [ ] free tot rpmRNA rpmRNA R R M     and 
'
22 2 [] [ ] [ ] [ ] [ ] free tot mRNA mRNA R R M R M     , respectively. The system expands by 
exponential growth with cell growth rate ȝ, defined by 
'
2
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     [A2] 
where ve is the average elongation rate of an uninhibited ribosome and ȡ0 is the 
concentration of amino acids incorporated in proteins. The total concentration of 50S 
subunits ([50Stot]) is kept constant and new 50S subunits are thus synthesised by rate 
ȝ·[50Stot] and the free concentration of 50S subunits varies according to 
''
11 222 2 [ 5 0][ 5 0 ][ 5 0 ][][ ][ ][ ][ ][ ] tot S S S M RR M RRR M R M       .21
The system was solved numerically by Euler’s method (Heath, 1997). Cell growth 
was calculated for the first 4 (Fig. 5) or 8 (Fig. 3A) hours after introduction of a 
certain macrolide concentration in the growth medium, [mm] by 
,
dt
tt d t VV e
P
     [A3] 
where dt is a small time-step and Vt-dt and Vt is the volume prior and after time-step dt,
respectively. Prior to macrolide exposure, the system resided at steady state for a 
certain synthesis rate of resistance peptide mRNA. The used program software was 
MATLAB 6.5 (The MathWorks, Inc., Natick, Massachusetts, U.S.A.). 
Peptide-mediated resistance against erythromycin 
The previously developed model for peptide-mediated erythromycin resistance was 
used for Fig. 5 (A and B) (see Supplementary material online of (Lovmar et al.,
2006)) but with the more detailed description of the flows over the inner membrane 
described in the differential equation for mtot in eq. [A1]. The extension of the model 
account for the difference in macrolide concentrations where cell growth are affected 
in the wild-type and in the TolC mutant.  22
Appendix table 1. Definitions and values of used parameters. 
Description Value  Reference 
ka
association rate constant of ribosomal subunits at initiation 
of translation  2·10
6 M
-1s
-1 (1)
k1
rate constant for translation of the first codons when the 
ribosome is susceptible for the antibiotic or for translation 
of a resistance peptide by a drug-free ribosome 
1 s
-1 (2)
k2
rate constant for translation of a resistance peptide by an 
erythromycin-infected ribosome 
0.008 s
-1 (josa) 
0.1 s
-1 (eryt) Present study and (3)
k3
rate constant for translation beyond the first codons of a 
protein mRNA and translation termination  0.03 s
-1 (2)
k4
drop-off rate constant of peptidyl-tRNA from a stalled 
ribosome on a protein mRNA  0.06 s
-1 Lovmar, unpublished 
results
q association rate constant of erythromycin  3.3·10
4 M
-1s
-1 (josa) 
10
6 M
-1s
-1 (eryt) (4)
q1 dissociation rate constant of erythromycin  1.8·10
-4 s
-1 (josa) 
0.01 s
-1 (eryt) (4)
ks1 synthesis rate of resistance peptide mRNA (rpmRNA)  0 - 10 nMs
-1 in Fig. 3A
2 nMs
-1 in Figs. 5-6 
kd1 degradation rate constant of free rpmRNA  8.3·10
-3 s
-1
ks2max
maximal synthesis rate of protein mRNAs (in the absence 
of rpmRNA)  8.3·10
-9 Ms
-1 (5) 
ks2 synthesis rate of protein mRNAs  ks2max-0.05·ks1 Ms
-1
kd2 degradation rate constant of free protein mRNAs  8.3·10
-3 s
-1 (6)
kd3
degradation rate constant of protein mRNAs with a drug-
inhibited, stalled ribosome  4.2·10
-4 s
-1
cI rate constant of passive diffusion over outer cell membrane  2·10
-3 s
-1
cII rate constant of passive diffusion over inner cell membrane  0.1 s
-1 (7)
cIII rate constant of active transport by pump  0.9 s
-1
ve elongation rate of an uninhibited ribosome  20 s
-1 (2)
ȡ0 concentration of amino acids in proteins  2 M (2)
[50Stot] total concentration of 50S ribosomal subunits  4·10
-5 M( 2 )
[mm] concentration of macrolide in the growth medium  10
-7 – 1.5·10
-3 M  
(see figures)
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ABSTRACT 
Macrolide antibiotics bind to the large ribosomal subunit. They inhibit protein 
synthesis, probably by physically blocking the egress of nascent polypeptide chains 
on the ribosome thereby causing premature termination of translation. 
The most widespread resistance mechanism to macrolide antibiotics is 
methylation of a specific nucleotide residue in the 23S rRNA that substantially lowers 
the affinity of the drug to its binding site. Methylation is carried out by methyl 
transferases encoded by erm genes. Induction of ermC by erythromycin is the most 
extensively studied erm gene-macrolide interaction. The ermC mRNA contains a 
short open reading frame coding for a peptide, followed by the coding sequence of the 
methyl transferase. In the absence of erythromycin, only the peptide is synthesised. In 
the presence of erythromycin, a ribosome carrying the macrolide stalls, during 
translation of the small open reading frame. This leads to a conformational change of 
the secondary structure of the ermC transcript, which allows a ribosome to bind and 
start translation of the ErmC open reading frame. 
We have modelled the ermC resistance mechanism mathematically with 
particular attention to the binding affinity of a stalled ribosome in the short open 
reading frame of an ermC transcript, the specific activity of the methylase enzyme and 
the intracellular concentration of erythromycin.  To maximise the induction response 
rate and to attain a high fraction of ribosomes with a modified 23S rRNA, a high 
binding affinity of the stalled ribosome and a highly active methylase are required. 
Stabilisation of the ermC transcript has been suggested to be a second effect of the 
stalled ribosome. Our analysis shows that a prolonged half-life can greatly reduce the 
time it takes to convert the pool of susceptible ribosomes to resistant ribosomes and 
can further enhance the final fraction of immune ribosomes. The most conspicuous 
feature of the induction dynamics is the existence of an optimal macrolide 
concentration at which induction of ermC occurs most rapidly. We also relate 
parameters of resistance and the antibiotic concentration to cell growth and to 
selective pressures on the resistance mechanism.  
INTRODUCTION
The macrolides form a clinically important group of antibiotics, frequently used in the 
treatment of infectious diseases 
1, 2. The core structure of a macrolide is a lactone ring 
with 14-16 carbon atoms with sugar moieties 
1, 2. Macrolides probably inhibit protein 
synthesis by preventing the nascent peptide from entering the peptide exit tunnel in 2
the large ribosomal subunit. Crystal structures of the large ribosomal subunit in 
complex with different macrolides reveal that the antibiotics bind at the entrance to 
the exit tunnel 
3, 4, close to the peptidyl transferase centre 
5, 6. In accordance with that, 
an increased dissociation of peptidtyl-tRNA has been reported in the presence of the 
drugs
7, 8, 9, 10. Furthermore, there is a correlation between macrolide structure and the 
length of the aborted peptide chains 
10 and polysomes are immune to the antibiotics 
11.
Erythromycin is the most extensively characterised macrolide and is produced 
in nature by the soil actinomycete Saccharopolyspora erythraea (formerly 
Streptomyces erythraeus)
12. S. erythraea protects its own ribosomes from 
erythromycin by dimethylating a specific adenine residue located in the drug binding 
site in 23S rRNA (position 2058, Escherichia coli numbering) 
13, 14, 15. Methylation is 
carried out by a methyl transferase encoded by the ermE gene and considerably 
lowers the binding affinity of erythromycin and of other macrolide, lincosamide and 
streptogramin B (MLSB) antibiotics 
15, 16, 17. There are approximately 40 erm
(erythromycin  ribosome  methylation) genes known in pathogenic bacteria and 
methylation of 23S rRNA is the most widespread resistance mechanism to macrolides 
2, 18. The second most important resistance mechanism is enhanced antibiotic efflux 
mediated by transporter proteins, while enzymatic modification of the drugs seems to 
be less significant 
2, 18, 19. A fourth proposed mechanism is the expression of short 
specific cis-acting peptides, which confers low-level resistance to macrolides but its 
existence remains to be proven in clinical isolates 
20,  21,  22.
The most well studied erm gene is ermC from Staphylococcus aureus and 
ErmC synthesis is induced by erythromycin 
23. The ermC mRNA contains a small 
open reading frame (ORF) in the ermC leader region encoding a 19 amino acids long 
peptide, followed by the ORF of the methyl transferase. In the absence of 
erythromycin, the transcript assumes a translationally inactive conformation. The 
small ORF in the leader region is translated while synthesis of ErmC is initiated at a 
very low frequency since the ribosome-binding site and the start codon of the ErmC 
ORF are sequestered in a hairpin structure (Fig. 1(a)). In the presence of 
erythromycin, in contrast, a ribosome carrying the macrolide and translating the small 
ORF stalls when the first nine codons have been read. This causes a conformational 
change of the secondary structure of the ermC transcript, which allows for ErmC 
synthesis (Fig. 1(b)) 
23, 24. Stabilisation of the ermC transcript is a second effect of the 
stalled ribosome 
25, 26 and prolongs the mRNA half-life about twenty-fold in Bacillus 
subtilis
26.
In order to induce and sustain ErmC synthesis, both erythromycin-carrying 
ribosomes and erythromycin-free ribosomes are required. This suggests the existence 
of an optimal erythromycin concentration at which the induction rate is the fastest 
27,
28; at low drug concentrations the number of translationally active ermC transcripts is 
low and at high drug concentrations the number of translationally active ribosomes is 
low. Another question is how the putative ermC transcript stabilisation contributes to 
induce resistance. Here, we model mathematically the induction dynamics of ErmC 
synthesis and the subsequent transformation of the bacterium into an MLSB-resistant
cell. We discuss the effect of the binding affinity of a stalled ribosome to the leader 
sequence of the ermC mRNA, of the activity of the methyl transferase and of the 
concentration of erythromycin. We predict that an erythromycin concentration of the 
order of 10
-7 M maximises the induction response rate as reflected in the most rapid 
boost of the concentrations of methylase and resistant ribosomes. This is in good  3
Figure 1. Suggested conformations of the 5’end of ermC mRNA transcript. a) Translationally 
“inactive” conformation of the transcript. The hairpin strucure of segments I-II is temporarily disrupted 
when the peptide, encoded upstream of the open reading frame of the methylase, is synthesised. The 
downstream hairpin structure (segments III-IV) stays intact. Methylase synthesis is initiated at a low 
frequency since both the Shine-Dalgarno sequence (SDmet) and the initiation codon  (AUGmet) are 
sequestered. b) Translationally “active” conformation of the transcript. A ribosome with erythromycin 
stalls when the first nine codons of the peptide have been translated and segments II and III form a 
hairpin structure. The Shine-Dalgarno sequence and the initiation codon of the methylase in segment 
IV are uncovered. Adapted from Weisblum, 1995 
23.
agreement with previously reported optimal inducing concentrations between 10
-8 and 
10
-7 M of erythromycin in Staphylococcus aureus
27. However, we question the 
biological significance of the maximal induction rate since it is not accompanied by a 
maximal cell growth. Further, the highest gain of ermC transcript stabilisation is 
expected for bacteria with a low-active methyl transferase and where the stalled 
ribosome is tightly bound to the mRNA in the ermC leader region and at a high 
intracellular concentration of erythromycin. The time it takes to change the pool of 
susceptible ribosomes into a pool of resistant ribosomes is greatly reduced as seen by 
the increase in cell growth and the growth rate reaches a higher value after resistance 
is attained. We also relate parameters of induction and antibiotic concentration to 
selective pressures on the resistance mechanism.  
METHODS
The present model describes how the concentration of methyl transferase increases 
and is followed by the appearance of a large fraction of methylated ribosomes with 
time after induction by erythromycin. Throughout the paper “transformation” refers to 
the conversion a bacterium undergoes from an erythromycin susceptible cell to an 
MLSB-resistant cell when exposed to the antibiotic, and not to the introduction of 
DNA into a cell.
Induction of resistance occurs in three consecutive steps. Firstly, erythromycin 
binds to free unmethylated ribosomes. Secondly, synthesis of the methylase enzyme is 
induced by a stalled erythromycin-carrying ribosome in the leader sequence of the 4
ermC mRNA. Thirdly, ErmC methylates a specific nucleotide residue of nascent 23S 
rRNA molecules and methylated ribosomes assemble. Binding of erythromycin to 
susceptible ribosomes is assumed to equilibrate rapidly. The probability that a free 
unmethylated ribosome carries the macrolide is then a function of the dissociation 
constant for the drug binding to the ribosome and the intracellular concentration of 
free erythromycin. The dissociation constant has been measured in vivo and estimated 
to be 10
-7 M in S. aureus
29. More recent measurements in vitro estimate the 
dissociation constant to 10
-8 M in an E. coli translation system
30. Further, binding to 
the leader sequence of an ermC mRNA by a drug-containing ribosome is assumed to 
quickly equilibrate. The dissociation constant, KQ, for the stalled ribosome has to our 
knowledge not been determined. We varied the probability that an ermC mRNA is 
open for ErmC synthesis by changing the dissociation constant. Since experiments 
indicate that the substrate of the methylase enzyme is nascent 23S rRNA rather than 
mature 50S subunits 
15, 31, 32, there should exist a time window when methylation is 
possible. The time window is opened up when the recognition and binding sites for 
the enzyme on 23S rRNA have formed and is closed once the methylase no longer has 
access to the binding site, maybe after a conformational change during the first steps 
of assembly. The probability that a 23S rRNA becomes modified depends on the 
length of the time window during which methylation is possible, the specific activity 
of ErmC and the present concentration of the methylase in the cell. We varied the 
probability for a 23S rRNA to become methylated (modelled as the probability of a 
nascent ribosome to be methylated) by changing the KQM-value, the normalised 
kcat/Km -parameter defined in the Appendix, which is reflecting the activity of the 
methylase.  
Stabilisation of the ermC transcript has been proposed as a second effect of a 
stalled ribosome in the leader region. Bechhofer and Dubnau (1987) 
26 isolated RNA 
from B. subtilis carrying the wild-type ermC gene in the presence and in the absence 
of erythromycin. The physical half-life of an ermC transcript was estimated to 
increase roughly from 2 to 40 minutes with 27 nM of the drug. By measuring the 
ability of induced cells to synthesise ErmC, Shivakumar et al. (1980) 
25, suggested a 
corresponding prolongation of the functional half-life of the mRNA, which should be 
difficult to discriminate from the increased translation frequency per ermC mRNA. 
Further, a post-transcriptional induction of ErmC, when the stability of the transcript 
was unaffected, has been demonstrated in vitro
28, which was comparable to the 
induction in vivo. It is therefore unclear to what extent an increased physical half-life 
is accompanied with a prolonged functional half-life of the ermC mRNA
 33. If there is 
a stabilisation of the ermC transcript, it may be a rather intricate function of the 
concentration of erythromycin and concentration of unmethylated and methylated 
ribosomes in the cell. To model the suggested mRNA stabilisation we simply 
increased the half-life approximately 20 times, from 2 to 45 minutes, for ermC
transcripts with a stalled ribosome in the leader ORF. See Appendix for further details 
of the model and Table A1 for parameter values. 
Two more properties relevant for the ermC induction mechanism have been 
proposed but are omitted in the present model. Accumulation of intermediate particles 
of 50S subunits and increased degradation of 23S rRNA has been reported in presence 
of erythromycin 
34, 35, 36, 37. Therefore, erythromycin seems to interfere with ribosome 
assembly 
36. An alternative explanation might be the existence of a quality control 
mechanism of newborn ribosomes during their first round of translation 
37, 38 or a 
disturbed balance of the synthesis of ribosomal protein and rRNA resulting in 
erroneous or incomplete assembly of the subunits. Moreover, experiments indicate 5
that ErmC binds to its own mRNA, thus repressing its synthesis 
39. However, the 
footprint bound ErmC would leave on the transcript has not yet been demonstrated 
experimentally 
23.
RESULTS
How the binding affinity of a stalled ribosome to the leader region of the ermC
mRNA and the activity of ErmC influence induction of resistance 
Intuitively, the binding affinity by an erythromycin-carrying ribosome to the leader 
sequence and the rate by which ErmC attaches methyl groups to 23S rRNA should be 
of vital importance for the efficiency of the resistance mechanism. Fig. 2(a)-(b) show 
what happens after the introduction of erythromycin into bacterial cells with different 
dissociation constants of the stalled ribosome and with different activities of the 
methylase enzyme, respectively. The two parameters affect both the rate of 
transformation and the degree of transformation reached at steady state. The slower 
the induction response is, the lower is the final fraction of methylated ribosomes and 
vice versa. As the value of KQ decreases (stronger binding), the probability of active 
mRNAs increases and synthesis of the methylase and methylated ribosomes 
accelerate. The binding affinity of a stalled ribosome also influences the steady state 
concentration of the methylase, and thus indirectly controls the fraction of methylated 
ribosomes. With rising KQM-value the probability of methylation for a nascent 23S 
rRNA increases and the rate by which resistant ribosomes are formed boosts. At 
steady state the fraction of methylated ribosomes equals the probability for a 23S 
rRNA to become metylated, which in turn is a direct function of the KQM-parameter of 
the methylase. Stabilisation of the ermC transcript by a stalled ribosome reduces the 
transformation time and raises the fraction of methylated ribosomes at steady state 
beyond the limit when the half-life for the mRNA is unaffected (compare Fig. 2(c)-
(d)). With the prolonged half-life an increased concentration of ermC mRNA follows, 
which further helps to speed up ErmC synthesis during transformation. The largest 
effect of a stabilised transcript is seen for bacteria with a low dissociation constant for 
the stalled ribosome (KQ d 10
-5 M) and a methylase with a low to moderate activity 
(KQM= 10
-4-10
-6 M
-1) in Fig. 2(d). 
Impact of erythromycin concentration on induction response rate and cell 
growth rate 
With increasing intracellular concentration of free erythromycin, its impact on the 
translation machinery increases. Fig. 3(a) shows the induction response when the 
concentration of the macrolide is varied. The most salient feature is the appearance of 
an optimal erythromycin concentration at 10
-7 M where methylase synthesis and 
synthesis of methylated ribosomes increase with maximal rate. Induction depends 
critically on the presence of ribosomes both with and without a bound macrolide. The 
fastest inducing concentration of the drug reflects the existence of an optimal blend of 
both sorts of ribosomes in the cell. Beyond the optimal inducing drug concentration 
the induction response rate decreases monotonically while the final fraction of 
resistant ribosomes at steady state only increases slightly. Clearly, the antibiotic 
concentration sets the final degree of transformation and is unaffected by the 
transformation time. 
Fig. 3(b) shows how the growth rate of the cell is affected by different 
concentrations of erythromycin during the transformation phase. Our model   6
Figure 2. (a)-(b) Fraction of methylated ribosomes as a function of time after induction by 
erythromycin. (a) The dissociation constant of a stalled ribosome in the ermC mRNA leader region 
(KQ) is varied while the activity of the methylase is kept constant (KQM = 10
6 M
-1). (b) The normalised 
Michaelis-Menten parameter of the methylase is varied (KQM) while the binding affinity to the ermC
mRNA leader sequence is kept constant (KQ = 10
-5 M). (c)-(d) Fraction of methylated ribosomes 
attained at steady state as a function of KQ and KQM. The concentration of erythromycin is 10
-5 M. (c) 
Without  ermC transcript stabilisation. (d) With ermC transcript stabilisation. The half-life of the 
mRNA is prolonged from 2 to 45 minutes when a ribosome is stalled in the leader sequence. The 
intracellular concentration of free macrolide, e, is 10
-5 M. (10
5 seconds ~ 28 hours).
demonstrates that as erythromycin is introduced into the cell, the previous pools of 
non-elongating (free) and elongating ribosomes start to alter, shrinking the pool of 
elongating ribosomes while the pool of non-elongating ribosomes expands as more 
and more ribosomes become inhibited by the macrolide. The higher the intracellular 
concentration of eryhromycin becomes, the more the cell is initially drained away 
functional ribosomes capable of protein synthesis which is reflected in a reduced 
growth rate. High concentrations of free erythromycin ([e] t 10
-6 M in Fig. 3(b)), 
makes the cell virtually stop growing for a period of time. A high macrolide 
concentration confers an extensive trauma to the bacterial cell, which prolongs the 
transformation phase. The apparent optimal concentration (10
-7 M )  o f  f r e e  
erythromycin, where the methylase concentration and fraction of methylated 
ribosomes increase at maximal rate, has no counterpart in the cell growth rate. Also, 
the growth rate at steady state is slightly reduced as the concentration of free 
erythromycin increases, in contrast to the fraction of resistant ribosomes, which 
increases slightly (compare Fig. 3(a)-(b)). The amount of methylase and the fraction 
of methylated ribosomes in some sense reflect how well the resistance mechanism 7
works. However, the parameter genuinely subjected to selective pressure should be 
the growth rate of the cell, which motivates a closer study of cell growth and growth 
rate at steady state as a function of the three factors discussed above.
Figure 3. (a) Fraction of methylated ribosomes as a function of time after induction by erythromycin. 
The free concentration of the macrolide is changed whereas the dissociation constant of a stalled 
ribosome in the leader region of an ermC transcript (KQ) and the normalised kcat/Km-parameter of ErmC 
(KQM) are kept constant. The close up shows the first 20 000 seconds (~ 5.5 hours). (b) The growth rate 
of the cell in log-log scale for the same parameter values and time interval as in (a). (10
5 seconds ~ 28 
hours). 8
Figure 4. (a)-(c) Relative cell growth after 100 000 seconds (~28 hours) and the ratio between the 
growth rate at steady state before and after induction for the same parameter values as in Fig. 2(c)-(d). 
Relative cell growth is the number of cells a single cell gives rise to in the presence of erythromycin 
divided by the corresponding number of cells in the absence of the antibiotic. (a)-(b) Without ermC
transcript stabilisation. (c) With ermC transcript stabilisation. (d) Gain with ermC transcript 
stabilisation. Relative growth rate at steady state says how many times faster the growth rate with ermC
transcript stabilisation is compared to the growth rate without the stabilisation in Fig. 4(b)-(c).
Correlation between cell growth and parameters of the resistance mechanism 
Cell growth and the growth rate of the cell constitute a direct measure of the selective 
advantage of a certain combination of parameter values of the underlying resistance 
mechanism. From our definition of the cell growth rate as the rate amino acids are 
incorporated into proteins normalised to the current amount of amino acids in 
polypeptides, we calculated cell growth up till a given time (Appendix). Fig. 4(a)-(b) 
depict cell growth after 100 000 seconds (a28 hours) and the growth rate at steady 
state, respectively for the same parameter values as in Fig. 2(c). Relative growth in 
Fig. 4(a) is the number of cells a single bacterium would generate in the presence of 
erythromycin divided by the number of cells a bacterium would generate when grown 
in the absence of the antibiotic. To maximise the induction response rate both a high 
binding affinity of a stalled ribosome in the leader region of the ermC mRNA and a 
highly active methylase are required. As a consequence, cell growth increases and the 
post-transformation growth rate approaches the pre-induction growth rate. 
Stabilisation of the ermC transcript can further promote cell growth. Fig. 4(c)-(d) 
shows the impact of the prolonged half-life on the growth rate at steady state. 9
Figure 5. (a) Growth rate at steady state before induction divided by the corresponding growth rate 
after induction as a function of the concentration of free erythromycin. The dissociation constant of a 
stalled ribosome in the ermC mRNA leader region (KQ) is 10
-7 M. The normalised Michaelis-Menten 
parameter of the methylase (KQM) ranges between 10
4-10
6 M
-1. (b) Gain with ermC transcript 
stabilisation. Relative growth rate at steady state is defined as in Fig. 4(d).
Correlation between cell growth, drug dose and time periods of drug exposure 
Cell growth after a given period of time is the combined effect of how much the 
bacterium grows during the transformation phase when the cell growth rate can vary 
considerably as indicated by Fig. 3(b), plus the growth after the new steady state has 
been attained when the growth rate is approximately constant. A certain combination 
of KQ and KQM can give a faster growth during the transformation phase but a lower 
growth rate at steady state than compared to another KQ-KQM combination where the 
growth during transformation is somewhat lower but follows by a slightly higher 
growth rate at steady state. The encircled points in Fig. 4(a)-(b) provides an example. 
The time two bacteria have to be exposed to erythromycin before a larger cell growth 
during induction is out-competed by a higher growth rate at steady state is a function 
of the transformation time, cell growth during transformation and the growth rate at 
steady state of the two bacteria (Appendix). 
Fig. 5(a) depicts how the growth rate at steady state is affected by different 
concentrations of erythromycin. As anticipated, the higher the intracellular 
concentration of the antibiotic, the more the growth rate is reduced after 
transformation compared to the growth rate before induction. The advantage of a 
stabilised ermC transcript is expected to increase with increasing concentration of 
erythromycin as seen in Fig. 5(b).  
DISCUSSION 
Factors determining ermC induction dynamics 
We have modelled the ermC resistance mechanism as a function of the binding 
affinity of a stalled ribosome in the leader region of an ermC mRNA, the activity of 
the methyl transferase and the intracellular concentration of free erythromycin. The 
macrolide induces a course of events that converts a bacterium from a susceptible 
ribosome-producing cell into a cell synthesising ribosomes immune to MLSB-
antibiotics.  Both the time of this transformation and the degree of transformation, as 
seen by the fraction of methylated ribosomes (ribosomes with a methylated 23S 
rRNA), have been studied. To maximise the induction response rate and to attain a 
high fraction of methylated ribosomes at steady state, a high binding affinity of a 
stalled ribosome (a low dissociation constant, KQ) and a high activity of the methylase 10
(a high normalised kcat/Km-value, KQM) are required (Fig. 2(a)-(d)). A tightly bound 
ribosome to the ORF in the ermC leader region increases the time the mRNA is in a 
translationally active conformation and rapidly boosts the methylase concentration. A 
highly active methylase increases the portion of nascent methylated 23S rRNA before 
methylation becomes unfeasible during assembly.  
The most conspicuous feature of the induction dynamics, when changing the 
concentration of erythromycin, is the appearance of an optimal macrolide 
concentration at 10
-7 M generating a maximal response rate as shown by the fastest 
boost of both the ErmC concentration and the fraction of methylated ribosomes (Fig. 
3(a)). This is in good agreement with previous experiments by Weisblum et al. (1971) 
27. They added erythromycin at concentrations between 10
-9 and 10
-6 M to growing 
cultures of S. aureus. After 60 minutes of incubation, portions were withdrawn and 
plated on agar plates with 510
-5 M of erythromycin. The largest number of resistant 
cells was found in the range 10
-8 and 10
-7 M of erythromycin. As previously pointed 
out by Narayanan and Dubnau (1987) 
28, the optimal inducing concentration of 
erythromycin is explained by the requirement of ribosomes both with and without the 
macrolide to induce ErmC synthesis. The cell “senses” the presence of the drug 
through the concentration of erythromycin-carrying ribosomes. At low concentrations 
of the antibiotic many ribosomes are unaffected by the macrolide and there are not 
enough erythromycin-carrying ribosomes to substantially open up the pool of ermC
mRNAs for translation. On the other hand, with the cell saturated with erythromycin 
there is a high probability that an ermC transcript is in a translationally active 
conformation but there are hardly any active ribosomes left to synthesise ErmC. 
However, the optimal inducing concentration of erythromycin may not be biologically 
significant. When the cell growth rate is monitored during the transformation phase, 
instead of the concentration of the methylase and the fraction of methylated 
ribosomes, another pattern emerges (Fig. 3(b)). With increasing concentration of 
erythromycin the trauma experienced by a cell is monotonically increased which is 
shown by a larger initial reduction of the growth rate and a longer time for its 
recovery. Therefore, the apparent maximal response rate may only be a consequence 
of the induction mechanism, and may be of no relevance for cell growth, the 
parameter genuinely subjected to selection pressures. 
To test the potential effect of ermC mRNA stabilisation we increased the 
physical and functional half-life approximately 20 times from 2 to 45 minutes for 
transcripts with a stalled ribosome in the ORF in the leader region. Stabilisation 
makes the induction mechanism respond more strongly to erythromycin, and thus 
increases the sensitivity of the resistance mechanism to the drug. The transformation 
time is reduced and the fraction of methylated ribosomes at steady state is raised, 
compared to when the half-life of the mRNA is unaffected by the macrolide (Fig. 
2(c)-(d)). Bacteria with ribosomes binding with high affinity to the ermC leader 
region of the mRNA (a low KQ-value), a low active methylase (a low KQM-value) and 
subjected to a high concentration of the antibiotic are expected to experience the 
largest gain. An ermC mRNA receives a prolonged protection from degradation when 
the stalled ribosome is tightly bound and the time spent in the transformation phase 
increases with a low-active enzyme since the production rate of methylated ribosomes 
is slow. The probability for an ermC mRNA to be protected by a stalled ribosome 
increases as well as the transformation time by a raised initial concentration of 
erythromycin-carrying ribosomes at high intracellular concentrations of the drug. All 
three properties contribute to build-up a high pool of ermC mRNA. The end result is 11
promoted cell growth by a reduced transformation time and by a raised growth rate at 
steady state (Fig. 4(b)-(d) and Fig. 5(b)). 
Selective pressures on the ermC resistance mechanism 
Development of new improved antibiotics with a broader spectrum of action and the 
emergence of pathogenic bacteria resistant to the drugs seems to be an everlasting 
armed race. Inducible MLSB-resistant isolates of S. aureus appeared shortly after the 
introduction of eryhtromycin into the clinics in the early 1950s. Later, constitutively 
resistant mutants of the inducible strain emerged when the second generation of 
macrolides was launched into clinical practice. The extended range of effectiveness of 
the third generation of macrolides selected bacteria from Mycobacterium spp., which 
confer intrinsic MLSB-resistance 
18. The present analysis of bacteria carrying the 
inducible ermC gene connects cell growth to parameters of the resistance mechanism. 
Cell growth in turn is an important parameter on which natural selection acts. The 
model shows that a high cell growth during induction requires a high binding affinity 
of the stalled ribosome in the ermC leader region of the mRNA and a highly active 
methylase. The expected scenario is therefore that the resistance mechanism evolves 
towards an increasing normalised kcat/Km-value for ErmC (KQM-value) and a 
decreasing value of the dissociation constant of the stalled ribosome (KQ-value). This 
is under the assumption that the mutations involved do not reduce the fitness in an 
erythromycin-free environment. Imagine a bacterium with KQ= 10
-4 M and KQM = 10
5
M
-1 in Fig. 4(a)-(b). At first a mutation causing the dissociation constant to decrease 
or the kcat/Km-value of the methylase to increase, 10 times, is expected to significantly 
boost cell growth and the growth rate at steady state resulting in a high selective 
advantage compared to other bacteria in the population. As the bacterial population as 
a whole evolves a smaller and smaller KQ-value and higher and higher KQM-value, the 
selective pressure to further increase growth is anticipated to decrease along with a 
declining selective advantage (Fig. 4(a)-(b)). Our analysis also indicates the huge 
selective advantage ermC transcript stabilisation potentially can give. When a bound 
ribosome in the ermC leader region of the mRNA only makes the transcript accessible 
for methylase synthesis, the dissociation constant KQ, soon reaches a value beyond 
which further selective advantages are negligible as reflected by a minor increase in 
growth rate at steady state. For a low to moderately active enzyme (KQM = 10
4-10
5 M
-
1) an increase of KQM 10 times will not only give a vast selective advantage but is also 
necessary for improved adaptation to the antibiotic environment (Fig. 4(b)). When a 
stalled ribosome also protects the ermC mRNA from degradation, it is much more 
rewarding to continue to decrease the dissociation constant, KQ, even for a bacterium 
with a low-active methylase as shown in Fig. 4(c).  
Selective pressures connected to drug dose and time periods of drug exposure 
Both the dose and the length of the time periods bacteria are exposed to the drugs 
modulate the traits of the resistance mechanism. Short time periods favour bacteria 
with a low binding affinity of the stalled ribosome and a high methylase activity 
whereas bacteria with a higher binding affinity to the leader region of the ermC
mRNA and a less active enzyme is encouraged when exposed to longer periods of the 
antibiotic because of their slightly higher growth rate at steady state. An example is 
given in Fig. 4(a)-(b) by the encircled points. Bacterial cells with KQ = 10
-6 M and 
KQM = 10
6 M
-1 will eventually outgrow bacterial cells with KQ= 10
-4 M and KQM= 10
7
M
-1 since they have the highest growth rate at steady state (Fig. 4(b) and Appendix). 
If, however, the bacterial population is repeatedly exposed to the antibiotic only 12
during a short period of time as in Fig. 4(a), cells with KQ= 10
-4 M and KQM= 10
7 M
-1
will instead have a selective advantage. A bacterium with KQ= 10
-6 M and KQM = 10
6
M
-1 needs approximately 3 days to catch up with a bacterium with KQ = 10
-4 M and 
KQM= 10
7 M
-1. Fig. 5(a) and 3(b) indicate how the selective pressure should change if 
a bacterial population suddenly experiences, for example, a 10 times higher antibiotic 
concentration than never subjected to before. The growth rate at steady state is 
decreased and the prolonged transformation time reduces cell growth further. The 
bacteria would then be less well adapted to the new situation and the selective 
advantage of increasing the normalised kcat/Km-value as well as the binding affinity of 
a ribosome bound to the leader region of the ermC mRNA would rise, which exposes 
a principle problem. The effect of increasing the dose of an antibiotic in clinical 
practice when dealing with bacteria resistant to lower levels of the drug is double-
edged. At short-term it may be rewarding. Cell growth is suppressed a longer period 
of time and gives for instance the macrophages of the immune system time to trace 
and engulf pathogenic bacteria. The prise, however, may be an improved and more 
competent resistance mechanism in the long run. 
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APPENDIX
Basic equations 
Our model describes how the concentration of methylated (rmet) and unmethylated 
(runmet) ribosomes, proteins (p) and methyl transferase (m) change in time (t) at the 
introduction of erythromycin into a cell. Here we define proteins as all proteins in the 
cell, lumped together as one entity, except for ribosomal proteins and the methyl 
transferase. Ribosomes are synthesised in one step as a protein, i.e. we disregard 
ribosome assembly. Methylated/unmethylated ribosomes refer to ribosomes 
containing a methylated/unmethylated 23S rRNA. The model is implicitly defined by 
the following equations 
    , ,,, , m R N A , ,, ,
ff e e met
M IT E met unmet ribprot e unmet met met mt V Q r r t v r r t dr QI T r
dt
P ªº ¬¼     
    ,, , , , m R N A , , , , (1 )
ff ee unmet
M IT E met unmet ribprot e met unmet unmet mt V Q r r t v r r t dr QI T r
dt
P ªº ¬¼      
   (A1) 
  ,,, , m R N A ,, , ,
ff ee
IT E met unmet prot e met unmet VQr r t v r r t dp ITp
dt
P ªº ¬¼    
   >@  ,, , , ,, m R N A , ,,,
ff f e e
E unmet IT E met unmet met e met unmet Qr t VQr r t vr r t dm QI T m
dt
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where [mRNAx] is the concentration of mRNA coding for ribosomal protein (x = 
ribprot), proteins (x = prot) and methylase (x = met), respectively. The mRNA 
concentrations are assumed to be constant. Stabilisation of the ermC transcript is an 
exception. The ermC mRNA concentration is then changing over time and is therefore 
modelled by a separate equation 
>@   >@  >@ 12
mRNA
1 , , mRNA , , mRNA .
met ff
s d E unmet met d E unmet met
d
kk Q Q r t kQ Q r t
dt
       
(A2)
IT is the rate of translation initiation per mRNA molecule and P is the qrowth rate of 
the cell. QE, Q and QM are three probabilities essential in this model, describing the 
resistance mechanism to macrolides through induction of methylation of 23S rRNA. 
Below follows a more detailed description of the parameters of the model. 
Parameters of the ermC resistance mechanism 
Erythromycin bound to a ribosome causes dissociation of peptidyl-tRNA containing 
only six to eight amino acids which is less than the number of codons a translating 
ribosome must move before another ribosome can access the site of initiation. If 
translation initiation includes all steps a ribosome must pass before the next ribosome 
can start initiation, a ribosome susceptible to erythromycin is always free. If we 
further assume that association and dissociation of erythromycin always is quickly 
equilibrated, then the probability that a free unmethylated ribosome carries 
erythromycin can be described by 16
 ,, E
E
e
Qe t
eK
 

                                              (A3) 
where e is the intracellular concentration of free erythromycin and KE is the 
corresponding dissociation constant. Unmethylated elongating ribosomes are regarded 
as temporarily immune to erythromycin, as shown by experiments 
11.
The association and dissociation of a free unmethylated ribosome, with 
erythromycin, to the leader sequence of an ermC transcript is also supposed to quickly 
equilibrate and the probability of an ermC mRNA to be open for methylase synthesis, 
is approximated by 
 ,, ,
f
f Eu n m e t
Eu n m e t f
QE u n m e t
Qr
QQ r t
KQ r

 

                             (A4) 
where
f
unmet r  denotes the concentration of unmethylated ribosomes free to initiate 
translation and KQ is the dissociation constant of the stalled ribosome. Methylation 
and start of assembly are considered to occur during transcription of 23S rRNA. If 
methylation/escape of methylation of a nascent 23S rRNA are assumed to each take 
place with one rate-limiting step, the probability that a 23S rRNA becomes 
methylated can be calculated as 
 ,,
1
QM
M
QM
mK
Qm t
mK

 

                                     (A5) 
where m is the concentration of methylase and KQM = (kcat/Km)/kescape is a normalised 
Michaelis-Menten parameter of ErmC. Equation (A4) assumes that the enzyme is 
normally not saturated by its substrate. 
Translation 
The rate of initiation of translation of an mRNA molecule, IT, is given by 

    1
,,, , ,
ff
IT met E unmet ff
IT E met unmet ff
met unmet
Vr Qr
IT V Q r r t
Kr r
 
 

                    (A6) 
where
f
met r  and 
f
unmet r  are the concentration of methylated and unmethylated 
ribosomes, respectively, free to initiate translation. The probability that a free and 
unmethylated ribosome is not carrying erythromycin is 1 E Q  . The maximal rate that 
a ribosome may initiate translation of an mRNA is denoted VIT and K = VIT/10
6 is the 
corresponding Km-parameter. VIT is given by 
 ,,
e
IT e
ce
kv
Vv t
Nkv

 

                                           (A7) 17
where k is a constant for a rate-limiting step during initiation of translation, ve is the 
elongation rate of a ribosome and Nc is the number of codons a ribosome must move 
before the next ribosome may initiate translation on the same mRNA.  
The protein density or the concentration of amino acids bound in proteins in a 
cell is close to constant 
40 and 
 >@ mRNA
ee
em e tu n m e t
i
i
vr r
IT
N

  ¦                             (A8) 
follows. The expression on the left-hand side denotes the total rate of translation 
termination in the cell. The average number of codons in an mRNA is  N  and 
e
N
v
§·
¨¸
©¹
 is 
the expected time for translating an mRNA. The total rate of termination may then be 
written as a rate constant for termination times the total concentration of elongating 
ribosomes, i.e. 
ee
term met unmet kr r  , where  e
term
v
k
N
  . The expression on the right-hand 
side denotes the total rate of initiation of translation, which is simply the rate of 
initiation of translation per mRNA, IT, times the total concentration of mRNAs, 
> @ mRNAi
i ¦ , in the cell. After reshuffling of factors, eq. A8 can be written as 
 >@ mRNA ,
ee
met unmet i
i e
N
rr I T
v
    ¦                                  (A9) 
which gives a relation between free and elongating ribosomes. 
Cellular growth rate 
The growth rate of the cell, P, is defined as the rate by which amino acids become 
bound in proteins divided by the total concentration of amino acids already bound in 
proteins,
  
0
,,
ee
e met unmet ee
em e tu n m e t
vr r
vr r P
U

  .                                  (A10) 
The average elongation rate of a ribosome is  e v , the concentrations of elongating 
methylated and unmethylated ribosomes are 
e
met r  and 
e
unmet r , respectively, and  0 U  is the 
protein density or concentration of amino acids bound in proteins. 
Regulation of translation 
To give stability to the model and at the same time introduce a global control of 
translation in a bacterial cell, translation shifts between synthesising ribosomes and 
proteins according to the present concentration of amino acids in elongating 
ribosomes, 
e
r U , and proteins,  p U . The ribosome elongation rate is changed 
accordingly. In the model, translation regulation strives to keep  4
e
pr U U   , i.e. to keep 
the ribosomes elongating at maximal rate. When  4
e
pr U U !  holds there is an excess of 18
synthetases and translation factors etc to support translation, only new ribosomes are 
synthesised and the ribosomes are elongating at maximal rate 
max
e v . When  4
e
p r U U 
holds there is an excess of ribosomes and not enough synthetases and factors etc to 
support a maximal translation rate. Then only proteins are synthesised and the 
ribosome elongation rate  e v  is calculated according to 

max
,,
4
ep e
ep r e
r
v
vt
U
UU
U

  .                                         (A11) 
Computer analysis 
All programs, which were used in the simulations, were written in MATLAB 6.1 (The 
MathWorks, Inc., Natick, Massachusettes, U.S.A.). The system of rate equations was 
solved using ode45, one of MATLAB’s built-in functions for solving ordinary 
differential equations numerically. The ode45 solver is based on an explicit Runge-
Kutta formula. In between every time-step, when solving the system of rate equations, 
we used Newton’s method 
41 to solve 
f
met r ,
f
unmet r  and  e v  from eq. A9 and eq. A11. To 
be able to solve the system after the introduction of erythromycin even at high 
erythromycin concentrations, the final intracellular concentration of the macrolide 
was reached after 200 seconds. 
Cell growth 
The volume of cells, V(t), at time t, after the introduction of erythromycin, is 
0
() ( )
0 ()
T
ss ud u tT
Vt V e
PP   ³
  , t > T .                   (A12) 
T is the transformation time, P
ss is the post-transformation growth rate at steady state 
and V0 is the volume of cells when erythromycin was added. The number of cells at 
time t is the value of the exponential function since 
    
1
0 0
ln2 () ( )
2
T T
ss ss ud u tT ud u tT
e
PP PP
 §·
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The exponent,     
1
0
ln2
T
ss ud u t T PP
 §·
   ¨¸
©¹ ³ , is the number of cell generations up till 
time t. To compare cell growth between two bacteria, bacterium A and bacterium B, 
with different growth during transformation and different growth rate at steady state, 
we studied the volume ratio 
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Two outcomes are possible over time. Either bacterium B outgrows bacterium A 
eventually or bacterium A outgrows bacterium B. Eq. A14 shows that the value of the 19
growth rates at steady state, 
ss
A P  and 
ss
B P , decide the outcome. If 
sss s
B A P P ! , bacterium B 
will finally outgrow bacterium A and vice versa in agreement with intuition. Suppose 
bacterium A grows more than bacterium B during the transformation time 
(
00
() ()
AB TT
AB ud u ud u PP ! ³³ ) but bacterium B has the highest growth rate at steady state 
(
sss s
B A P P ! ). Assume further that the transformation time for bacterium B is longer than 
for bacterium A (TB> TA). The time, tcatch up, it takes B to catch up with A is given by 
00
catch up
(( ) ( ) )
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BB AA B A
ss ss
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TT u d uu d u
t
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
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.                    (A15) 
If TB < TA the time it takes bacterium B to catch up with bacterium A may still be 
given by eq. A15 if the numerator is a positive number. Otherwise bacterium B 
outgrows bacterium A already during the transformation phase of bacterium A. In the 
special case when
sss s
A B P P    the ratio in eq. A14 will instead be constant. 20
Table A1. Definitions and values of used parameters. 
Parameter Value  Reference 
e = intracellular concentration of free erythromycin  10
-8-10
-3M
KE = dissociation constant for erythromycin  10
-7 M   29 (modelling done 
before the 
measurements in ref 
30) 
KQ = dissociation constant for a stalled ribosome in the 
leader ORF of the ermC transcript 
10
-8-10
-3M
KQM = normalised kcat/Km-parameter for ErmC  10
-8-10
-4M
-1
K = Km-parameter for initiation of translation by a 
ribsome 
510
-7 M 
max-value          
42, 43 
k = constant for a rate-limiting step during initiation of 
translation 
1 s
-1
Nc = number of codons a ribosome must move before 
another ribosome may initiate translation on the same 
mRNA 
15
N = the average number of amino acids in a protein    200 40 
max
e v = maximal elongation rate of a ribosome  15 codons·s
-1 40
0 U  = concentration of amino acids bound in proteins  2 M  40 
0 r =initial concentration of ribosomes  410
-5 M  40
0
f r =initial concentration of free ribosomes  810
-7 M 
p0 = initial concentration of proteins (all proteins in the 
cell except ribosomal proteins and ErmC) 
810
-3 M  40
[mRNA]ribprot = concentration of ribosomal mRNA  210
-7 M  43
[mRNA]prot = concentration of protein mRNA (all mRNA 
in the cell except ribosomal mRNA and ermC mRNA) 
10
-5 M  43 
[mRNA]met =concentration of ermC mRNA (when 
modelled without ermC mRNA stabilisation)
10
-8 M 
ks= synthesis rate of ermC mRNA (when modelled with 
ermC mRNA stabilisation) 
8.3·10
-11 Ms
-1
kd1 = degradation rate constant of ermC mRNA without a 
stalled ribosome in its 5’ end (when modelled with ermC
mRNA stabilisation) 
8.3·10-3 s
-1 26 
kd2 = degradation rate constant of ermC mRNA with a 
stalled ribosome in its 5’ end (when modelled with ermC
mRNA stabilisation) 
3.7·10-4 s
-1 26 Bi-stable Bacterial Growth Rate in Response to Antibiotics 
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We demonstrate that growth rate bi-stability can be expected for 
bacterial cells growing exponentially at a fixed external antibiotic 
concentration. Bi-stability requires low membrane permeability and 
high growth rate sensitivity to the intracellular drug concentration. 
Rapidly, but not slowly, growing cells will effectively dilute the 
intracellular drug concentration by volume expansion. Therefore, the 
former may continue to grow rapidly and the latter to grow slowly at 
the same external drug concentration. Our findings have implications 
for the testing of novel antibiotics on growing bacterial strains.     2
Bacterial infection is a major cause of human suffering and death. Therefore, design 
of new antibiotics and development of more efficient ways to deliver already 
existing antibiotics are mandatory. Antibiotics with low membrane permeability for 
gram-negative bacteria have been regarded as clinically less interesting, although 
they often are very efficient when they have reached their intracellular targets. The 
current letter addresses this class of antibiotics and how its members could become 
clinically more useful by taking into account some striking relations between 
bacterial growth and intracellular drug concentration. We develop a general 
dynamic model for the intracellular concentration of these antibiotics and show that 
the bacterial growth rate will be bi-stable in response to the antibiotic if the 
membrane permeability is sufficiently small and the intracellular response to the 
antibiotic is sufficiently sensitive. Accordingly, these bacteria will respond 
differently to the same antibiotic concentration depending on the state of growth 
when the drug is administered. Practical consequences for the use of antibiotics and 
a novel interpretation of the concept of Minimal Inhibitory Concentration (MIC) are 
suggested. 
In general, the total concentration, a, of an antibiotic in a bacterial cell 
depends on its net-flow over the membrane, Jmem, and its dilution by cell volume 
growth, Jgr . When the drug transport in to and out from the cell is passive, we 
model the time evolution of a by the ordinary differential equation 
 N    
 	 

gr
mem
ex fr
J J
da
ca a μ a
dt
.   (1) 
The inflow is proportional to the external antibiotic concentration aex and the 
outflow is proportional to the free intracellular concentration of the antibiotic, afr.
The constant of proportionality is defined as the membrane permeability, c. Both the 
free antibiotic concentration afr and the growth rate μ will depend on the total 
intracellular drug concentration a, i.e. afr = afr(a) and μ=μ(a). A mathematically 
equivalent expression can be obtained when there is active transport by an 
unsaturated efflux pump system 
1, 2, leading to different permeability for the in-flow 
and the out-flow:   
1
12 2 1 2 mem ex fr ex fr Jc a c a c c c a a
     . Here, c2 replaces  c and 
1
12
 cc  is a scale factor for the external concentration aex in Eq. 1. 
We will show that biologically motivated constraints on the functions afr(a)
and μ(a) in Eq. 1 in conjunction with a sufficiently small permeability c lead to bi-
stability for a range of external antibiotic concentrations aex.    
We will first make the natural assumption that the real valued and 
continuous function afr=afr(a) is smaller than the total intracellular concentration a,
i.e. fr aa d , and that both the free and the target bound intracellular drug 
concentrations increase with increasing a, so that  /' 1 fr fr da da a  d . We further 
assume that afr is concave in a ( 0 fr acc t ), since  'fr a is expected to increase as the 
target binding sites become saturated. When a of, all binding sites are occupied 
so that  fr aa o  and, therefore,  1 fr ac o . Some functions, afr(a), that fulfill the 3
criteria for bi-stability are illustrated in Fig 1A and the corresponding convex 
membrane flow functions    () ()    mem ex fr Ja c aa a in Fig. 1B.  (0) mem ex Jc a   , the 
slope of  () mem Ja  is determined by 'fr ca   and  () mem Ja  is zero when  () fre x aa a   .
The exponential growth rate μ=μ(a) is assumed to be a continuous, finite, 
positive function that decreases monotonically with increasing a, such that the 
dilution flow gr Ja P   <fand  '0 gr J    in the limit a of. We will, finally, assume 
that  () 0 gr dJ d a   in some interval of a, implying that here  'gr J decreases more 
rapidly than 1/a with increasing a. If, to give an example, the growth rate can be 
modeled by a Hill function, then     1 1/
h
gr H Jaa k a K P     , and the 
requirement is that h>1, meaning that in this special case aμ  =0 in the limit 
a of. Together, these constraints imply that Jgr=0 when a=0, Jgr is positive for all 
values of a, and that Jgr reaches a finite asymptote for large values of a. This 
asymptote may or may not be equal to zero but must be smaller than the maximal 
value of  gr J  (Fig 1D). 
Figure 1. Graphical illustration of the constraints on afr(a) and μ(a). A. Examples of how the free 
intracellular antibiotic concentration, afr, may depend on the intracellular antibiotic concentration, a.
B. Examples of how the flow over the membrane, Jmem, may change with a. C. Examples of  how the 
growth rate may depend on a. D. Examples of dilution flows, Jgr, compatible with bi-stability. E. 
Examples of how intersections between Jgr and Jmem give rise to two stable (filled discs) and one 
unstable (unfilled disc) steady state(s). F. Graphical demonstration of why multiple steady states 
always emerge when the convex Jmem –curve intersects the inflexion point of the Jgr-curve, which is 
concave to the right of its maximum.4
It is now straight forward to show that when these constraints on afr(a) and μ(a) are 
fulfilled and the permeability c is sufficiently  small, there will always be values of 
the external antibiotic concentration  ex a for which there exist at least two stable 
steady state solutions of Eq. (1). To demonstrate this graphically, we first note that 
for an attracting (stable) steady state, where  * aa    is a solution to the 
equation () () 
  
 mem gr Ja J a , the inequality  () -  ()0 cc 

  mem gr JaJ a  is fulfilled 
3.
This corresponds to intersections between the Jmem–curve (dotted) and the Jgr-curve 
(solid) in Fig 1E, where Jmem is larger than Jgr just to the left and smaller than Jgr just 
to the right of either steady state point. Under the conditions stated above,  gr J will 
always have an inflection point ( '' 0 gr J   ) to the right of its maximum, since  'gr J =0 
also in the limit a of. Furthermore, by adjusting the external drug concentration 
ex a it will always be possible to create an intersection of the  gr J and  mem J curves at 
the inflection point of  gr J , which corresponds to an unstable steady state. By 
reducing the permeability parameter c it will, finally, always be possible to create 
additional intersections of the gr J and mem J curves to the left of the maximum and to 
the right of the inflection point of gr J , both of which fulfill the criteria of a stable 
steady state (Fig. 1F). Accordingly, the emergence of bi-stability depends critically 
on the membrane permeability c.
To further illustrate the importance of the permeability parameter c, we will 
derive and expression for the highest value of c that is compatible with bi-stability 
for a simple and yet realistic model system, in which the antibiotic drug inhibits 
ribosome function and thereby reduces the growth rateP .  It can be noted that there 
is a plethora of clinically useful antibiotics with the ribosome as their target 
4, 5.  In 
this model, there is a fixed total concentration, r, of ribosomes in the cell, each of 
which has a single binding site for the drug with the equilibrium dissociation 
constant d K , irrespective of the state of the ribosome. We assume rapid intracellular 
equilibration of drug-bound and drug-free ribosomes with concentrations  fr aa 
and   fr ra a  , respectively. The functional relation afr(a), introduced in Eq. (1), 
between free and total intracellular concentration of the drug is then given by 
     
2 1
() 4
2
             fr fr d fr fr d d d ar a a Ka a aa aK r a K K ra . (2) 
On the assumption that the total rate of protein synthesis and the growth rate P  are 
proportional to the concentration of drug-free ribosomes, the functional dependence 
() a P P    introduced in Eq. (1) is given by 
6, 7
            
0
()
() .
mf r vr aaa
a P
U

       (3) 5
For  E. coli cells growing in a rich medium, 
1 20 m vs
 | , r=10 μM and the 
concentration  0 U  of amino acids in peptide chains  2M |
8. As long as  d K r  ,   
() gr Ja μ a    fulfills the above stated criteria for potential bi-stability. The Jmem and
Jgr curves that result from this model with c=0.0001s
-1, aex=2μM and Kd=10nM
demonstrate the existence of bi-stable growth rate (Fig. 2A).   
Figure 2 A. The figure shows the flow in through the membrane,  Jmem  (dashed) and the dilution 
flow,  Jgr (solid) for different intracellular concentration of antibiotic, a. The intersections indicate 
the stationary states. B. The stationary states are plotted for three different permeability values, c.
Solid lines correspond to stable and dashed lines to unstable states. The stationary states for  aex=
2μM on the  c=0.0001s
-1 curve correspond to the situation in Fig. 2A. Other parameters are     
r=10μM, Kd=10nM, vm=20 s
-1
How the region of bi-stability depends on the c and aex parameters is illustrated in 
Fig. (2B). Here, the total intracellular drug concentration a is plotted as a function of 
the external drug concentration aex for three different values of the permeability c.
For the highest c-value (0.005s
-1) there is only one stable state, but for the other two 
c-values (0.001 and 0.0001 s
-1) there are two. When the permeability c decreases 
below a critical value c*, there is a saddle node bifurcation in which the single 
stable steady state splits into two stable and one unstable steady states. This means 
that bi-stability exists when c<c*, while there is only a single steady state when 
c>c*.  The critical value c* is given by the expression 
 ^`
3 2
00
*.
27 27
d mm
d
dd
rK vv r
cK r
rK K UU

 |   |      (4) 
The critical c* value in Eq. (4) was derived by analyzing the solutions to the 
equation  () -  () 0 cc   mem gr Ja J a  for varying c-values. For small c-values there are two 
real and positive roots for a, which indicates bi-stability for some aex-values. For 
large c-values, in contrast, there are only complex valued roots for a, suggesting 
lack of bi-stability for all aex-values. The c-value at which the solutions switch from two 6
real, positive to complex valued a-roots is c*. For the parameter values in Fig. 2, 
1 *0 . 0 3 7 cs
 | .
The bi-stability leads to hysteresis in the growth rate, as demonstrated for
c=0.0001s
-1 in Fig. 3A. The two solid curves illustrate the steady state growth rates 
as functions of the external drug concentration for bacterial populations initially 
started out with small (upper curve) or large (lower curve) intracellular drug 
concentration. It is seen how these different initial conditions lead to two different 
growth rates in the bi-stable region of aex (0.6μM -3μM). The dashed curve 
illustrates the unstable steady solution. The arrows show the direction in which the 
growth rate changes if the system is initialized in different regions of the (aex,μ)-
space. 
It may take very long times to establish steady state growth in new media 
with different external drug concentrations, in particular for cells initially containing 
a large intracellular drug concentration (Fig. 3B, dashed lines). For bacteria, initially 
growing very slowly in a medium with 10 μM drug concentration, it takes about 
fifty hours to attain the fast steady state growth to the left of the bi-stable aex region. 
For bacteria, initially growing rapidly in a medium with 0.1 μM drug concentration, 
it also takes quite a long time to attain the slow growth to the right of the bi-stable 
region (solid lines). These long times to establish steady state rates of growth for 
bacteria with different initial intracellular drug concentrations give rise to an 
experimental problem. That is, to experimentally identify growth bi-stability and 
hysteresis, it is essential to allow the growth rates to come near their steady values 
as the cell populations are shifted from environments with large or small to an 
intermediate current drug concentration as in Fig. 3B. Since, however, the steady 
state relaxation times are so long, pleiotropic drug-effects related to mutations or 
other effects secondary to their primary inhibition of the target obscure the analysis 
of the long time (>8h) growth properties in a fixed external antibiotic concentration 
(L. Kosenkranius and T. Tenson, unpublished observations).  
In conclusion, we have shown how the presence of antibiotics that diffuse slowly 
over the bacterial cell wall may lead to bi-stability in intracellular drug 
concentration and bacterial growth rate. We have also shown hysteresis effects, in 
that bacteria subjected to increasing external drug concentrations will display larger 
growth rates in the bi-stable region than bacteria subjected to decreasing external 
drug concentrations. We have outlined the general criteria for when drug-dependent 
growth bi-stability can arise. We have, in particular, shown that there must be an 
interval of the intracellular drug concentration a in which the growth rate is reduced 
more strongly than 1/a.  We have also emphasized the importance of low cell wall 
permeability for bi-stability to emerge. In addition, we used a simple model system, 
where the drug binds to ribosomes and inhibits protein synthesis, to derive the 
critical membrane permeability value below, which bi-stability exists for a range of 
external drug concentrations. 
Non-genetic biochemical memory effects have previously been described for 
gene-regulatory and signaling circuits with multiple steady states 
9-16. However, the 
possibility of memory effects directly mediated by the rate of growth has, to our 
knowledge, not been recognized before.7
    
Figure 3 A. The steady state growth rate is plotted as a function of the external antibiotic 
concentration. The solid lines indicate stable and the dashed line indicates unstable steady states.  
The arrows indicate the direction of growth rate change in different regions for a fixed external 
concentration of antibiotic. B. This panel illustrates the times to establish steady state growth for 
bacteria exposed to different external drug concentrations and starting out with small (solid lines) or 
a large (dashed lines) internal drug concentrations.  Parameters:  r=10μM, Kd=10nM, c=0.0001s
-1,
vm=20 s
-1
  The starting condition for the growth of a bacterial culture may have 
profound effects on the growth rate, seen also in the transient phase before steady 
state has been established (Fig. 3). The Minimal Inhibitory Concentration (MIC) 
value is commonly used to characterize how susceptible a bacterial strain is to an 
antibiotic 
17. The present finding that responses of bacterial populations to antibiotic 
drugs may be growth history dependent, could explain why, in some cases, MIC-
estimates are hyper-sensitive to experimental conditions
18. When low-permeability 
drugs are tested, our theory reveals that conditions under which a bacterial growth 
culture has not reached a large growth rate when the drug is added may result in a 
low MIC value compared to the MIC value obtained for the very same culture when 
exposed under maximal growth rate conditions.  Normally, MIC values are obtained 
for cultures growing in rich media with large growth rates, while the growth rates 
during clinical infections often are very small, suggesting that MIC values should be 
estimated for bacteria growing in poor, rather than in rich, media. This is 
particularly relevant for the testing of new antibacterial compounds, which may be 
discarded as ineffective from rich medium data although they may turn out to be 
clinically useful.    
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